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Abstract
On the background of severe clinical conditions as diabetes type I, it is essential to un-
derstand pancreas development, in particular endocrine cell differentiation. Pancreas 
development is under control of signalling pathways and a complex transcription factor 
network. It was previously reported that in      Xenopus laevis retinoic acid (RA)- signalling 
was required for dorsal pancreas development and endocrine cell differentiation as early as 
during gastrulation. It was also shown, that a combined expression of the two transcription    
factors Pdx1/ XlHbox8 and Ptf1a/Xp48 in the endoderm is sufficient to induce pancreatic           
cell fate. However, it remained unknown how these early RA induced prepatterning events 
contribute to later organ formation that is marked by the onset of Pdx1/XlHbox8 and Pt-
f1a/p48 expression in the gut epithelium.    
This study focused on the identification of regulatory factors that link early RA- signalling 
with the onset of pancreas formation in Xenopus laevis. In this context, the two transcrip-
tion factors HNF1β/TCF2 and HNF6/ onecut-1 were identified as positive upstream regu-
lators for Pdx1/XlHbox8 and Ptf1a/Xp48. HNF1β was shown to be necessary but not suf-
ficient for pancreas specification and outgrowth. Whereby, in contrast to HNF1β deficient 
mice, knockdown of HNF1β in Xenopus laevis did not lead to complete pancreas agenesis. 
HNF1β was also shown to be responsive to RA- signalling within the early endoderm, and 
that it was able to promote endocrine cell differentiation. HNF6 was newly isolated, its spa-
tial and temporal expression was confind to the anterior endoderm, and gain of function 
studies revealed a pancreas promoting activity. 
A second aspect in this study concerned the identification of new pancreas specific marker 
genes that could serve as useful tools for the descriptive analysis of organogensis. The puta-
tive pancreatic marker gene malectin revealed an ubiquitous expression in Xenopus laevis 
and an intracellular ER residence. In collaboration, it was shown that malectin was a car-
bohydrate binding protein playing a putative role in the N- glycosylation pathway, imply-
ing a general function in Xenopus laevis development.

11  Introduction
The importance of the pancreas is evident from the number of clinical conditions resulting 
from the malfunction of this organ, notably diabetes mellitus. Diabetes is characterised 
by abnormal high blood glucose levels that are caused by absence of pancreatic β-cells, 
their impaired insulin secretion or reduced insulin responsiveness of the metabolic system. 
According to the time point of clinical manifestation and insulin requirement, diabetes 
is classified into two major forms: an early insulin- dependent diabetes type I and a later 
non-insulin dependent diabetes type II. The most frequent form of diabetes type I is an 
autoimmune disease leading to neonatal self-destruction of β-cells. A second variant of 
β-cell disorder is the maturity onset diabetes of the young (MOD�). This milder form of 
diabetes is based on genetic mutations that lead to disrupted β-cell formation or impaired 
insulin production (summarized in table 1, reviewed in Fajans et al., 2001). 
Over several years, basic research has gathered information on factors, which are crucial 
to activate the genetic program for β-cell generation during normal pancreas development. 
Type affected gene function reference
MOD�1 HNF4α (TCF14) TF regulating HNF1α and HNF1β as well 
as gene expression for glucose metabolism
Frayling et al., 2001; 
�agamata et al., 1996
MOD�2 Glucokinase blood glucose sensor Hattersley et al., 1992
MOD�3 HNF1α (TCF1) TF regulating insulin expression Frayling et al., 2001
MOD�4 Ipf1 (Pdx1, XlHbox8) TF regulating pancreas development and 
gene expression of glucose metabolism
Stoffers et al., 1997
MOD�5 HNF1β (TCF2, LFB3) TF regulating pancreas development and 
gene expression for glucose metabolism
Horikawa et al., 1997; 
Haumatire et al., 2005
MOD�6 Neurogenic differenti-
ation 1 (NeuroD1)
TF promoting exocrine versus endocrine 
cell differentiation
Copeman et al., 1995
MOD�7 Krüppel-like factor 11 
(KLF-11)
TF promoting endocrine gene expression 
versus exocrine differentiation
Neve et al., 2005
MOD�8 Bile salt dependent 
lipase (CEL)
enzyme involved in lipid metabolism and 
linked by observational studies to diabetes
Raeder et al., 2006
Table 1: Genetic mutations that are linked to MODY-type of diabetes. The table lists all types of �iabeti�� 
�isor�ers known for human maturity onset �iabetes of the youn�� ������. �enes relate� to the �isor�er            
an� their fun��tion are state� as well as their literature referen��e. TF= trans��ription fa��tor; names in bra-
��kets state synonymes.
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Due to the identification of essential regulating factors, as transcriptional regulators and 
signalling molecules, human embryonic stem cells could be fated under optimized condi-
tions towards a mature insulin producing β-cell in vitro (D A´mour et al., 2006). Recently a 
breakthrough in diabetes research was achieved by in vitro generation of pancreatic endo-
derm that was transplanted into mice and that subsequently generated endocrine cells that 
were responsive to high blood glucose levels in vivo (Kroon et al., 2008). 
Many of these factors, that direct endocrine cell fate are not only essential to determine 
and maintain identity of a mature pancreatic cell, but they also play decisive roles during 
the three key events of pancreas development, namely endoderm specification, gut tube 
formation and patterning as well as pancreas organogenesis (reviewed in Oliver-Krasinski 
and Stoffers, 2008).
Most studies that focus on revealing the developmental aspects during pancreas organoge-
nesis made use of vertebrate model systems as mouse (Mus musculus) and zebrafish (Danio 
rerio). In this study, the amphibian model system       Xenopus laevis was used to reveal in 
detail the regulatory mechanisms that direct pancreas development. 
1.1 From endoderm specification to pancreas organogenesis in Xenopus laevis
1.1.1 Endoderm specification
The early Xenopus laevis embryo is divided into three regions: the animal pole, the mar-
ginal zone and the vegetal pole (figure 1.1). Upon dynamic cell movements during gas-
trulation, these distinguished regions give rise to the three germ layers, namely the ecto-, 
meso- and endoderm respectively. The ectoderm differentiates into the epidermis and the 
nervous system, the mesoderm develops into muscle, vascular system, kidney and connec-
tive tissue, while the endoderm forms the digestive tract, including liver and pancreas, as 
well as the respiratory organ. 
Establishment of the endodermal fate depends on maternal factors in the vegetal hemis-
phere as the T-box transcription factor VegT (Zhang et al.,        1998; �asuo and Lemaire, 1999). 
Veg-T induces zygotic expression of downstream targets as the nodal-relates genes (Xnr;          
Jones et al., 1995), the homeobox factor Mixer and mix-like protein (Henry and Melton,   
1998), which in turn induce expression of pro-endodermal transcription factors as Xsox17,            
FoxA1 and 2 (HNF3α, HNF3β) and GATA 4- 6 as well as synthesis of vegetal mesoderm           
antagonists like Cerberus (Xanthos et al., 2001). Maintenance of Gata 4-6 and Xsox17 ex-
pression is mediated by TGFβ (nodal) signalling. Their persistent expression is required to 
activate expression of genes that promote general endoderm and genes that coordinate axis 
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specification (Afouda et al., 2005). Dorso- ventral axis specification is already established       
after fertilisation by stabilisation of the transcriptional regulator β-catenin in the prospec-
tive dorsal half of the embryo, where it overlaps the VegT containing region, specifying the 
Nieuwkoop center. Studies using the animal cap system in Xenopus laevis demonstrated 
that combined overexpression of VegT and β-catenin changed the prospective ectodermal 
fate of isolated animal pole cells into dorso- endodermal fate. The dorsal endoderm in-
ducing activity of VegT/β-catenin was shown by their capacity to induce gene expression 
of pancreas specific genes as Pdx1/XlHbox8, insulin and XPDIp (Chen et al., 2004). Spe- 
cification of dorsal-ventral and anterior-posterior axis is crucial for subsequent gut tube 
formation and patterning. 
1.1.2 Gut tube formation and patterning
Anterior-posterior axis specification in respect to the gut tube occurs between stage 12 
and 20. Transplantation experiments revealed that dorsal vegetal cells give rise to the an-
terior gut endoderm and the ventral vegetal cells to the posterior gut endoderm (Gamer 
and Wright, 1995; Henry et al., 1996). Establishment of the A-P axis is also reflected by the 
asymmetric gene expression within the dorsal involuting endoderm of the hematopoieti-
cally expressed homeobox transcription factor (Hex), the secreted factor Cerberus (Bou-
wmeester et al., 1996) and the pancreatic progenitor gene XlHbox8 (Wright et al., 1989). 
Fate mapping determined that Hex, Cerberus and XlHbox8 expressing cells translocate to 
the anterior region of the embryo and will give rise to the organs of the anterior foregut,      
Figure 1.1 Endoderm formation and gut tube patterning. Before sta��e 10, the embryo is sub�ivi�e� into 
three re��ions: animal pole, mar��inal zone an� ve��etal pole, the later en�o�ermal ��ermlayer �yellow�. At 
the onset of ��astrulation the �orsal blastopore lip spe��ifies �orso-ventral axis ��, V� evi�ent in asymmetri�� 
��ene expression, e.��. Hex ���reen�. At sta��e 1�� the three ��erm layers e��to- meso- an� en�o�erm are sepa-             
rate� an� the anterio-posteror axis �A, P� is �etermine�. The en�o�erm forms the primitive ��ut tube that 
a��tivates or��an spe��ifi�� ��ene expression �sta��e ���� in �istin��t re��ions like P�x1�� �lHbox� �re�� an� Ptf1a��          
�p4� �bla��k lines�, both markin�� the prospe��tive pan��reati�� epithelium. �urin�� subsequent �evelopment 
the primtive ��ut tube ��ives rise to the lun�� an� the ��astroinstentinal tra��t at sta��e 41 �mo�ifie� after �orn:   
http:����www.��in��innati��hil�rens.or����resear��h���iv���ev-biolo��y��fa��-labs��zorn-lab��liver-�ev.htm�
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including liver and pancreas, whereas ventral involuting endoderm was fated to become         
posterior gut tissue (Chalmers and Slack, 2000). Apart from Wnt-signalling it was shown 
that BMP signalling was repressed in order to determine dorsal endoderm tissue (Sasai et 
al., 1996). 
The primitive gut tube is patterned along the anterior- posterior (A- P) and dorsal- ventral 
(D- V) axis into subregions that form different organs. Tissue identity within the gut tube  
relies on mesoderm- endoderm interactions that promote region restricted expression of    
genes via intrinsic and extrinsic factors. Region specific gene expression establishes organ      
boundaries that are required to coordinate anterior-posterior, dorsal-ventral and left-right     
position of the organ in the primitive gut (Horb and Slack, 2001). In context of pancreas     
organogenesis, research focused predominatly on the gene expression profile of the ante-
rior gut epithelium. 
1.1.3 Pancreas organogenesis
In Xenopus laevis, the pancreas develops from the anterior foregut epithelium as one dor-
sal anlage and two ventral anlagen at stage 35 and 37, respectively. The pancreatic buds, 
positioned posterior to the liver diverticulum, grow and branch from the foregut into the 
mesenchyme. At stage 40, the pancreatic lobes fuse to one discrete organ that is positioned 
to the right side of the embryos due to gut rotation movements, behind the stomach and 
duodenum (Figure 1.2; Pieler and Chen, 2006). 
Based on studies in mouse, many transcription factors have been identified that are re-
quired for the specification of pancreatic cell fate in the primitive gut, among them the 
pancreatic and duodenum transcription factor 1 (Pdx1; also called XlHbox8 in Xenopus 
laevis; Jonsson et al., 1994) and pancreatic transcription factor 1a (Ptf1a; also called Xp48; 
Kawaguchi et al., 2002). These two transcription factors mark a subset of multipotent pro-          
genitor cells that give rise to all cell lineages of the mature organ (Gu et al., 2002).
Also in Xenopus laevis, XlHbox8 (Wright et al., 1989) and Xp48 (Afelik et al., 2006) are 
the first genes that exclusively mark multipotent pancreatic progenitor cells in the anterior         
foregut, the pre-pancreatic endoderm, and it was reported that they play crucial roles for              
pancreas specification and differentiation of cell lineages of the mature organ (Afelik et al, 
2006; Jarikji et al., 2007).
The mature pancreas contains two functional units: the exocrine and the endocrine com-
partment. The exocrine pancreas represents the majority of the tissue and comprises acinar 
and duct cells. During food uptake, acinar cells secrete digestive enzymes that are collected 
in the pancreatic duct system and that are further educed into the intestine. To prevent self-
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digestion of the organ, duct cells secrete bicarbonate, sodium chloride and water to buffer 
the pancreatic fluid. The earliest exocrine differentiation marker in Xenopus is the pancreas 
specific protein disulfide isomerase (XPDIp). It is expressed from stage 39 onwards in the 
Figure 1.2 Pancreas development in Xenopus laevis. (A) At sta��e 39 two ventral an� one �orsal pan��reati�� 
anla��en are marke� by exo��rine �P�Ip, also seen in the transversal se��tion �1�. At sta��e 40 �3� the ventral 
pan��reati�� anla��e ��ome in ��lose proximity to the �orsal bu� �ue to ��ut rotation movements an� fuse to        
one or��an (4, re� arrow in�i��ates the fusin�� re��ion�. After fusion, the pan��reas is positione� to the left 
si�e of the embryo un�erneith the stoma��h an� �uo�enum re��ion. �evelopmental sta��es are in�i��tae� 
to the left. White lines represent the position of transversal se��tions. (B) Temporal expression profile of 
pan��reati�� ��enes in �enopus embryos. P�x1���lHbox� an� Ptf1a��p4� are expresse� early �sta��e ��9��30�, an� 
this early expression ��an serve in the i�entifi��ation of the pan��reati�� pre��ursor ��ells �Afelik et al., ��006�. �u-
rin�� late �evelopment, P�x1���lHbox� expression is restri��te� to β-��ells, whereas Ptf1a��p4� expression is 
��onfine� to exo��rine ��ells. Insulin is expresse� sli��htly later at sta��e 3�� an� is initiallly observe� only in the 
�orsal pan��reati�� bu�. In ��ontrast ��lu��a��on expression in the pan��reas is quite late �sta��e 46��47; Kelly an� 
�elton, ��000; Horb an� Sla��k, ��00��; Afelik et al., ��004�. As for exo��rine markers, �P�Ip is expresse� earlier 
�sta��e 39� than trypsino��en �sta��e 41��4��; Afelik et al., ��004�. Abbreviations: vp: ventral pan��reas, �p: �orsal 
pan��reas, st: stoma��h, �u: �uo�enum. �Pieler an� Chen, ��006�
A
B
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dorsal and ventral pancreatic anlage whereas digestive enzymes as amylase, trypsinogen 
and elastase are initiated after bud fusion at stage 41- 42 and carboxypeptidase at stage 44 
(Figure 1.2; Pieler and Chen, 2006; Horb and Slack, 2002). 
The endocrine compartment is composed of five cell types that are clustered as islets of 
Langerhans within the exocrine tissue. Specific peptide hormones involved in glucose 
homeostasis and metabolism are produced in these cell types, namely glucagon by α-cells, 
insulin and amylin by β-cells, somatostatin by δ-cells, pancreatic polypeptide by PP-cells 
and the appetite stimulating hormone ghrelin by ε- cells (reviewed in Blitz et al., 2006; 
Murtaugh, 2007). 
As observed in mouse, differentiation of endocrine cells occurs in two distinct waves, re-
ferred as primary and secondary transition. During primary transition between E9.5 and 
E13.0 early endocrine cells expressing glucagon and insulin appear in the Pdx1- positive 
epithelium. Lineage tracing experiments revealed that these early endocrine cells do not 
originate from Pdx1- positive progenitor cells and that they do not contribute to the endo-
crine cell mass of the mature islet (Burlison et al., 2008). 
Endocrine cells of the mature islets rather differentiate from a common progenitor pool 
of the branching Pdx1- positive epithelium at E13.5 and E16 during secondary transition. 
Appearance of Ngn3 that is expressed in all endocrine progenitor cells marks the onset of 
the secondary transition which is characterised by a vast increase in cell proliferation and 
subsequent differentiation of all endocrine as well as exocrine cell types (Gradwohl et al., 
2000). 
In Xenopus laevis, the first endocrine gene insulin is expressed from stage 32 onwards 
exclusively in the dorsal gut epithelium. These insulin positive cells move anteriorly along 
with the XlHbox8 positive pancreatic anlage and accumulate in the forming dorsal pancre-
as (Kelly and Melton, 2000). Studies showed that these insulin positive cells appear to dif-             
ferentiate within the dorsal pancreatic region independently from the XlHbox8- p48 posi-
tive progenitor cell pool and it was suggested that they correspond to cells of the primary 
transition in mouse (Afelik et al., 2006). A later endocrine differentiation phase is initiated           
at stage 46 when glucagon, somatostatin and PP positive cells appear scattered in the exo-   
crine tissue. During subsequent development, all endocrine cells cluster to form islet- like 
structures at stage 50 (Afelik et al., 2004; Kelly and Melton, 2000). However, in contrast to        
the mouse system, it remains unclear when and how this later phase of endocrine differ-
entiation is initiated in Xenopus laevis. So far, there is no gene known in this system that 
specifies a common endocrine progenitor pool, thereby rising the interest to investigate 
transcriptional regulation in context of endocrine cell differentiation in Xenopus laevis. 
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The pancreas arises as ventral and dorsal anlage that fuse during development to one ma-
ture organ. The ventral gut epithelium gives not only rise to the pancreatic rudiment but 
also to the adjacent liver. It was shown that both organs derive from a common bipotential 
progenitor pool (Deutsch et al., 2001). On one side, the genetic program must be similar in 
both pancreatic anlagen to generate a common tissue, but at the same time it must differ to 
specify the two organ anlagen from its neighbouring tissue, that differs between the ventral 
and dorsal gut epithelium. Specification of ventral and dorsal pancreas from a different 
location and varying surrounding tissues requires a divergent set of genetic regulators in 
the ventral versus dorsal gut epithelium (reviewed in Zaret, 2008).
1.2 Molecular mechanism regulating pancreas de�elopment
1.2.1 Signalling pathways in�ol�ed in pancreas de�elopment
Various extrinsic signals from the surrounding mesoderm are required for region- specific 
gene expression in the epithelium that coordinates organogenesis along the anteroposte-
rior and dorsoventral axis of the gastro-intestinal tract, emphasizing the importance of 
mesenchymal- endodermal cross-talk for gut tube patterning (Oliver-Krasinski and Stof-
fers 2008; Pieler and Chen, 2006). Extrinsic signals include members of the secreted fac-
tors of the Wnt-, TGFβ-, hedgehog (HH)-, Notch-, FGF- and retinoic acid (RA)- signalling 
pathways. These signalling pathways maintain either a negative or a positive regulatory 
function on pancreas specification and determination of cell lineage. In this context, it 
was shown that canonical Wnt- signalling was required for exocrine cell differentiation 
in the mouse (Murtaugh et al., 2005). A recent study demonstrated that early endodermal 
Wnt- signalling must be inhibited during gastrulation, to maintain foregut identity and to 
promote liver and pancreas development in Xenopus laevis (McLin et al., 2007). These find-
ings define a strict time window of signalling action for endoderm patterning. 
The segregation of neighbouring tissues as liver and ventral pancreas, shown to derived 
from a common progenitor pool, requires distinct molecular mechanism to determine ei-
ther hepatic or pancreatic cell fate in the ventroanterior gut tube. Ventroanterior endoder-
mal progenitor cells would normally adopt pancreatic fate. The exposure of these ventro-
anterior cells to secreted molecules of the TGFβ superfamily, namely BMP and FGF, they 
adopt hepatic cell fate. BMP and FGF are secreted from the adjacent cardiac mesoderm 
and septum transversum (Deutsch et al., 2001). Apart from Wnt- signalling, hedgehog 
signalling is also repressed in restricted territories in order to render the epithelium com-
petent for pancreatic cell fate aquisition. From studies in chicken, it was postulated that 
FGF2, secreted from the notochord, represses sonic hedgehog (SHH) the gut epithelium 
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and consequently activates Pdx1 expression and permits pancreas organogenesis (Hebrok 
et al., 1998). Expansion of SHH can be induced in the pancreatic region upon inhibition of 
the RA-signalling pathway which is associated with a reduced Pdx1/ XlHbox8 and insulin 
expression (Chen et al., 2004).
1.2.1.1 Signalling pathways in�ol�ed in endocrine cell differentiation
Specification of the endocrine cell lineage depends on permissive signals from the sour-
rounding tissues as the vascular epithelium (Lammert et al., 2001; Nicolova et al., 2006) 
or the neural crest cells (Nekrep et al., 2008). However, the best analysed molecular mech-
anism regulating the segregation of the exocrine and the endocrine cell lineage is the 
Notch- signalling pathway. 
This cell-cell signalling pathway is activated by binding of Notch- ligands, the transmem-
brane proteins delta and serrate, to the Notch receptor of the neighbouring cell. Upon 
ligand binding, the intracellular domain of the Notch receptor, Notch- ICD, translocates 
into the nucleus, where it recruits the DNA-binding protein RBP-Jκ (recombining binding 
protein suppressor of hairless) and activates gene expression of the Hairy and Enhancer 
of Split (HES) gene family. Hes1 has been shown to repress expression of the pro- endo-
crine gene Ngn3 in the same cell, thereby promoting its exocrine fate (Jensen et al., 2000). 
This negative regulation of gene expression between neighbouring cells is therefore called 
lateral inhibition. Lack of Ngn3 resulted in absence of all endocrine cell types within the 
pancreatic islets (Gradwohl et al., 2000).
Overactivation of Notch- signalling maintained pancreatic progenitor cells in a prolifer-
ating state, resulting in delayed cell differentiation. Consequently, impaired maturation 
of endocrine and exocrine tissue was evident in a hypoplastic pancreas (Murtaugh et al., 
2003). In contrast, inhibition of Notch- signalling or overexpression of Ngn3 leads to pre-
mature differentiation of endocrine cells and to defects in pancreatic outgrowth (Apelqvist 
et al., 1999; Kim et al., 1997; Schwitzgebel, 2000). Hes1 also was reported to directly repress 
Ptf1/p48 expression and therefore inhibiting exocrine differentiation in mouse (Ghosh 
and Leach, 2006). Together these data underline the bifunctional role of Notch- signalling 
during early proliferation and on later differentiation of the pancreas. Another signalling 
factor that has been associated with pancreatic cell lineage commitment of the endocrine 
compartment is retinoic acid (RA). 
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Figure 1.3 Metabolic pathway and mechanism of retinoic acid (RA)- signalling. (A) Cellular retinol bin�-
in�� protein �CRBP� bin�s retinol, whi��h is oxi�ise� to retinal by retinal�ehy�e �ehy�ro��enase �A�H� or 
short-��hain �ehy�ro��enase��re�u��tase �R�H��S�R�. Retinal is oxi�ise� to retinoi�� a��i� by retinal�ehy�e �e-
hy�ro��enase �� �Ral�h���, whi��h is boun� by ��ellular retinoi�� a��i� bin�in�� protein �CRABP�. Retinoi�� a��i� is 
�e��ra�e� by the enzyme C�P��6. (B) In the absen��e of RA, the retinoi�� re��eptors RAR an� R�R are boun� 
as hetero�imer to their �NA tar��et sequen��e an� re��ruits a ��orepressor ��omplex that inhibits trans��rip-
tion of tar��et ��enes �A, B, C� throu��h histone �ea��etylation. Bin�in�� of li��an� �RA� in�u��es ��onformational 
��han��es an� bin�in�� of ��o-a��tivator lea�in�� to histone a��etylation an� a��tivation of trans��ription �mo�i-
fie� after �arlétaz et al., ��006�.
1.2.1.2 Retinoic acid signalling
Retinoic acid (RA) a is a small lipophilic molecule that derives from vitamine A (retinol) 
that is uptaken by dietry and maintained in the blood system bound to retinoic binding 
proteins (Noy, 2000). After passive diffusion into the cell, retinol binds to the retinal bind-
ing protein (CRPB) and is oxidised to retinal by retinal dehydrogenases (RDH). Retinal is 
subsequently metabolised by the enzyme Raldh2 in a rate limiting step to RA (figure 1.3). 
Binding to CRAB promotes translocation of RA into the nucleus where it is transferred to 
its nuclear receptor RAR and the retinoic X receptors RXR that are both members of the 
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Cx- type zinc finger family. RAR and RXR are composed of α, β and γ isoforms, which 
homo- or heterodimerise to form DNA binding complexes (reviewed in Maden, 2001). 
DNA binding is restricted to conserved sequences referred to as retinoic acid responsive 
elements (RAREs). Further cofactors are recruited to the RA- receptor complex to achieve 
transcriptional induction or repression. After activating its nuclear receptors, RA returns 
to the cytoplasm binds to the retinol binding protein 1 (RBP1) that targets RA for its me-
tabolizing enzyme C�P26. This P450- class enzyme oxidises RA to inactive metabolites.
In Xenopus laevis, RA is synthesised at the beginning of gastrulation by the retinol dehy-
drogenase 2 (RALDH2). RALDH2 expression is initiated in the deep mesodermal layer 
adjacent to the involuting endoderm region (figure 1.4; Chen et al., 2001). According to 
Figure 1.4 Expression of RALDH2 and CYP26 at gastrula stage of Xenopus laevis. The RA synthesisin�� 
enzyme RAL�H�� �1; 3 blue� is expresse� as two lateral stripes in the involutin�� meso�erm a�ja��ent to 
the prospe��tive pan��reati�� pro��enitor ��ells in the en�o�erm �yellow, PPP�. The RA �e��ra�in�� enzyme 
C�P��6A1 ���� is expresse� in the epithelial layer of the �orsal animal hemisphere, the neuro e��to�erm, an� 
the ��ir��umporal mar��inal zone �Chen et al., ��004�.
lineage tracing experiments this region, expressing anterior endodermal marker genes like 
XHex and XlHbox8 (Zorn et al., 1999), will give rise to pancreatic and hepatic progeni-
tor cells (Kelly and Melton, 2000; Chalmers and Slack, 2000) and thereby supporting the 
idea that RA is involved in prepatterning the prospective anterior gut endoderm. Cyp26 is 
expressed in the gastrula ectoderm adjacent to the involuting endoderm (figure 1.4; Hol-
lemann et al., 1998). 
Inhibition of RA signalling by the synthetic RA antagonist BMS453, directed against retin-
oic acid receptor α and γ (Matt et al., 2003), leads to reduced exocrine and endocrine tis-
sue in the dorsal pancreas and to a slightly reduced ventral pancreas (Chen et al., 2004). 
Conversely, RA treatment of gastrula stage embryos causes an increase of endocrine at the 
expense of exocrine tissue in the dorsal pancreas whereas the ventral exocrine pancreas 
was expanded. 
Since later RA application did not result in a pancreatic phenotype (Zeynali and Dixon, 
1998), these data suggest an early role for RA in patterning the endoderm and in Xenopus 
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pancreas organogenesis, in particular for the dorsal anlage (Chen et al., 2004). The require-
ment of the vitamine A derivate for pancreas development was further observed in Xeno-
pus laevis using the animal cap assay. Coinjection of VegT and β-catenin activates a dorsal 
endodermal fate in pluripotent animal cap cells. Exocrine and endocrine gene expression 
was only initiated upon RA treatment (Chen et al., 2004). As VegT is also inducing meso-
dermal tissue, the question of indirect or direct signalling of RA on the endoderm was sub-
sequently studied by analyzing changes in gene expression within dissected endodermal 
explants that were exogenously treated with RA or BMS453 (Pan et al., 2007). 
Until now it remains obscure how pancreas development proceeds between these RA in-
duced pre-patterning steps and the actual induction of pancreas formation that is marked 
by the onset of the expression of two transcription factors Pdx1/XlHbox8 andPtf1a/p48 
in the foregut. The two transcription factors Pdx1/XlHbox8 and Ptf1a are not the only 
modulators that direct pancreas development in the gut endoderm promoting endocrine 
cell differentiation. Indeed, it is a whole set of transcription factors that form a complex 
regulatory network (reviewed in Zaret, 2008). 
1.2.2 Transcription factors in�ol�ed in pancreas de�elopment
Specification of the different pancreatic cell types from pancreatic progenitors in the gut 
epithelium is driven by a variety of transcription factors. Previously these transcription 
factors were supposed to regulate their downstream targets in a linear cascade. But the 
constant growing number of genetic regulators and analysis of their interactive relations 
implies a complex regulatory network rather than a simple hierachical model (Zaret, 2008; 
Oliver-Krasinski and Stoffers, 2008). 
Focusing on the factors analysed in the context of this study, the key regulators in pancreas 
development are the two transcription factors Pdx1/ XlHbox8 and Ptf1a/ p48. Pdx1- Ptf1a 
positive cells give rise to all pancreatic cell types of the mature organ (figure 1.5; Kawaguchi 
et al., 2002; Burlison et al., 2008).
1.2.2.1 The homeobox transcription factor Pdx1/ XlHbox8
In mice, the homeobox domain protein Pdx1 is expressed in the foregut from E8.5 onwards 
including the stomach, duodenal and pancreatic region (Ohlson et al., 1993; Jonsson et al.,       
1994). At E11.5 the expression extends towards the cystic duct, the antral stomach and the               
common bile duct. Analysis of Pdx1-/- mice revealed that ventral and dorsal pancreatic 
budding from the posterior foregut still occured. However, further outgrowth and diffe-
rentiation of the rudiment was impaired. Inhibited pancreatic development upon Pdx1 
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depletion also became obvious by the lack of endocrine islet cells in the adult organ. Here, 
Pdx1 was essential for β-cells maintenance as it was evident by the linkage to MOD�4 (ta-
ble 1; Gannon et al., 2008; Holland et al., 2005). 
In contrast, activation of early glucagon and insulin expressing cells deriving from the pri-
mary transition within the Pdx1+ epithelium were still detectable in the Pdx1-homozygous 
mutants demonstrating that these early endocrine cells are Pdx1 independent (Offield et    
al., 1996; Burlison et al., 2008). In the dorsal pancreas Pdx1 is regulated by transcription          
factors Hb9 or by Isl1, a lim1 homeobox protein which is expressed in the surrounding 
mesoderm (reviewed in Edlund, 2002). In the ventral pancreas Pdx1 expression is regula-
ted by HNF1β and HNF6 (Haumaitre et al., 2005; Jaquemin et al., 2003a). Although Pdx1 
owns a high pancreas promoting capacity, it was otherwise shown that Pdx1 alone is not 
sufficient to induce pancreatic tissue (Horb et al., 2003; Grapin-Botton et al., 2001).        
The second key regulator that is subscribed to pancreatic development is the basic helix 
loop helix (bHLH) protein Ptf1a/ p48 (pancreatic transcription factor 1a). Ptf1a is part of 
a trimeric DNA binding complex Ptf1. This complex was originally identified as protein           
complex, activating expression of exocrine genes in the adult pancreas in mice (Krapp et 
al., 1998). In addition to the bHLH protein p48, the trimeric complex consists of the two 
transcription factor subunits ribosomal binding protein -J (RBP-J) and an E-box bind-
ing bHLH protein (E-box protein). p48 dimerises with the E-box protein and binds to a          
specific PTF1a-binding site on the DNA. Gene activation requires recruitement of RBP-J. 
Recent studies in knockout mice showed that lack of p48 disrupts proper outgrowth of the             
dorsal pancreas and the specification of the ventral pancreas. Instead, the p48-/- foregut 
epithelium acquires duodenal fate (Kawaguchi et al., 2002). In humans, p48 mutations     
manifest pancreatic and cerebellar agenesis (Sellick et al., 2004). In context of endocrine    
cell differentiation, it was shown that upon p48 depletion, few endocrine cells can be found 
in the adjacent intestine (Kawaguchi et al., 2002).   
P48 not only plays a role in establishing a pancreatic progenitor pool, but it was also de-
scribed as driving factor for differentiation of the exocrine compartment as it was shown            
to promote outgrowth of the proliferating tips of the branching epithelium. During sub-
sequent morphogenesis, these tip structures differentiate into acinar cells (Stanger et al., 
2007). The Ptf1 complex is differentially active within these tips, as it replaces RBPJl against 
RBPJk after which precursor cell proliferation is blocked and exocrine cell differentiation 
is initiated (Masui et al., 2007). Similar to Pdx1, dorsal and ventral p48 expression depends 
on permissive signals from the surrounding tissue as the endothelial cells (�oshitomi and 
Zaret, 2004) and FGF10 (Jaquemin et al., 2006).
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In Xenopus laevis, it was reported that a combined expression of XlHbox8 and Xp48 was 
sufficient to induce pancreatic fate in the gut epithelium (Afelik et al., 2006). Downregula-
tion of Xp48 and XlHbox8 function resulted in loss of exocrine and late endocrine pancre-
atic tissue, whereas early insulin expressing cells remained unaffected. 
Similar observations were reported upon overactivation of p48 within the pancreatic en-
doderm in Hes1- knockout mice. Here, pancreatic enlargement only occurred where p48 
expression overlapped with endogenous Pdx1 expression within the stomach, bile duct and 
duodenum, thereby causing cell fate conversion into pancreas of the Pdx1- p48 positive 
domain (Fukuda et al., 2006). 
Data obtained from in vivo experiments using transgenic mice indicated that Pdx1 and 
p48 regulate each other and auto-regulate themselves (Hale et al., 2005; Wiebe et al., 2007). 
However, it remained unclear how initial gene activation of Pdx1 and p48 is activated in 
the restricted boundary of the gut epithelium. Direct gene activation requires earlier ex-
pression of the upstream regulator in the same cell, which is supposed to induce target gene 
expession. In this regard, the two transcription factors HNF1β and HNF6, that are both 
expressed prior the onset of Pdx1 and p48 in an overlapping but broader regions of the 
foregut epithelium, represented potential upstream regulators. 
1.2.2.2 The role of HNF1β in pancreas de�elopment
The transcription factor HNF1β [variant hepatocyte factor one (vHNF1), transcription cell 
factor two (TCF2) or homologue liver specific factor B (LFB3) (DeSimone et al., 1991; De-
martis et al., 1994)], belongs to the group of liver enriched transcription factors known as 
hepatocyte nuclear factors (HNFs). HNF-group members belong to different transcription 
factor families, like the homeobox proteins HNF1β and its close relative HNF1α, nuclear 
receptor HNF4α, forkhead box proteins HNF3α, β and γ (FoxA1-3) and the onecut fam-
ily member HNF6 (onecut-1: Cereghini, 1996). All group members were reported to play 
essential roles during liver specification, as it was also recently demonstrated for HNF1β 
(Lokmane et al., 2008). As previously described, dominant negative mutations in the 
HNF1β gene are also linked to diabetic disorder MOD�5 that is characterised by impaired 
glucose- stimulated insulin secretion and is associated with a severe glomerulocystic kid-
ney disease (GCKD; Fajans et al., 2001). 
HNF1β was first isolated as albumin promotor binding protein from a rat hepatoma cell 
line (Cereghini et al., 1988) and demonstrated to be a strong transcriptional activator (DeS-
imone et al., 1991). The HNF1β protein contains an N-terminal DNA-binding region that 
is composed of a dimerisation domain, a POU-like DNA binding motif and a downstream 
HOMEOBOX motif (Nicosia et al., 1990). Structural analysis of the human homologue      
14
Introduction
revealed that the homeobox contains a helix- turn- helix motif (HTH), but which differs 
from other homeobox proteins by an extention of 21 amino acids between the second and 
third helix (Bach et al., 1991) and which was suggested to stabilize DNA- binding (Fin-
ney et al., 1990). The POU- like DNA binding motif is formed by five helices, similar to 
the POU DNA binding domain, and is therefore also referred as pseudo- POU structure 
(Kissinger et al., 1990). Apart from this human HNF1β-A form, two additional human iso-     
Figure 1.5 Regulatory factors directing pancreatic lineage specification in Xenopus laevis. A simplifie� 
mo�el for the role of the major trans��ription fa��tors an� si��nallin�� pathaways involve� in pan��reati�� li-
nea��e �etermination. Cir��les in�i��ate ��ell subtypes. Boxes state trans��ription fa��tors that are require� for 
��ell fate �etermination. Arrows in�i��ate �ire��tions of ��ell linea��es that are spe��ifie� a����or�in�� to the ex-
presse� marker ��ene �s�. �ifferent arrow len��hts in�i��ate the relative time point of final �ifferentiation mo-
�us after pre��ursor ��ell �etermination. Blunt lines in�i��ate inhibition of parti��ular ��ell linea��es. Question 
marks in�i��ate instan��es where ��ene �s� in parti��ular linea��e �etermination is not known in Xenopus laevis 
�mo�ifie� after Pieler an� Chen, ��006�. 
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forms were identified, namely HNF1β- B and HNF1β- C (Tronche and �aniv, 1992). In this           
respect, HNF1β- C that lacks the C- terminal transactivation domain might function as an 
endogenous dominant negative variant of the transcription factor (Bach and �aniv, 1993). 
HNF1β and the closely related HNF1α bind to identical DNA binding sites as homo- or          
heterodimers (g/aGTTAATNATTAACc/a; Rey-Campos et al.,1991) but it is unclear which 
protein region is preferred for either interaction. The dimerisation process is promoted by 
the dimerisation cofactor DCoH. DCoH does not bind to the DNA but stabilizes the struc-
ture of the HNF1 dimer, thereby enhancing interaction with nucleic acids (Cerenghini,         
1996). Subsequent studies in mice specified its expression profile during development to           
the extraembryonic visceral endoderm and later to the definitive endoderm where it is ex-            
pressed in cells of the neural tube and of the foregut epithelium, including the hepatic and 
pancreatic primordia. Along the gut tube, differential HNF1β expression was detectable    
in the gallbladder, duodenum and both pancreatic anlagen at stage E8.5. Here, HNF1β 
expression was detectable in the Pdx1-positive epithelium of the budding pancreatic rudi-
ments, where it became restricted to the developing duct cells, excluded from acinar or             
endocrine cells, in the branching pancreatic epithelium (E12.5). In adult mice, HNF1β was      
transcribed in the epithelial cells of liver, genital tract, kidney, pancreas and lung (Barbacci 
et al., 1999; Reber et al., 2001).
HNF1β-deficient mice died before gastrulation due to defective formation of the viscer-
al endoderm. This lethality was prevented by generation of HNF1β-null embryos with a 
wildtype (WT) extraembryonic endoderm using tetraploid embryo complementation (Bar-
bacci et al., 1999). These teraploid HNF1β deficient mice were completely devoid of ventral        
pancreatic structures and demonstrated a severe hyploplasia of dorsal pancreas (Haumai-
tre et al., 2005). Interestingly, inhibited pancreatic development upon HNF1β depletion        
phenocopied effects caused by impaired expression of the pancreatic progenitor marker 
Pdx1 (Offield et al., 1996) and Ptf1a/p48 (Kawaguchi et al., 2002). Therefore, data obtained  
from studies in knockout mice support the idea that the transcription factor HNF1β func-
tions as an upstream regulator of Pdx1 and p48. HNF1β-hypomorphic zebrafish mutants 
showed a similar phenotype regarding pancreatic agenesis, suggesting that HNF1β func-
tion during vertebrate development is conserved (Sun and Hopkins, 2001). 
In 1994, the Xenopus laevis HNF1β homologue was isolated and its expression traced dur-
ing different stages of embryogenesis (Demartis et al., 1994). HNF1β expression was ac-
tivated after mid blastula transition (MBT) in ecto- and endoderm as well as later in the 
mesoderm. In early tadpole stages, HNF1β transcripts were found in the foregut marking 
the prospective hepatic and pancreatic domain. In adult tissues, HNF1β transcripts were 
detected abundantly in liver, kidney, digestive tract and lung, but also in the pancreas (De-
martis et al., 1994; Vignali et al., 2000). 
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HNF1β regulates a gene expression cascade essential for differentiation of epithelial cells 
lining the ducts. In 2002, Clotman et al. revealed that one of the upstream regulators of 
HNF1β in biliary duct differentiation is the onecut 1 transcription factor HNF6 (Clotman 
et al., 2002; Coffinier et al., 2002). An additional link between HNF1β and HNF6 was dis-
covered regarding endocrine cell differentiation as both were reported as Ngn3 upstream     
regulators associated with the diabetic disorder MOD�6 (Maestro et al., 2003; Horikawa 
et al., 1997).
Conversely, it was revealed that the mouse HNF6 gene contained an intronic HNF1β bind-  
ing site with high potency to activate transcription of a reporter construct          in vitro. These 
data located HNF1β upstream of HNF6 in the regulation hierarchy (Poll et al., 2006).
1.2.2.3 The role of HNF6 in pancreas de�elopment
The hepatic nuclear factor 6 (HNF6) belongs to the class of the cut- homeobox domain 
transcription factors. The name of the cut- transcription factor family is based on the pre-
viously identified CUT protein from Drosophila melanogaster (Blochlinger et al., 1988). All 
onecut family members contain a characteristic C-terminal DNA binding domain, com-
posed of one CUT motif and one downstream HOMEOBOX motif. The N-terminus differs 
between onecut family members classifying them into three subgroups: onecut-1, 2 and 3 
(OC-1, 2 and 3). 
HNF6 contains one CUT DNA binding motif, therefore also called onecut-1 (OC-1), that 
functions together or independent with the downstreamHOMEOBOX. Beside onecut-1, 
there are two paralogues known in mice and humans, namely onecut-2 (OC-2) and onecut-
3 (OC-3) that share common expression domains with OC-1, but play different or partially 
redundant roles in organogenesis (Jaquemin et al., 1999; Vanhorenbeeck et al., 2007).        
HNF6/ OC-1 was originally identified in rat as liver enriched transcription factor binding 
to a gene involved in glucose metabolism (Lemaigre et al., 1996). Studies on its temporal 
and spatial expression profile in mouse embryogenesis reported an early onset of expressi-
on in the developing nervous system and in endoderm derivatives like liver and pancreas 
at E8.0 (Landry et al., 1997). In the pancreas, HNF6 transcripts were detectable next to              
HNF1β in the Pdx1 positive epithelium of the developing foregut. Therefore HNF6 expres-
sion in the anterior endoderm was present in all pancreatic progenitor cells prior to pan-
creatic bud formation. Later, HNF6 RNA became restricted to the pancreatic acinar and 
duct cells (Pierreux et al., 2006). In the adult organism HNF6 expression was evident in the 
liver, brain, testis, spleen and pancreas (Lemaigre et al., 1996; Hong et al., 2002).   
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In accordance with its early endodermal expression, gene knockout studies in mice de-
monstrated that HNF6 plays an important role in liver and biliary duct specification (Clot-
man et al., 2005), as well as in pancreas organogenesis (Poll et al., 2006). Studies in knock-             
out mice reported that lack of HNF6 caused a delay in Pdx1 induction at E9 resulting 
in pancreatic hypoplasia. Promotor studies confirmed that the Pdx1 promotor contained 
HNF6 site (Jacquemin et al., 2003a). In addition to its role during early pancreas organo-        
genesis it was also shown that HNF6 stimulated the promotor of the endocrine precursor             
marker Ngn3 and maintained its activity for proper endocrine cell differentiation and islet 
formation (Jacquemin et al., 2000; Maestro et al., 2003). 
As the Xenopus laevis homologue was not yet identified, it would be of further interest to 
identify the homologue and to elucidate its function during Xenopus laevis organogen-
esis. 
1.3 Screening for no�el pancreas specific marker genes in Xenopus laevis
In an attempt to identify new molecular markers for pancreas development, a cDNA library 
screen was performed of an adult pancreas cDNA library from Xenopus laevis (Afelik et al., 
2004). The substractive filter hybridization screen excluded all clones corresponding to di-
gestive enzymes. Clones that were negative in the filter hybridisation screen were randomly 
picked and used for expression analysis in Xenopus laevis embryos. One of them was clone 
number 150 (“pancreas clone 150”/ p150), that showed pancreas expression at tadpole stage 
41. Hence, p150 became interesting for subsequent analysis of pancreas organogenesis. 
1.4 Xenopus laevis as experimental model system
In this study, the African clawed frog Xenopus laevis is used as model sytem to study or-
ganogenesis. The possibility of easy in vitro fertilization, high number of progeny and fast 
external development allows rapid and effective manipulation by microinjection and che-
mical treatment. Existing cell fate maps allow to target microinjected substances to a pre-
dicted region of interest at later developmental stages. In addition, the generation of em-
bryonic tissue explants and transplantation assays can serve as important tools to analyze 
the influence of extrinsic factors on cell fate determination (Vize et al., 1991). 
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1.5 Aims of this study
Pancreas formation from the gut epithelium requires the activation of a genetic program 
to specify organ precursor cells. It was shown that early RA- signalling is essential for 
pancreas specification and early endocrine cell fate determination. Pancreas formation is 
initiated with the onset of the expression of the transcription factors Pdx1/XlHbox8 and 
Ptf1a/p48. The two transcription factors HNF1β and HNF6 were described as putative       
upstream regulators of Pdx1/XlHbox8 and Ptf1/P48 in mouse. However in Xenopus laevis 
Pdx1/XlHbox8 and Ptf1/P48 regulation remains obscure.    
This study focused on the identification of regulatory mechanism, that link early RA- si-
gnalling to later expression of Pdx1/ XlHbox8 and Ptf1a/ p48 during organogenesis. The-
refore, we analysed the two transcription factors HNF1β and HNF6. This included the 
isolation of the Xenopus laevis HNF6 homologue, the generation of its temporal and spatial 
expression profile and primary functional analysis by ectopic expression within the endo-
derm. The HNF1β expression profile was refined and its role during pancreas development 
characterised by loss- and gain of function approaches. As HNF1β was known to be a RA 
downstream target in the nervous system (Hernandez et al., 2004), it was of further interest 
how RA influenced HNF1β expression within the endoderm. Therefore, RA- signalling 
was activated and inhibited in whole embyros and in endodermal explants. Furthermore, 
the novel putative pancreas specific marker gene p150 was analysed regarding its expres-
sion and its functional analysis was approached by loss- and gain of function studies. In 
addition, protein structure and biochemical interactions of this undescribed protein were 
analysed in collaboration with the group of Muhle-Goll (EMBL, Heidelberg). 
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2 Materials and Methods
2.1 Materials
2.1.1 Chemicals: 
Basic chemicals used in this study were obtained from companies Fluka, Baker, Sigma-Al-
drich, Roth and Merck in high purity grade (p.A.). Special chemicals were obtained from 
Roche Diagnostics, Fluka, Sigma-Aldrich and Serva. 
2.1.2 Buffers and solutions
All media and buffer solutions were made as described in (Sambrook et al., 1989). If not 
stated differently solutions were made in dH2O and autoclaved for 20 min at 120°C. Heat 
sensitive chemicals were filtersterilzed (0.2µm, Sartorius). 
2.1.3 Enzymes
DNaseI ( 10 U/µl) Biozyme, Cardiff (UK)
RNase Out ( 40U/µl) Invitrogen, Karlsruhe
RNaseT1 (R-8251) ( 2000 U/µl) Sigma-Aldrich, Deisenhofen
RNaseA (R-5000) ( 10 mg/ml) Sigma-Aldrich, Deisenhofen
Restriction enzymes ( 10 U/µl) MBI-Fermentas, St. Leon-Rot
Pyrophosphatase ( 0.1 U/µl) MBI-Fermentas, St. Leon-Rot
T4 DNA- ligase ( 3 U/µl) Promega Germany, Mannheim
Sp6 RNA- polymerase ( 50 U/µl) Stratagene GmBH, Heidelberg
T3 RNA- polymerase ( 50 U/µl) Stratagene GmBH, Heidelberg
T7 RNA- polymerase ( 50 U/µl) Stratagene GmBH, Heidelberg
GoTaq Flexi DNA-Polymerase ( 50 U/µl) Promega Germany, Mannheim
High Fidelity Polymerase Mix MBI-Fermentas, St. Leon-Rot
PowerScript ReverseTranscriptase ( 50 U/µl) BD Bioscience Clontech, Heidelberg
Lysozyme ( 10 mg/ml) Invitrogen, Karlsruhe
Proteinase K ( 20 mg/ml) Merck KGaA, Darmstadt
AcTEV protease ( 10U/µl) Invitrogen, Karlsruhe
 
2.1.4 Reaction and purification kits
mMESSAGE mMACHINETM SP6, T7, T3 Ambion Ltd., Huntingdon (UK)
ECL+ plus Western Blotting Detection Kit Applied Bioscience GmbH, Weiterstadt
SMARTTM RACE cDNA Amplification Kit BD Bioscience Clontech, Heidelberg
TNT®-coupled Reticulocyte Lysate System Promega Germany, Mannheim
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IllustraTM plasmid spin Mini Kit GE healthcare, Buckinghamshire (UK)
IllustraTM GFX PCR DNA and Gel Band
purification Kit
GE healthcare, Buckinghamshire (UK)
IllustraTM RNAspin Mini Kit GE healthcare, Buckinghamshire (UK)
Plasmid Midi purification Kit Quiagen GmBH, Hilden
pGEM®-T and pGEM®-T Easy Vector Systems Promega Germany, Mannheim
AminoLink© Plus Immobilisation Kit PIERCE, Rockford (US)
High fidelity polymerase Kit MBI-Fermentas
Big Dye Terminator v.1.1 Cycle Sequenceing Kit Applied Biosystems, Weiterstadt
2.1.5 Antibodies
Sheep- anti- Digoxigenin- AP (11093274910) Roche Diagnostics, Mannheim
Sheep- anti- Fluoreszein- AP (11426338910)   Roche Diagnostics, Mannheim
Mouse- anti- FlagM2- FITC (F4049)   Sigma, Deisenhofen
Mouse- anti- human Hsp47 (SR-B470)   MoBiTec, Göttingen
Goat- anti- mouse- Alexa 594 (A-11005)    Invitrogen, Karlsruhe
Goat- anti- rabbit- HRP (111-035-003)   Dianova, Hamburg
Mouse- anti- FlagM2 (F 3195)   Sigma, Deisenhofen
Goat-anti-mouse-HRP (sc-2005) SantaCruz
Goat-anti-rabbit-FITC Sigma, Deisenhofen
Rabbit-anti-malectin Biosystems, Göttingen
2.1.6 Antibiotics
Ampicillin 100 mg/ml in dH2O (use 50 µg/ml) 
Kanamycin 10 mg/ml in dH2O (use 50 µg/ml) 
Penicillin/ Streptomycin 10 000 U/ml penicillin, 
10 mg/ml streptomycin in 0.9% (w/v) NaCl 
(use 10 U/ 10 µg/ml)   
2.1.7 Oligonucleotides
2.1.7.1 Morpholinos
Morpholino antisense oligonucleotides were purchased from Gene Tools (Philomath, 
USA). Translation intitiation side is marked in brackets.
name sequence 5�  3�
XHNF1β- Mo1 GCAAAGGCGATAGCTTGGACAC(CAT)
XHNF1β- Mo2 C(CAT)TTTCAAGGGGAAAAAAGAAGG
p150/malectin- Mo1 GCCCTAGTACTGTCCGGATGCTGAG-3 -´(CAT)
p150/malectin- Mo2 TCCGGATGCTGAG(CAT)CTCCTCCAG
standard control (CoMo) CCTCTTACCTCAGTTACAATTTATA
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2.1.7.2 DNA oligonucleotides 
Oligonucleotides used for DNA sequencing, RT-PCR and general cloning were obtained      
from Sigma-Genosys (Steinheim).
Oligonucleotides used for sequencing
name sequence 5�  3� aT
SP6 TTAGGTGACACTATAGAATAC 50°C
T3 (pCS2+) ATTAACCCTCACTAAAGGGA 56°C
T7 (pCS2+) TCTACGTAATACGACTCACTATAG 56°C
T7 (pGEM-T) TAATACGACTCACTATAGGGCGA 56°C
CMV-for CGCGCCTGCAGGTCGACACTA 58°C
CMV-rev GCAAGGCGATTAAGTTGGGTA 58°C
P150/malectin-F2 GCTAAGCATCATACAGCC 56°C
P150/malectin-R1 GTGAGCCTGTACAGAGGTG 56°C
Oligonucleotides used for RT-PCR
name sequence 5�  3� aT, cycles
Histone H4- for CGGGATAACATTCAGGGTATCACT 56°C, 26× 
Histone H4- rev ATCCATGGCGGTAACTGTCTTCCT
Insulin- for GCCTCAGCGACCCAATAGAA 56°C, 32×
Insulin- rev ATGGCTCTATGGATGCAGTG
XPDIp- for GGAGGAAAGAGGGACCAA 60°C, 30×
XPDIp- rev GCGCCAGGGCAAAAGTG
XlHbox8- for AATCCACCAAATCCCACACCT 60°C, 32×
XlHbox8- rev GCCTCAGCGACCCAATAGAA
Xp48 RT-R CATCAGTCCATGAGAGAG 60°C, 30×
Xp48 RT-F GAGAAGCGACTGTCCAAG
p150/malectin RT-5´ ACGACAACCCCAAAGTATG 60°C, 30×
p150/malectin RT-3´ CCGAAGGCCACCAGGAT
HNF1β-RT F TGTACAGTTTTCACAGCA 56°C, 30×
HNF1β-RT R ATTATTCCTGTCAGCAGC
HNF1β-∆26 for GAGGATCCATGGAGGGCTGC 56°C, 30×
HNF1β-∆26 rev GGCAGGCTCTGAGCAGGAAT
CX397211_for CATGAACGCTCAGCTGACTAT 56°C, 32×
CX397211_rev GCACTGGGATGGGCATAGTG
Xbra-for GGATCGTTATCACCTCTG 56°C, 30×
Xbra-rev GTGTAGTCTGTAGCAGCA
N-tubulin F ACACGGCATTGATCCTACAG 56°C, 32×
N-tubulin R AGCTCCTTCGGTGTAATGAC
Cerberus F TGCCCATGGAAACAAAAGTGC 56°C; 28×
Cerberus R AGCGTCAGGTGGTTCAGGGTAA
XHNF6 3 r´ace GTAGTTCGTGAACATGGTTTCGTACT 56°C, 30×
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Oligonucleotides used for cloning
name sequence 5�  3� aT
xHNF1β_5´ClaI ccATCGATATGGTGTCCAAGCTATCGCC 60°C, 30×
xHNF1β_3´XhoI ccgCTCGAGCCATGCTTGCAAAGGACACTG
xHNF1β-5´UTR ClaI ccATCGATGGAGGAGTTCCTG 60°C, 30×
xHNF1β-5´UTR BamHI-2 TGGGACAAGGGGATCCAGAT
Xl_HNF6-5´ClaI ccATCGATATGAACGCTCAGCTGACTAT 60°C, 30×
Xl_HNF6-3´XhoI ccCTCGAGTCATGCTTTGGTACAAGTGCTT
HNF6-Mo1 5´BamHI cgGGATCCACGTTCCACCATGAACGCTC 60°C, 30×
HNF6 Mo1 3´ClaI ccATCGATGATGCTCATGGCTCACCCCG
Xp150-5 -´ClaI gcgATCGATATGCTCAGCATCCGGACAGTACTAG 60°C, 30×
Xp150-3 -´XhoI cgcCTCGAGTAATAGCCGACACAGACAGAAGAG
N-flag-p150-5´BamHI cgGGATCCATGCTCAGCATCCCGGAC 60°C, 30×
N-flag-p150-3´ClaI ccATCGATCGCTAGACCAGATCCATGC
P150-Mo2 BamHI cgGGATCCTGGAGGAGATGCTCAGCATC 60°C, 30×
Np150-GFP-ClaI ccATCGATTCGCTAGACCAGATCCATGCG
dN-flag p150 5´XhoI ccCTCGAGGATAAAGTGATGTGGGCAGTG 60°C, 30×
dN-flagp150 5XhoI ccTCTAGATTATAGCCGACACAGACAGAAG
N-flag-p150-5´BamHI cgGGATCCATGCTCAGCATCCCGGAC 60°C, 30×
N-flag-p150-3´ClaI ccATCGATCGCTAGACCAGATCCATGC
2.1.8 Vector systems
2.1.8.1 pGEM®-T and pGEM®-T Easy �ector system    (Promega)
The pGEM®-T vector is a bacterial expression vector that allows non side directed cloning             
of PCR fragments. After PCR reaction the Taq-DNA polymerase adds a poly-Adenine (A) 
stretch to the 5´ -end during a final elongation step (10 min, 72°C). This poly-A stretch can 
pair to an overhanging Thymidine (T) residue at the 3 e´nd of the vector thereby improving 
insertion efficiency. An additional advantage of the system is the possibility of IPTG en-
hanced blue-white screening of positive clones. The insertion of a DNA fragment leads to 
destruction of an LacZ cassette resulting in white colonies on the LBAmp agar. 
2.1.8.2 pCS2+ �ector and deri�ati�es
The pCS2+ expression vector (Rupp et al.,   1994; Turner und Weintraub, 1994), a  derivative 
of the pBluescript II KS+ vector, was used for site directed cloning of open reading frames 
(ORF) for overexpression analysis. 5´ and 3´ untranslated regions (UTR) were excluded to           
prevent translational regulation in the embryo. pCS2+ derivatives like the inducible vari-
ants containing a glucocorticoid receptor binding site (GR) pCS2+-GR, pCS2+-EngGR, 
pCS2+VP16GR (�onglong Chen, unpublished) as well as pCS2+- Flag, pCS2+myc-GFP 
were used. 
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2.1.8.3 pETZ2-9d 
This prokaryotic expression vector contains a negative charged 6× His-tag that allows af-
finity purification of fusion proteins over a Ni2+ matrix. In addition the vector encodes a 
SET 2 (soluble enhancement tag, “Z 2”) carrier, a short amino acid sequence that improves             
solubility of a fusion protein. To remove the tag after purification, a TEV protease cleavage 
site (aa DNL�FQ) is located between the 6× His-tag/ Z2-carrier and the protein of interest.          
Expression is controlled by the IPTG inducible LacO-operon. As expression efficiency var-   
ies between constructs optimal IPTG concentration and protein expression is optimized in         
a time course experiment. (Günther Stier, EMBL Heidelberg; http://www.embl-heidelberg.    
de/ExternalInfo/geerlof/draft_frames/index.html)
2.1.9 Constructs 
- HNF1β- WT: The ORF of HNF1β (1686 bp) was isolated by RT- PCR from stage 
39 total RNA extracts using primers xHNF1β_5´ClaI: ccATCGATATGGTGTC-
CAAGCTATCGCC and xHNF1β_3´XhoI: ccgCTCGAGCCATGCTTGCAAAG-
GACACTG and fused into ClaI and XhoI restriction sides of the pCS2+ vector. This 
construct was used for overexpression analysis in embryos. The plasmid was linearized 
with NotI and capRNA transcribed with Sp6 polymerase.
- HNF1β- GR: The ORF of HNF1β was PCR amplified from the HNF1β-WT construct  
using the primers xHNF1β_5´ClaI and HNF1β_3´XhoI and fused to the 5´ end of the lig-
and binding domain of the glucocorticoid receptor (GR). Therefore pCS2±GR vector was 
restricted using ClaI and XhoI and the ORF fused inframe to the GR domain (810 bp). 
This dexamethason inducible construct was used to analyse time point specific function of 
HNF1β in embryos. The plasmid was linerarized with NotI and capRNA transcribed with 
Sp6 polymerase. 
- HNF1β- EngGR: The ORF of HNF1β was PCR amplified from the HNF1β-WT construct           
using the primers xHNF1β_5´ClaI and HNF1β_3´Xho and fused to the 5´ end of the En-
grailed repressor domain. Therefore pCS2±EngGR vector was restricted using ClaI and 
XhoI and the ORF fused inframe to the EngGR domain (ca.1.6kb). This dexamethason 
inducible construct was used to analyse time point specific function of HNF1β in embryos. 
The plasmid was linerarized with NotI and capRNA transcribed with Sp6 polymerase.
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- HNF1β-VP16GR: The ORF of HNF1β was PCR amplified from the HNF1β-WT con-
struct using the primers xHNF1β_5´ClaI and HNF1β_3´XhoI and fused to the 5´ end of 
the VP16 activation domain. Therefore pCS2±VP16GR vector was restricted using ClaI 
and XhoI and the ORF fused inframe to the GR domain (ca. 1210 bp). This dexamethason 
inducible construct was used to analyse time point specific function of HNF1β in embryos. 
The plasmid was linerarized with NotI and capRNA transcribed with Sp6 polymerase.
- HNF1β- 5´UTR- GFP: A fragment of from the HNF1β 5´ end containing the correspon-    
ding sequence of HNF1β- Mo1 and HNF1β- Mo2 was amplified using the HNF1β-5´ UTR-         
BamHI and HNF1β-5´ UTR-ClaI. The vector pCS2-myc-GFP was restricted with BamHI       
and ClaI and the fragment, including 60 bp of HNF1β 5´ UTR and 42 bp of HNF1β ORF, 
fused inframe to the 5´ end of myc-GFP coding sequence. This construct was used to test in 
vivo efficiency of translational inhibition by morpholino binding. The plasmid was linear-
ized with NotI and capRNA transcribed with Sp6 polymerase. 
- XHNF6- pGEMT- E: Xenopus laevis XHNF6 was isolated by RT-PCR from stage 37 Oli-
godT amplified cDNA using the primers CX397211 for: CATGAACGCTCAGCTGAC-
TAT and XHNF6 3 e´nd-2: CGGAGTTTAAGTTTCTGGGGTTT (58°C, 40 ×) and cloned 
into pGEMT- E. This construct, containing the complete ORF (1482 bp) and 34 bp of the 
3´UTR. This construct was used for asRNA transcription. The plasmid was linerarised 
with AatII and asRNA transcribed with SP6 polymerase. 
- XHNF6- WT: The XHNF6 ORF was PCR amplified out of the XHNF6/pGEMT-E 
construct using the primers Xl_XHNF6 5´ClaI: ccATCGATATGAACGCTCAGCT-
GACTAT and Xl_XHNF6 3´XhoI: ccCTCGAGTCATGCTTTGGTACAAGTGCTT and 
cloned into the ClaI and XhoI restrcition sides of the pCS2+ vector. This construct was 
used for overexpression analysis of XHNF6 in embryos. The plasmid was linerized with 
XbaI and capRNA transcribed with Sp6 polymerase.
- XHNF6- Mo1- GFP: A fragment of 73 bp of XHNF6 5´ end flanking the ATG codon, was 
PCR amplified using the primers XHNF6-Mo1 5´BamHI: cgGGATCCACGTTCCAC-
CATGAACGCTCAGCTGAC and XHNF6-Mo1 3´ClaI: ccATCGATGATGCTCATGG-
CTCAC CCCGTG. The vector pCS2±myc-GFP was restricted with BamHI and ClaI and 
the fragment fused inframe to the 5´ end of myc-GFP coding sequence. This construct was 
used to test in vivo efficiency of translational inhibition by morpholino binding. Plasmid    
was lienarized with NotI and capRNA transcribed with Sp6 polymerase. 
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- malectin: The ORF of p150/ malectin (831 bp) was PCR amplified out of the original 
cDNA library clone pBK-CMV-p150 using the oligonucleotides Xp150-5´ClaI: gcgATC-
GATATGCTCAGCATCCGGACAGTACTAG and Xp150-3´XhoI: cgcCTCGAGTAAT-
AGCCGACACAGACAGAAGAG and cloned into ClaI and XhoI restriction sides of the 
pCS2+ vector. This contruct was used for overexpression experiments in embryos. 
- ∆N- flag- malectin: A fragment lacking the N-terminal signal pepteide (aa 1-30 = dN-p150) 
was PCR amplified out of the p150- ORF construct using the primers chd-flag-5 -´xhoI: cc-
CTCGAGGATAAAGTGATGTGGGCAGTG and chd-flag-3 -´XbaI: ccTCTAGATTATA-
GCCGACACAGACAGAAG cloned into XhoI and XbaI restriction sides of the pCS2+/flag 
vector. This construct was used for analysis of the intracellular localisation of malectin.
- N-flag-malectin: The N-terminal signal peptide N-p150 (aa 1-30) was PCR amplified from 
the p150-ORF construct using the primers N-flag-p150-5´BamHI: cgGGATCCATG-
CTCAGCATCCCGGAC and N-flag-p150-3´ClaI: ccATCGATCGCTAGACCAGATC-
CATGC and fused inframe into BamHI and ClaI restriction sides of the dN-flag-p150 
construct. This construct was used for intracellular localisation of malectin. 
- malectin-Mo1-GFP: The N-terminal signal peptide was PCR amplified from the N-flag-
p150 contruct using primers N-flag-p150-5´BamHI: cgGGATCCATGCTCAGCATCC-
CGGAC and Np150-GFP-ClaI: ccATCGATTCGCTAGACCAGATCCATGCG. The frag-
ment was restricted with BamHI and ClaI and fused inframe into the restriction sides of 
mycGFP-pCS2+. This construct was used to test in vivo efficiency of translational inhi-
bition by morpholino binding. The plasmid was linearized with NotI and capRNA was 
transcribed with Sp6 polymerase. 
- malectin-Mo2-GFP: The 5´ UTR sequence (102 bp) of p150 was PCR amplified out of the 
original pBK-CMV-p150 using the primers P150-Mo2 BamHI cgGGATCCTGGAGGA-
GATGCTCAGCATC and Np150-GFP-ClaI. An EST- alignment showed in 50% of com-
pared sequences 3 mismatches for the Mo2 sequence. The fragment was fused inframe           
into the restriction side of mycGFP-pCS2+. This construct was used to test in vivo and in 
vitro inhibitory efficiency of p150-Mo2. The plasmid was linearised with and capRNA was 
transcribed with Sp6 polymerase. 
- HNF1β-full- pGEMT- 7Z: This construct, obtained from Robert Vignali (Demartis et al., 
1994), contains the full-length cDNA sequence of HNF1β ( LFB3; NCBI: X76052) including 
3 a´nd 5´ UTR. This construct was only used for asRNA synthesis, since it includes a point 
mutation in the ORF at nt 1414 (T- insertion). 
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Constructs used for antisense and sense „capRNA“ transcription
construct restriction polymerase reference
XlHbox8- pGEM-T NotI T7 Afelik et al., 2006
Xp48- pGEM-T NotI T7 Chen et al., 2003
XPDIp- pBK-CMV BamHI T7 Afelik et al., 2004
Insulin- pGEM-T NotI T7 Chen et al., 2004
p150/ malectin- pBK-CMV BamHI T7 Schallus et al., 2008
HNF1β- pGEMT- 7Z (pXLFB3) KpnI T7 Vignali et al., 2000
XHNF6- pGEM-T Easy AatII Sp6 Jäckh, unpublished
Trypsin- pCS2+ BamHI T7 Afelik et al., 2004
eGFP-pCS2+ (capRNA) NotI Sp6 Klymkowsky, unpublished
β-galactosidase-pCS2+ (capRNA) NotI Sp6 Bier et al., 1989
2.1.10 Experimental organisms
Xenopus laevis: Albino or pigmented African clawed frogs (family Pipidae, subfamily 
Xenopinae) were purchased from NASCO (Ft. Atkinson, Wisconsin, USA). 
Embryos were staged according to Nieuwkoop and Faber (1967).
Escherichia coli: XL1-Blue I: recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac 
[F´proAB, laclqZ∆M15, Tn10(Tetr)]c (Bullock et al., 1987).
Stratagene GmBH, Heidelberg 
BL21(DE3): F´dcm ompT hsdS(rB-mB) gal λ(DE3)
NIH 3T3: swiss embryonic 
mouse fibroblasts 
obtained from DSMZ (Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmBH); stock stored in liquid N2; adherent growth,  cultured 
in DMEM with 10% FCS
2.1.11 Technical equipment
Regular laboratory material was obtained from Eppendorf AG (Hamburg), BD Falcon 
(Heidelberg), Greiner Bio-One GmBH (Frickenhausen), Schütt Labortechnick (Göttin-
gen), Schott (Mainz), Biometra GmBH (Göttingen), Corning GmBH-Corning Internati-
onal (Wiesbaden).
Cell culture
Cell Casy Counter Schärfe System Reutlingen
CO2 Incubator Heraeus BBD 6220 Kendro, Langenselbold
Liquid nitrogen container Arpege 140 Air Liquide, Düsseldorf
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Histology  
Vibratom Leica VT1000 S Leica Mikrosystems, Bensheim
Mikrotom Leica RM2065 Leica Mikrosystems, Bensheim
Gastromaster mikrodissector XENOTEC Engeneering, Belleville (USA)
Micromanipulation 
Gastromaster Xenotec Ltd., Corona del Mar, Ca, USA 
Microinjector PV820 Harry Fein World Precision Instruments, Berlin
Needlepuller PN-30 Narishige, Japan
Glass kapillaries GC100F-10, Harvard apparatus (Electromedical Instru-
ments, Pangbourne Reading, Clark, England)
PCR
T3 Thermoycycler Biometra, Göttingen
Microscopes   
Fluorescence Microskop Axioplan 2 Carl Zeiss AG, Oberkochen
Microscope Axioskop Carl Zeiss AG, Oberkochen
Confocal Microskop Zeiss LSM 510 META Carl Zeiss AG, Oberkochen
Confocal microscope Leica DRM IRE2 TCS SP2 Leica, Bensheim
Stereomicroscope SZX12 Olympus Microscopy, Hamburg
Stereomicroscope Stemi 2000 Carl Zeiss AG, Oberkochen
Camera MC 80 Carl Zeiss AG, Oberkochen
DXC-950P Colour Video Camera Carl Zeiss AG, Oberkochen
Inverse Microscopee Axiovert 25 Carl Zeiss AG, Oberkochen
2.1.12 Hard- and Software
Microsoft Office (Word, Exel, Powerpoint)
Adobe Creative Suite CS (Photoshop, Illustrator, Indesign)
MacMolly Tetra, ImageJ, CLC free Workbench
Apple- Power Book G4
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2.2 Methods
2.2.1 Working with Xenopus laevis 
2.2.1.1 Culturing Xenopus laevis embryos
Preparation of sperm solution
Male Xenopus laevis frogs were narcotized in ice water for 20 min. The frogs were deca-
pitated and testis removed. The testis was washed in fresh 1× MBS, dried on a napkin to 
remove sticking tissue and stored in 1× MBS + Penicillin/Streptomycin at 4°C until usage.        
For in vitro fertilization small peaces of testis were homogenized in 1× MBS using forceps. 
The freshly prepared sperm solution was kept on ice. 
5× MBS: 50 mM HEPES pH 7.4, 440 mM NaCl, 5 mM KCl, 12 mM NaHCO3,
  4.1 mM MgSO4, 2.05 mM CaCl2, 1,65 mM Ca(NO3)2, pH 7.4 autoclave.
Pen-Strep : use 100 U/ml Penicillin, 100 µg/ml Streptomycin 
O�ulation and in vitro fertilization 
Female frogs were stimulated with 1000 U Human Chorionic Gonadotropin (HCG) for 
ovulation one day before egg collection by subcutanous injection, close to the dorsal lym-
ph sac. Frogs were kept at 16°C so that ovulation started 10 hr later. Eggs were collected 
in a petri dish and immediately in vitro fertilized by mixing them with freshly prepared 
sperm solution that was diluted 1:10 in dH2O. After 10  min the eggs were covered with 
0.1× MBS. The lower salt concentration leads to activation of sperm movements. Upon           
sperm entry the egg surrounding vitellin membrane detaches. The following egg rotation, 
turning pigmented animal pole up and heavier yolky vegetal pole down, allows estimation 
of fertilisation rate. 
HCG 2000 U/ml stock solution, store -20°C (Sigma)
Dejellying of embryos
After 30 to 40 min the eggs jelly coat was removed by gently shaking them in 2% cystein-
solution. When eggs contacted each other cysteination was stopped by an extensive wash 
with 0.1× MBS. After washing, embryos were kept at 12.5°C till they reached the desired 
cleavage stage for injection. 
Cystein- solution: 2% (w/v) L- cystein hydrochlorid-monohydrat, pH 8.0 in dH2O 
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In vivo staining of albino embryos
To visualize cleavage stages of albino embryos, they were stained for 3 min with the vital 
colour dye Nile Blue after cysteination. 
Nile Blue: 0.01% (w/v) Nile Blue chloride, 50 mM Na2HPO4*2H2O, 50 
mM NaH2PO4* H2O, pH 7.8 in H2O; mix oN and filter
2.2.1.2 Microinjection
Gene function analysis was performed by injection of morpholino antisense oligonucleo-
tides or capped messenger RNA (capRNA) into Xenopus laevis embryos. Injection needles 
were prepared from glas capillaries using a needle puller. The sample to be injected was fil-
led into a needle with microloading tips (Eppendorf) prior to be clamped to an air pressure 
regulated microinjector. By cutting the needle tip carefully with forceps, the drop size was            
scaled to 2 nl using a scale ( d= 0.2 mm ≈ 4.2 nl; d= 0.25 mm ≈ 8.2 nl) . Just before injection    
embryos were transferred to injection buffer containing 1% Ficoll. Its higher density pre-
vents diffusion of injected material out of the embryo. Injection was performed under high 
pressure (2000 hPa) and short injection time (0.1- 0.3 s) on a glas slide with 1.6× objective 
enlargement. Embryos were kept in inejction buffer for 1 hr retransfered to 0.1× MBS and   
cultured at 12- 18°C till desired developmental stage. To prevent embryo pigmentation 5% 
PTU was added to 0.1× MBS (40 µl/ 50 ml).      
10% (w/v) Ficoll-400: in dH2O, filter sterilize, store at -20°C; Sigma 
Injection buffer: 1× MBS, 1% (v/v) Ficoll; Sigma
N-phenylthiourea 5% PTU in DMSO; Sigma
2.2.1.3 Embryo fixation
When embryos reached the desired developmental stage, they were collected in 5 ml screw-
cup tubes, fixed with 1× MEMFA for 1 hr on a shaker, dehydrated using 100% EtOH and 
stored until usage at -20°C. 
10× MEM: 1M MOPS, 20 mM EGTA, 10 mM MgSO4, ph 7.4; filter sterilize, 
keep dark
1× MEMFA: 1× MEM, 4% (v/v) formaldehyde, prepare fresh!
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2.2.1.4 β-galactosidase staining
Coinjection of β-galactosidase capRNA was used as cell lineage tracer. For detection em-          
bryos were fixed in 1× MEMFA for 20 min and incubated with the staining solution inclu-           
ding β-galactosidase substrate X-Gal., When embyros showed light blue staining, colou-
ring was stoped, embryos fixed and stored in 100% EtOH for WMISH. 
step buffer time repeat
1 1× MEMFA 20 min 1×
2 1× PBS 10 min 3×
3 colour solution 3 hr or oN at 4°C 1×
4 1× PBS 10 min 3×
5 1× MEMFA 40 min 1×
X-Gal: 40 mg/ml in DMSO or formamid, aliquot and store -20°C
colour solution: 1 mg/ml X-Gal, 2 mM MgCl2, 5 mM K4Fe(CN)6, 
5 mM K3Fe (CN)6 in 1× PBS 
K4Fe(CN)6 : 0.5 M in dH2O, keep dark at RT, toxic
K3Fe(CN)6 : 0.5 M in dH2O, keep dark at RT, toxic
2.2.1.5 Embryonic explant preparation
Animal cap explants
Embryos were injected at 2 to 4-cell stage into the animal pole of all blastomeres. At bla-
stula stage 7-8 the vitellin membrane was removed with forceps and the blastocoel roof 
dissected using a gastromaster apparatus, equipped with a microsurgery tip (400-500 µm 
width). Animal cap explants were transferred onto an agarose- coated petri dish and cul-
tured in 0.8× MBS/ 0.1× Pen-Strep at 16°C till control siblings reached the desired develop-            
mental stage. Chemical treatments were performed as described in 2.2.1.7.
Agarose dish 0.7% agarose in 0.8× MBS (Ø 90 mm)
Endoderm explants
Whole endoderm explants were isolated from stage 10.5 by removing the surrounding 
ecto-and mesodermal tissue using forceps and transferring the endodermal cone to an 0.7 
% agarose dish. Dorsal (DE) and ventral (VE) endoderm were distinguished according to 
the position of the blastopore lip. Explants were cultured in 1× MBS till control siblings 
reached the desired developmental stage. 
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2.2.1.6 Chemical treatments of embryos and explants 
Retinoic acid (RA) 
Whole embryos stage 8-9, endodermal explants or animal caps were incubated in 5 µM  
RA (all-trans-RA) in corresponding buffer for 1 hr. After treatment, embryos and explants       
were cultured in their buffer till control siblings reached the desired developmental stage. 
Control treatment was done with corresponding amount of EtOH (Chen et al., 2004).
RA: 10 mM stock in 100% EtOH, store at -20°C, light sensitive; Sigma 
BMS453 
Whole embryos stage 8-9, endodermal explants or animal caps were incubated in 1 µM BMS453   
for 1 hr. After treatment, embryos and explants were cultured in 0.8× MBS till control sib-    
lings reached the desired developmental stage. Control treatment was done corresponding 
amount of DMSO (Chen et al., 2004).
BMS 453: 10 mM stock in DMSO, store at -20°C, light sensitive;  
gift from Bristol Myers Squibb
Dexamethason (Dex)
Proteins fused to the glucocorticoid receptor (GR) binding domain are immobilised in the       
cytoplasm by heat shock poteins. Dexamethason, a steroid hormone, compatitively binds 
to the GR domain releasing the protein from its heat shock inhibitors. 
Dex (1000×): 8 mg/ml in 100% EtOH, store at -20°C, dilute 1:1000; 
2.2.2 Bacterial work
2.2.2.1 Generation of chemical competent cells 
To obtain chemical competent cells (Hanahan et al., 1991), a 5 ml oN culture was          inocula-
ted and diluted into 300 ml prewarmed LB-medium in a 2 l Erlenmeyer flask, shaking at 
220 rpm. When the culture reached OD600= 0.3, cells were grown at 18°C until OD   600= 0.4− 
0.5 (exponential growth phase). The culture was split in 50 ml falcon tubes and centrifuged              
at 4°C and 6000 × g for 10 min. Working on ice, the supernatant was decanted, the pellet 
resuspended in 15 ml prechilled transformation buffer and incubated on ice for 15 min 
The suspension of three tubes was pooled and re-centrifuged for 5 min at 4°C, 6000 × g. 
The pellet was resolved in 15 ml transformation buffer and supplied with 525 µl DMSO, 
incubated on ice for 5 min and supplied again with 525 µl DMSO. After an incubation of 5 
min 200 µl aliquots were shock-frozen in liquid nitrogen and stored at -80°C .             
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LB- Medium: 1% (w/v) Bacto-Trypton (Difco), 0.5% (w/v) �east      extract (Dif-
co), 1% (w/v) NaCl, pH 7.5.   
Transformation buffer: 10 mM PIPES (pH 6.7 with KOH), 15 mM CaCl2, 250 mM KCl, 
addition of +55 mM MnCl2 prior to usage
2.2.2.2 Chemical transformation of competent cells
An 200 µl cell aliquot was unfrozen on ice. 5-10 ng of plasmid- DNA or 1 µl ligation mix-
ture were added and cells incubated for 30 min on ice. DNA uptake was induced upon heat 
shock at 42°C for 50 s followed by immediate incubation on ice for 3           min. Bacteria were 
directly spread onto prewarmed LB-agarose plates using small glass beads and incubated 
oN at 37°C in an incubator. LB-plates contained antibiotics for selection   (see 2.1.6) and, in  
need of blue-white screening, they were preincubated at 37°C with 40 µl X-Gal and 100µl        
IPTG.
LB- Agar: 1.5% (w/v) Agar (Difco) in LB-media
X-Gal: 20 mg/ml X-Gal in Dimethylformamid, store –20°C; Sigma
IPTG: 100 mM IPTG in dH2O, store –20°C; Roth
2.2.2.3 Glycerol stocks 
A glycerol stock was made for long time storage of bacterial culture. 1 ml of oN culture        
was spin down for 2 min in a table centrifuge. The pellet was resuspended in 500 µl fresh 
LB-media. 250 µl of 100% glycerol was added and the solution mixed on a rotor for 10 min. 
The glycerol stock was stored at -80°C. 
2.2.3 DNA work (according to Sambrook et al., 1989)
2.2.3.1 Nati�e agarose gel electrophoresis
1%− 2% (w/v) agarose gels were prepared in 1× TAE and supplied with 0.5 µg/ml EtBr. 
Analytic samples were mixed on parafilm with a drop of DNA loading dye prior to laoding            
the sample to the gel pocket. Gels were run in 1× TAE (8    min, 100 mA) in a home made 
horizontal electrophorese chamber. The negative charged DNA fragments migrate in an 
electric field from anode to the kathode thereby separating according to their size.Frag-
ment sizes were estimated in comparison to a molecular standard marker (Low-, Middle-, 
High range ladder, MBI- Fermentas). Images were taken with a video documentation sy-
stem (Chemidoc, Biorad).
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Glycerol loading buffer: 10 mM Tris-HCl pH 7.5, 10 mM EDTA pH 8, 0.025% 
(w/v) Bromphenol blue, 0.025% (w/v) Xylencyanol, 30% 
(v/v) Glycerol 99%
50× TAE buffer: 2 M TrisHCl, 1M acetat, 0.1 M EDTA
0.5 M EDTA 0.5 M Na2EDTA*2H2O, pH 8
2.2.3.2 DNA purification 
Mini plasmid purification
Small amounts of plasmid were isolated using the IllustraTM plasmid spin Mini Kit accor-
ding to the manufacturers protocol. 5 ml bacterial culture was spin down, resuspended and 
lysed in an alkaline buffer including RNase A. After 5 min incubation at RT the reaction 
was stoped by addition of a neutralisation buffer. Precipitate including lipids and denatured 
proteins, was spin down for 10 min. The supernatant was applied to the column and spin 
down whereby DNA bound to the column matrix. Salts were washed away using a EtOH 
containing buffer. Finally the DNA was eluted from the column in 50 µl elution buffer (1M 
TrisHCL, pH 8) or dH2O. Plasmids were confirmed by sequencing and stored at -20°C.         
Midi plasmid purification
To obtain high plasmid amounts, large scale plasmid preparation was done using Plasmid 
Midi purification Kit (Quiagen). 50 ml bacterial culture were spin down at 6000 × g (Herae-            
us megafuge 1.0 R) for 15 min. The pellet was resuspended in an alkaline lysis buffer and 
incubated for 5 min. To eliminate cell debries and proteins after addition of 5 ml neutrali-           
sation buffer, the solution was filtered before column application (Sartorius, grade 3 Hw). 
The column was emptied by gravity and washed twice with 10 ml highsalt/ EtOH washing 
buffer. DNA was eluted by 5 ml elution buffer, precipitated by addition of 3.5 ml Isopropa-
nol and pelleted for 30 min. at 15000 × g at 4°C ( Heraeus megafuge 1.0 R). The supernatant           
was discarded, the pellet was carefully transferred into a 1.5 ml eppendorf tube, washed 
with 70% EtOH, recentrifuged for 10 min and the pellet finally airdried (37°C). After re-    
suspension in 50 µl elution buffer, the concentration was measured, adjusted to 1 µg/µl and 
the sample stored at -20°C. 
DNA purification from enzymatic reaction
DNA fragments from enzymatic reactions were purified using the IllustraTM GFX PCR 
DNA and Gel Band purification Kit according to the manufacturers protocol. Samples were 
mixed with acetate containing buffer, applied to a glass fiber matrix column and spin down. 
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DNA bound to the matrix while proteins and salts were eliminated by EtOH containing 
wash buffer (10mM TrisHCl, pH 8.0, 1mM EDTA). DNA was eluted in 50 µl dH2O and 1µl  
analysed on a agarosegel. Concentration was measured and samples stored at -20°C. 
Agarosegelpurification of DNA fragments
DNA fragments from restriction digests or PCR amplification were isolated by gelextrac-
tion using the IllustraTM GFX PCR DNA and Gel Band purification Kit according to the 
manufacturers protocol. DNA was eluted in 50 µl dH2O. 1 µl of the sample was analysed 
on an agarosegel and the rest stored at -20°C until usage.
2.2.3.3 Measurement of nucleic acid concentration
The nucleic acid content of a solution was measured using a quarzküvette and UV-spec-
trophotometer. The RNA/ DNA sample was diluted 1:50 in H2O and measured at a wave-
length of 260 nm.  O∆260 = 1: 50 µg dsDNA
   O∆260 = 1: 40 µg RNA
Additionally the protein content of the sample was measured at OD280 to estimate the pu-
rity of the sample. Protein contamination was excluded if the ratio of O∆260/ OD280 was 1.8 for 
DNA and 2.0 for RNA samples.
2.2.3.4 Polymerase chain reaction (PCR) 
DNA fragments were specifically amplified using PCR (Mullis et al., 1987; Saiki et al., 1988). 
The Taq- DNA polymerase was used for general purpose. The  High fidelity polymerase Kit 
was used for amplification of ORFs. The enzyme maintains a 3´→ 5´  exonuclease “proof- 
reading” activity that reduces chances for point mutations during the amplification pro-
cess. In addition, PCR was used to identify insert-positive bacterial clones (colony- PCR) 
after transformation. Single colonies were picked from the LB-plate, transferred to 100 µl 
LB-media (incl. antibiotic) in a 96-well plate and grown for 2.5 hr. Therfore 0.5 µl bacterial 
culture were used for a 25 µl PCR reaction.  
reaction mix: 10 µl 5× reaction buffer incl. MgCl2
1 µl primer-mix ( each 10µM)
0.5 µl 25mM dNTPs
1 µl GoTag polymerase
1 µl template
ad 50 µl dH2O
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thermocycler program: 95 °C 2 min (denaturation)
95°C 45 s (denaturation)
✴56°C 45 s × 30 cycles (annealing)
 ✴✴72°C 1-3 min (synthesis)
72°C 10 min (final elongation)
4°C ∞ (cooling)
✴primer specific annealing temperature; ✴✴insert specific synthesis time ( 1 kb/min)
PCR products were analysed on a 1.5% agarose gel. In case of a colony- PCR, positive trans-
formants were selected from the 96-well plate and grown for small or large scale plasmid 
purification. 
25mM dNTPs: MBI Fermentas; 100 mM stock of dATP, dTTP, dGTP and dCTP 
were mixed in equal volumes, aliquoted and stored -20°C.
2.2.3.5 DNA sequencing
Correct DNA sequences were confirmed by sequencing (Sanger et al., 1977). The sequenci-
ng reaction was done according to the manufacturesr protocol Big Dye Terminator Kit. 
Sequencing reaction: 300 ng plasmid template
0.8 µl sequencing primer (10 µM)
1.5 µl “Seq- Mix” 
1.5 µl “Seq- buffer” 
ad 10 µl dH2O
thermocyler program: 95°C 2 min
95°C 30 sec
50°C 20 sec × 25
60°C 4 min
4°C ∞
DNA products were precipitated by addition of 1 µl 125 mM EDTA, 1 µl 3 M NaAc and 50 
µl 100% EtOH. The sample was mixed, incubated for 5 min at RT and centrifuged for 15 
min at max. speed in a table centrifuge. The supernatant was discarded, the pellet washed 
with 70% EtOH and centrifuged for 5 min at max. speed. The supernatant was removed 
entirely and the pellet air-dried at 37°C. The DNA pellet was resolved in 15 µl „HiDi“ 
formamid. Sequencing and documentation were performed at the internal service unit 
by Andreas Nolte using Abi Prism 3100 genetic analyzer (Applied Biosystems). Analysis 
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of the sequence read out was done using free available software: 4 Peaks, MacMolly Tetra 
Version 1.2 (Soft Gene GmbH, Berlin), CLC Free Workbench 4 as well as the NCBI BLAST 
(Altschul et al., 1997).
2.2.3.6 Plasmid linearization 
Plasmids were linearized for in vitro sense and antisense RNA transcription (Sambrock 
et al., 1989). 
reaction mix: 5-10 µg plasmid
 5 µl 10× restriction buffer 
 10 U restriction enzyme 
ad 50 µl dH2O
The reaction was incubated oN at 37°C. Complete linearisation was confirmed by testing 1 
µl on a 1% agarose gel. Linearized fragments were purified using IllustraTM GFX PCR DNA 
and Gel Band purification Kit. Elution was done in 50 µl dH2O and samples used for in vitro 
RNA transcription.
2.2.3.7 Double restriction digest
For cloning purposes, DNA fragments and vectors were restricted with two differing en-
zymes resulting in overhanging „sticky“ ends. 
reaction mix: 0.5-1 ng DNA
1 µl restriction enzyme (10 U/µl) 
1 µl restriction enzyme II (10 U/µl)
5 µl 10 × restriction enzyme buffer
ad 50 µl dH2O
The reaction mix was incubated oN at 37 °C, tested on a 1% agarose gel and the band of 
interest was purified with the gel- purifiaction Kit. Double digest using two different en-
zymes at once could be performed using adequate enzyme amount and corresponding 
buffer condition (MBI-Fermentas online).
37
Materials and Methods
2.2.3.8 Ligation of DNA fragments
Nondirected ligation using the pGEM-T Easy �ector 
The reaction was setup according to the manufacturer protocol.
reaction mix: 10 ng DNA insert
0.5 µl vector 
0.5 µl ligase enzyme mix
1 µl 10× ligation buffer
ad 10 µl dH2O
Reaction was incubated for 2 hr at RT or 16°C oN prior to chemical transformation into 
E.coli.
Site directed ligation into pCS2+ and deri�ati�es
Introduction of restricted DNA inserts into pCS2+ for cloning purposes was done using an 
T4 ligation reaction.
reaction mix: 10- 100 ng DNA insert (restricted)
10- 100 ng pCS2+ vector (restricted) 
1µl T4 ligase ( 3 U/ µl)
1µl 10× T4 ligase buffer
ad 10µl dH2O
Reaction was incubated oN at 16°C prior to chemical transformation into E.coli.
2.2.4 RNA work
RNase free environment was assured by working on ice, using gloves, filter tips, autoclaved 
glas ware and solutions as well as DEPC- H 2O. 
DEPC- H2O: 0.1% (v/v) Diethylpyrocarbon in dH2O, stirred oN at RT; autoclave
2.2.4.1 Total RNA extraction from embryos, adult tissues and explants     
Total RNA was isolated from whole embryos, adult tissues and explants for semiquantita-     
tive RT-PCR analysis using the TRIzol Reagent (Invitrogen, Chomczynski, P. & Sacchi, N, 
1987). RNA quality was analysed using Agilent 2100 Bioanalyzer (Agilent Technologies,          
Germany) prior to RT-PCR analysis.
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RNA extraction from whole embryos
To analyse temporal gene expression patterns, total RNA was extracted and used in a se-
miquantitative RT-PCR analysis (see 2.2.4.3). Five embryos were shock frozen in liquid 
nitrogen, homogenized in 400 µl TRIzol reagent (Invitrogen) using a syringe (Ø. 0.4 mm) 
and vortexed well. After a 5 min incubation at RT cell debries were spin down for 10 min 
(4 °C) and RNA containing supernatant was transfered into a clean eppendorf tube. 0.2 
Vol chloroform were added, the mixture vortexed for 1 min, incubated at RT for 5 min and 
centrifuged for 10 min at 4 °C. The upper phase inlcuding soluble nucleic acids was trans-
ferred carefully to a clean tube and supplied again with 1 Vol chloroform, vortexed and             
centrifuged for 10 min at 4 °C. The lower organic phase including lipids and denatured pro-      
teins was discarded to phenol waste (fume hood). After the 2nd centrifugation, the aquatic 
phase was transferred into a new eppendorf tube to precipitate nucleic acids with Isopro-
panol for 2 hr at -20°C. Precipitate was pelleted for 30 min at 13.000 rpm at 4°C, washed             
with 75% EtOH, centrifuged for 10 min at 4°C and the pellet airdried before resolving it in 
30 µl DEPC-H2O. To obtain DNA- free samples an DNaseI digest was performed for 1h at 
37°C by addition of 1/10 vol 10× DNase buffer and 1 µl DNaseI. The endonuclease, cutting 
single and double stranded DNA strands, was afterwards inactivated at 75°C for 15    min. 
The samples were stored at -20°C. 
RNA extraction from adult tissues
Adult organs were dissected in the process of     Xenopus laevis testis preparation. Organs 
were quickly washed in 1× MBS and shock frozen in liquid nitrogen and stored at -80°C. 
The tissue was grinded in liquid nitrogen in a grander that was prewashed with 1M NaOH, 
100% EtOH and DEPC-H2O. The powder was filled into a clean 1.5 eppendorf tube. RNA 
extraction was done after addition of 1 ml TRIzol/ 100 mg tissue as previously described. 
RNA extraction from explants
Total RNA extraction from 20 animal caps, 20 whole endoderm or 30 dissected endoder-
mal explants was done after addition of 400 µl TRIzol as previously described. 
2.2.4.2 RNA purification from enzymatic reactions
In vitro synthesised RNA was purified using the IllustraTM RNAspin Mini Kit according to 
the manufacturers protocol. The method is based on affinity chromatography by binding 
RNA to the column matrix. Samples were mixed with coupling buffer and 100% EtOH and 
the solution applied to the column. After washing away enzmyes, salts and free ribonucleo-
tides with a supplied washing buffer, RNA was eluted with 50 µl RNase free H2O (2 min at 
70°C), concentration was measured and samples were stored at -20°C. 
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2.2.4.3 Re�erse transcriptase polymerase chain reaction (RT-PCR)
RT-PCR analysis was used to study temporal gene expression profiles or alterations of gene 
expression upon chemical treatment or microinjection. Total- RNA (equalized to 100 ng/
µl for „semiquantitative RT-PCR analysis“) was reverse transcribed into cDNA that was 
used as template for the following PCR reaction. The general RT reaction was done using 
an unspecific “random XHexamer primer” (RH, Invitrogen) binding randomly to RNA 
strands. This short double stranded fragment serves as initiation side for the viral reverse 
transcriptase. An „Oligo-dT primer“ (dT, Invitrogen) for predominant reverse transcripti-     
on, of mRNA was used in case of XHNF6 gene isolation. A primer containing RT- premix 
was prepared and stored at -20°C till usage. cDNA was stored at -20°C or used directly for         
gene expression analysis in a PCR reaction.
RT Premix: 100 µl 25 mM MgCl2
400 µl 5× Flexi GoTaq buffer (wo MgCl2)
50 µl RH/ Oligo- dT( 100 ng/µl)
100 µl dNTP mix ( each 10 mM)
300 µl DEPC-H2O
RT reaction mix: 7.5 µl RT premix
0.1 µl MuLV RT enzyme ( 50 U/µl)
0.2 µl RNase Out ( 40 U/µl)
1.5 µl Total RNA ( 100 ng/µl)
ad 10 µl DEPC-H2O
thermocycler program: 22°C    20 min (primer annealing)
42°C  60 min (reverse transcription)
99°C  5 min (denaturation)
 4°C   ∞ (cooling)
PCR reaction mix: 5 µl cDNA
1 µl 25 mM MgCl2
4 µl 5× Flexi GoTaq buffer
1.25 µl gene specific primer mix (each 10µM) 
0.25 µl GoTaq polymerase
ad 25 µl dH2O
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thermocycler program: 95°C  2 min
95°C  45 s
X °C  45 s × Y
72°C  45 s 
72°C  5 min
 4°C  ∞ 
X= primer specific annealing temperature; Y= cycle number depends on the mRNA abundancy of the gene          
of interest. Variables have to be optimized for each primer pair.
After PCR reaction, 20 µl of the PCR product were analysed on a 2% agarose gel. For clo-
ning purposes the band of interest was cut out, purified and cloned into pGEM-T.
2.2.4.4 5 -´/ 3 -´ Rapid amplification of cDNA ends (RACE- PCR)  
To obtain cDNA information of Xenopus laevis XHNF6 including the 5` and 3´ UTR re-
gion 5´  and 3´ RACE PCRs were performed using the SMARTTMRACE- PCR amplification 
Kit (Clonetech) according to the manufacturers protocol. 
Synthesis of 5 /´ 3´ RACE cDNA 
5´ / 3´RACE- Ready cDNA, needed for the later PCR amplification step, was reverse tran-
scribed from a total RNA pool. 
In the process of reverse transcription in the 5´ RACE reaction, the reverse transcriptase         
adds a poly-G sequence to end of every transcript. This poly-G tail serves as complentary 
site for a kit- supplied poly-C oligomer (SMART-II Oligo). Docking of this poly C oligo 
leads to a second transcription initiation side and the transcript will automatically be elon-
gated by an oligo linked sequence. This artificial sequence is binding side for the universal 
primer used in the following PCR amplification step. 
reaction mix: 1 µg total RNA
 1 µl 5´ cDNA synthesis primer
[1 µl SMART II oligo ( just for 5´ RACE)]
ad 5 µl dH2O
Reaction mixture was incubated at 70°C for 2 min. in a thermocycler (denaturing) and 
cooled down for 2 min on ice (primer annealing).  
+ 2 µl 5× first strand synthesis buffer
1 µl 20 mM DTT
1 µl dNTP Mix (10 mM each)
1 µl Power script reverse transcriptase (200 U/µl)
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After the addition of first strand synthesis components, cDNA revers transcription was 
performed at 42°C for 1.5 hr. Product was supplied with 90 µl Tricine- EDTA buffer, incu-
bated for 7 min at 72°C and stored at -20°C. 
Amplification of 5 /´ 3´ cDNA ends (RACE- PCR)
For the PCR amplification of 5´ / 3 e´nds a PCR premix was mixed and complemented by 
5´ -RACE or 3 -´RACE specific components
reaction premix: 31 µl dH2O
5 µl 10× PCR buffer  
1 µl dNTP mix (each 10mM)
1 µl 50× Advantage 2 Polymerase Mix    
+ 5 µl 5´RACE ready cDNA + 5 µl 3´RACE ready cDNA
 5 µl 10× Universal Primer Mix  5 µl 10× Universal Primer Mix
 1 µl gene specific primer 1 (10 µM)  1 µl gene specific primer 2 (10 µM)
To amplify gene specific products a „touchdown PCR“ was performed.
thermocycler program: 94°C  5 s
72°C  3 min × 5
94°C  5 s
70°C  10 s × 5
72°C  3 min
94°C  5 s
68°C  10 s × 35- 40
72°C  3 min
4°C ∞
PCR product was analysed on a preparative 1.5% agarose gel. Bands of expected size were 
cut out, gel purified and cloned into pGEMT-E vector.
2.2.4.5 In vitro RNA transcription
Transcription of capped sense RNA
Capped sense RNA (capRNA) for microinjection was generated using the SP6 mMESSAGE 
mMACHINETM Kit according to the manufacturers protocol. Transcripts are synthesised        
with a 7- methylguanosin „cap“ at the 5´  end leading to increase mRNA stability. 
→→
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reaction mix: 3 µl linearised plasmid [ 150 ng]
1 µl RNA- polymerase ( 10 U/µl)
5 µl 2x rNTP/ CAP Mix
1 µl 5× Sp6 reaction buffer 
0.2 µl Pyrophosphatase
The reaction was incubated at 37°C for 2 hr. The template was afterwards digested for 15 
min at 37°C using 5 U DNaseI. RNA was purified using IllustraTM RNAspin Mini Kit accor-
ding to the manufacturers protocol. After elution in 25 µl DEPC- H2O the concentration 
was measured and the sample aliquoted in 2 µl for storage at -20°C. 
Transcription of labeled antisense RNA
Antisense RNA (asRNA) used for in situ hybridisation techiniques was in vitro transcribed 
from 1µg linearised template using the corresponding polymerase (construct list see 2.1.9) 
and thereby labeled with digoxigenin (Dig)-11-UTP (Roche) or fluorescein (Flu)-11- UTP 
(Roche). (Melton et al., 1984)
reaction mix: 5 µl 5× transcription buffer  
4 µl Dig/ Flu- rNTP Mix
1 µl DTT (0.75 mM)
0.5 µl RNase OUT
1 µl RNA polymerase (Sp6, T7, T3)
0.5 µl Pyrophosphatase
5 µl template
ad 25 µl DEPC- H2O 
After 2,5 hr the template was digested for 15 min at 37°C using DNaseI. AsRNA was pu-
rified using IllustraTM RNAspin Mini Kit according to the manufacturers protocol. After 
elution in DEPC-H2O the RNA was analysed on a 2% agarosegel, supplied with 50 µl hy-
bridisation mix and stored until usage at -20°C.
Dig-or Flu- Mix: 2 nM rATP, 2 nM rGTP, 2 nM rCTP, 1.9 nM rUTP, 
0.1 nM Dig- or Flu-11-rU TP
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2.2.4.6 Whole mount in situ hybridisation (WMISH) 
Embryos were stained by whole mount in situ hybridisation (Harland et al.,   1991; modi-
fied after Hollemann et al., 1999) using organ or tissue specific markers to visualize effects         
upon microinjection or chemical treatments.
10× PBS 1.75 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM 
KH2PO4, pH 7.4 
1× PTw 1× PBS, 0.1% (v/v) Tween-20, pH 7.4
100× Denhart´ s 2% (w/v) BSA, 2% (w/v) PVP, 2% (w/v) Ficoll-400, store 
-20°C
Heparin 10 mg/ml in DEPC-H2O stock solution, store at -20°C
Torula RNA 50 mg/ml stock solution in DEPC-dH2O, store at -20°C
Proteinase K 20 mg/ml stock (Merck, Darmstadt)
Hybridisation-Mix 
(Hyb-Mix):
50% (v/v) formamid, 1 mg/ml Torula-RNA, 10 µg/ml 
Heparin, 1× Denhardt´ s, 0.1% (v/v) Tween-20TM, 0.1% 
(w/v) CHAPS, 10 mM EDTA, 5x SSC in DEPC-      H2O
TEA 0.1 M TEA (= 0.675 ml TEA/ 50 ml dH2O), pH 7.5
20× SSC 3 M NaCl, 0.3M NaCitrat, pH 7.4
2× SSC incl. RNases 20 µg/ml RNaseA, 10 U/ml RNaseT1
5× MAB 500 mM maleic acid, 750mM NaCl, pH 7.5 autoclave
10% BMB 10% (w/v) were dissolved slowly at 60°C in 1× MAB, al-
iquoted in 50ml; stored at -20°C, autoclaved
100% Horse Serum Horse Serum was heat inactivated for and aliquoted in 
50 ml; stored at -20°C
APB 100 mM TrisHCl, 100 mM NaCl, 50 mM MgCl2, 0,1% 
(v/v) Tween-20TM , pH 9.0-9.1
BCIP 50 mg/ml in 100% DMSO (Roche Diagnostics)
NBT 100 mg/ml in 70% DMSO (Roche Diagnostics)
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Rehydration
MEMFA fixed embryos (30/ glass tube) were rehydrated in reverse ethanol steps on a ro-
tating shaker. 
step EtOH buffer time repeat
1 100% - 5 min 1 ×
2 75% H2O 25% 5 min 1 ×
3 50% H2O 50% 5 min 1 ×
4 25% PTw 75% 5 min 1 ×
5 - PTw 100% 5 min 4 ×
Proteinase K treatment
Embryos were treated with 10 µg/ml Proteinase K for optimal penetration of the antisense 
RNA. Duration of treatment depended on developmental stage of embryos.
stage time temp stage time temp
10- 14 10 min RT 33- 35 25 min RT
15- 18 12 min RT 36- 39 28 min RT
19- 22 15 min RT 40- 41 30 min RT
23- 26 20 min RT 42 32 min RT
28- 32 22 min RT 43- 44 35 min 37°C
Acetylation and Refixation
Delicate embryos were transferred to 0.1 M TEA (pH 7.5), acetylated with acetic anhydrid 
(AA) and refixed in 1× PTw/ 4% (v/v) formaldehyde.    
 
step buffer time repeat
1 TEA 5 min 2 ×
2 TEA + 12.5 µl AA   5 min 1 ×
3  + 12.5 µl AA 5 min 1 ×
4 1× PTw 100% 5 min 2 ×
5 1× PTw/ 4% FA  20 min 1 ×
6 1× PTw 100% 5 min 5 ×
Hybridisation
The Hybridisation buffer (Hyb-Mix) was preheated in the steam (65°C) of a 68°C water-
bath. For hybridisation 1× PTw was removed up to 1 ml and filled with 250 µl Hyb- Mix.               
The solution was gently mixed. When embryos sink to the bottom liquid was completely 
removed, refilled with 500 µl Hyb- Mix and then preincubated for 10 min at 65°C in the                 
Table 2: Duration of proteinase K treatment during WMISH for different developmental stages
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shaking waterbath. The solution was replaced by fresh Hyb- Mix in which embryos were 
prehybridized for 6 hr at 65°C to prevent unspecific RNA binding. The Hyb- Mix, colle-
cted and kept for a later washing step at 65°C, was repalced by 500 µl Hyb- Mix including 
labeled asRNA (1 µg/ml). Hybridization process was performed oN at 65°C in the shaking 
waterbath. 
Washing
The next day the asRNA samples were collected (stored at -20°C for reuse) and the embryos 
washed with preheated “used” Hyb- Mix for 10 min. The embryos were washed under 
stringent conditions and treated with 10 µg/ml RNAseA (1 µl/ml) and 10 U/ml RNaseT1 
(0,33 µl/ml) to remove unspecific bound and single stranded RNA. 
step buffer time temp repeat
1 Hyb- Mix 10 min 60°C 1×
2 2× SSC 20 min 60°C 3×
3 2× SSC including RNase   60 min 37°C 1×✴
4 2× SCC 10 min RT 1×
5 0.2× SSC 30 min 60°C 2×
6 1× MAB 15 min RT 1×
✴incubation in an 37°C incubator and shaked manually from time to time
Antibody incubation
After the stringent SSC wash the embryos were equilibrated to MAB buffer and incubated 
in a mixture of 2% Böhriger Mannheim Blocking reagent (BMB) and 20% heat inactivated 
horse serum (HS) in 1xMAB, to prevent unspecific antibody binding in the later detection 
step. Hybrids of endogenous RNA and asRNA (Dig- or Flu labeled) were detected by a spe-
cific antibody against Digoxigenin or Fluorescein that is couppeld to alkaline phosphatase 
(anti- Dig-AP or anti- Flu-AP).    
step buffer time temp repeat
1 1× MAB 15 RT 3×
2 1× MAB/2%BMB 20 RT 1×
3 1× MAB/2%BMB/ 20% HS   60 RT 1×
4 1× MAB/2%BMB/ 20% HS   
α-Dig/ α-Flu 1:5000 ✴
240 RT 1×
5 1× MAB 10 RT 1×
6 1× MAB oN 4°C
✴Sheep-anti-Dig/ Flu; linked with alkaline phosphatase (AP; LaRoche)       
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Colour detection
Samples were washed multiple times with 1× MAB to reduce background staining upon       
unspecific antibody binding. To detect labeled RNA- hybrids, embryos were incubated         
in NBT/ BCIP colour solution. Colour reagents are dephosphorylated by antibody linked 
alkaline phosphatase, resulting in a coloured precipitate in cells (dark purple for NBT/
BCIP).
step buffer time temp repeat
1 1× MAB 20 min RT 3×
2 APB 5 min RT 2×
3 APB incl. NBT/ BCIP✴ 3h- 4d 4°C till staining
✴ 1.5µl NBT/ ml APB+ 3.5µl BCIP/ ml APB
Colour reaction ending
When embryos showed a clear staining signal, colour reaction was stopped using 100% 
Methanol. Overstained samples could partialy be destained. 
step buffer time temp repeat
1 dH2O 2 min RT 1×
2 100% MetOH 2-5 min RT 1×
3 50% MetOH 2 min RT 1×
4 MEMFA fixation 4°C ∞
Fast embryo bleeching
After WMISH the colour solution is discarded and embryos washed in 2 ml dH2O, fixed 
in 1× MEMFA for 30 min. and 2× 20 min in 5× SSC. Pigments were destained using 5×                 
SSC/ 50% Formamid (v/v) + 1% H2O2. After 2× 20 min in 5× SSC embryos were stored in          
1× MEMFA. 
2.2.5 Vibratome sections 
To analyse interembryonic staining embryos were enbedded into gelatine/albumine after 
WMISH (Holleman et al., 1999). On ice, 105 µl 25% glutaraldialdehyde were stirred into 2 
ml gelatine/ albumin and the first layer was poured into a well of an icecube container. Em-
bryos were preincubated for 10 min. in gelatine/ albumine and layed on top of the polyme-
rized layer and remaining liquid removed. A second level of embedding media was poured. 
After hardening the block was cut to a proper size and the embryo fixed on a cutting board. 
Using a vibrotome 30 µm sections were done in soap containing dH         2O, collected on a glass 
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slide, airdried and mounted in moviol. Pictures were taken by an phasecontrast microsope 
(Nomarski-Optik, Axioskop) and digitalized with a camera (DXC-950P Colour Video Ca-
mera). Sections were stored at -20°C. 
Gelatine/ albumine Dissolve 4.88 mg/ml gelatine in 1× PBS slowly at 60°C. After      
cooling down 0.3 g/ ml albumine fraction V and 0.2 mg/ml         
succrose are added and dissolved oN at 37°C; filtersterilize and 
store at -20°C. 
Moviol 4-88 dissolve 5 g moviol in 20 ml 1x PBS oN, add 10 ml Glycerol and 
stirr oN. After centrifugation for 30 min at 20000 g the super-
natant is aliquoted, pH 6-7; stor at -20°C
2.2.6 Protein work
2.2.6.1 Protein extraction from Xenopus laevis embryos
Protein extraction from whole embryos were done to analyse the temporal protein ex-
pression pattern of p150/ malectin. 10 Embryos were shock frozen in liquid nitrogen and 
homogenized on ice in 400 µl homogenisation buffer with a syringe (26 G, Terumo Neo-             
lus) and by vortexing. Total protein extracts were separated into membrane and soluble             
compounds by centrifugating for 10 min at 4°C. The supernatan was tranferred into a new 
tube for FREON lipid extraction. The pellet containing cell debries and membrane com-
partments was resolved in SDS-sample buffer ( 20µl/ embryo) by vortexing and heating to     
95°C. 1/10 volume was loaded onto a SDS- gel for electrophoretic separation, the remaining 
sample stored at -20°C. 
Homogenisation buffer 50 mM TrisHCL pH 7.5, 150 mM NaCl, 5% Glycerin, 
1 mM DTT, 1 tablet/ 10 ml protease inhibitors ( Roche) ,
50 mM NaF, aliquot store -20°C
FREON extraction and TCA Precipitation
Soluble proteins were concentrated after FREON extraction by mixing with 0.1 Vol 1% Na-
DOC, incubating for 15 min. at RT and supplying 0.22Vol 50% TCA solution. After protein 
precipitation for 2 hr at 4°C, samples were spin down for 30 min at 4°C with 14.000 rpm. The 
supernatant was decanted and the pellet washed with 1 ml icecold aceton. After mixing 
proteins were precipitated for 1h at -80°C, spin for 1 min at max speed, the pellet washed 
with 70% EtOH, airdried and resuspended in 30 µl dH2O. 
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2.2.6.2 SDS- Polyacrylamide gel electrophoresis (PAGE) 
SDS- PAGE (Laemmli, 1970) was used to seperate proteins according to their molecular 
weight. Due to SDS, proteins obtain a negative charge that allows them to migrate through 
polymerized acrylamide in an electric field depending on their molecular weight. Molec-
ular weight of proteins was estimated by comparison to protein standard “Broad Range 
Marker“ (Biorad). Prior to protein separation in the separation gel, differing in acrylamid 
concentrations, a the protein extract was focused in a stack gel. 
mini gel size ( 60 × 130 × 0.5 mm)  separation stack 
12% 15% 12%
30% Acrylamid Mix 4.0 ml 5.0 ml 2.0ml
1.5 M TrisHCl pH 8.8 2.5 ml 2.5 ml -
0.5 M TrisHCl ph 6.8 - - 1.3 ml
10% ( w/v) APS 0.1 ml 0.1 ml 0.05 ml
10% ( w/v) SDS 0.1 ml 0.1 ml 0.05 ml
dH2O 3.3 ml 2.3 ml 1.7 ml
midi gel size ( 87× 77 × 1 mm) separation stack
12% 15% 5%
30% Acrylamid Mix 8.0 ml 10 ml 0.83 ml
1.5 M TrisHCl pH 8.8 5.0 ml 5.0 ml -
0.5 M TrisHCl ph 6.8 - - 1.26 ml
10% ( w/v) APS 0.2 ml 0.2 ml 0.04 ml
10% ( w/v) SDS 0.2 ml 0.2 ml 0.04 ml
dH2O 6.6 ml 4.6 ml 2.77 ml
The stack gel was runned in 1× Laemmli buffer using a selfmade electrophorese chamber 
with 35 mA for 45 min. Than power was increased to 45 mA for 3 hr. Gels were used for 
Coomassie blue staining (see 2.2.4.3) or for western blot analysis (see 2.2.4.4).
2× SDS- sample buffer: 120mM TrisHCl pH 6.8, 20% (v/v) Glycerol, 4% (v/v) SDS, 
200mM DTT; aliquot and store -20°C
10× Laemmli buffer: 250 mM Tris, 2.5 M Glycin, 1% SDS, pH 8.3
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2.2.6.3 Coomassie staining
After SDS- PAGE, proteins could be visualized by staining the gel for 30 min in coomassie 
colour solution. 
Coomassie colour solution: 40% (v/v) Methanol, 10% (v/v) acetic acid, 50% dH2O, 
0.1% (w/v) Coomassie Blue G-250
Coomassie destaining 
solution:
40% (v/v) Methanol, 10% (v/v) acetic acid, 50% dH2O
2.2.6.4 Western blotting
The analysis of one specific protein from whole protein extracts was done by immuno-
detection assays. Proteins were transferred, blottet, from the SDS gel onto a nitrocellulose 
membrane (Ø 0.45 µm, BA85; Schleicher & Schuell). Therefore, the gel and nitrocellulose 
membrane were briefly washed, and 6 gel- size whatman papers were soaked, in 1× protein 
blotting buffer prior to setting up the „Western Blot sandwich“ (figure 2).
The proteins were transferred onto the membrane using a blotting cassette ( Fastblot B 34, Bi-
orad) with 0.8 mA/ cm2 for 1 hr. The membrane was washed in 1× PBS /Tween and unspecific 
binding sites were blocked oN at 4°C with 5% (w/v) milc buffer.
The following day the membrane was washed briefly in PBS/Tween. First antibodies were 
diluted in 5% (w/v) milk buffer and incubated for 1 hr at RT (Mouse- anti- FlagM2 1: 
5000; rabbit- anti-p150/ malectin 1:15 000). The blot was washed 3× with PBS/Tween for 
10 min. Second antibodies, coupled with horse-radish-peroxidase (HRP), were diluted in 
PBS/ Tween (goat-anti -rabbit- HRP 1: 5000) and incubated for 1 hr at RT. After an inten-
sive wash with PBS/ Tween protein detection was visualized by chemilumineszence using 
the ECL+ plus Wetsern Blotting Detection System. Solution A (50 µl/ cm2) was mixed 40:1 
with solution B, poured over the membrane and incubated for 5 min at RT. The membrane 
was sealed in plastic and exposed to chemiluminescense photofilm (GE healthcare) that 
was afterwards developed (Optimax Type TR).
Figure 2: Schematic drawing of a semi-dry western blot sandwich (Khyse-Anderson, 1984)
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Protein blotting buffer: 39 mM Glycine, 48 mM Tris Base, 0.037% (v/v) SDS, 20% 
(v/v) MetOH, pH 9.2, store at 4°C
1× PBS/ Tween: 0.05% (v/v) Tween-20 in 1x PBS
2.2.6.5 Bradford assay
Protein concentration was estimated by Bradford. A standard curve was made using 0- 20 
µg BSA (1mg/ml). Dilutions were made in the protein buffer. 1 ml Bradford were added, 
incubated for 10 min. at RT. Change in Extiction was measured at 595nm. Protein concen-
tration of the sample were estimated using the standard curve. Measurements were done 
twice. 
Bradford solution 100 ml 95% EtOH, 200 ml 88% Phosphoric acid, 
350 mg Coomassie G250
Bradford reagent 425ml H2O, 15 ml 95% EtOH, 30 ml 88% Phospho-
ric acid, 30 ml Bradford solution
2.2.6.6 In vitro transcription and translation assay (TnT©)
The TnT©-coupled reticulocyte lysate sytem (Promega) was used to test in vitro translation 
of constructs and to analyse efficiency of morpholino binding. The system is based on a          
transcription and 
Nonradioactive as well as radioactive (hot TNT(hTnT)), using       35S labeled methionine, were 
performed according to the manufacturers protocol with some modifications.
reaction mix: 6.25 µl TnT rabbit reticulocyte lysate
0.5 µl TnT reaction buffer
0.25 µl TnT Sp6 RNA polymerase
0,25 µl AA mix (w/o methionin)
[0.25 µl (35S)-methinonin (Ci/µmol at 10 µCi/ml)]✳
0.25 µl RNase Out
1 µl DNA template [300 ng/µl] 
[1 µl morpholino (different concentrations)]✳
 ad 12.5 µl dH2O
✳ if addition was required
The reaction was incubated at 30°C for 90 min in a thermo block. To analyse products by 
SDS- PAGE ( see 2.2.4.1), samples were mixed with 12.5 µl SDS- sample buffer and heated 
for 5 min at 95°C before loading 10 µl on a SDS- gel. After electrophoresis, nonradioactive 
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TnTs were used for western blot analysis. Radioactive SDS- gels were first vacuum dried 
for 2 hr at 80°C (Geldryer, model 583) and afterwards scanned by a Variable Mode Image 
Typhoon 9400 for digital analysis. 
2.2.7. Generation of malectin specific antibody
Analysis of intracellular localization, study of embryonic protein expression and confor-
mation of disrupted protein synthesis upon morpholino injection required a malectin 
specific antibody. The N- terminus of malectin was predicted as signal peptide (aa 1-30),  
potentially cleaved of during modification processes while the hydrophobic C-terminus 
was possibly a transmembrane domain (aa 208-276). For the purpose of antigen generation      
both regions were excluded and just the soluble core domain was overexpressed in bacteria,   
affinity purified and used for rabbit immunisation.    
2.2.7.1 Cloning of malectin core domains
The malectin core domain was PCR amplified out of the pCS2+/p150-ORF plasmid. Four 
different core fragments were generated to test optimal conditions for overepxression in 
bacteria. Two different primer sets were used: tg1- 4 (named after collaboration partner 
Toby Gibson (EMBL, Heidelberg; cloning was done by Günther Stier (EMBL, Heidel-
berg).
name sequence 5�  3�
tg1 (for): GCTGCTCATGAGCGGTCTAGCGGATAAAGTGATCTGG
tg2 (for): GCTGCTCATGAGCGATAAAGTGATCTGGGCAGTGAATG
tg3 (rev): GCTGGTACCTTACTCCAGACCTGGGTGAGGCTGC
tg4 (rev): GCTGGTACCTTAAGGCTGCAGCATTGGGACATC
The resulting four fragments were subcloned into pETZ2-9d vector, in frame to a 6× His-
tag (thereby destroying the NcoI (nt 932) cloning site). Correct in frame fusion was con-
firmed by sequencing. All proteins could be efficiently expressed and purified in bacteria 
(personal communication with Günther Stier). Due to size advantages the largest construct 
TG1 was used by Thomas Schallus (EMBL, Heidelberg) for structural analysis by NMR. 
The smallest fragment TG4 protein was used for antibody generation as subsequently de-
scribed. 
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2.2.7.2 O�erexpression and purification of antigen 
TG4 protein expression and purification was done using the protocol: ”E.coli expression- 
High speed protocols” (Jeanne Perry, UCLA Los Angeles; Günther Stier, EMBL, Heidel-
berg) with some modifications. In general, all buffers contained Tris and DTT for protein          
stabilization, disulfide bond reducing β-mercaptoethanol, proteinase inhibitors as PMSF or 
PEFAC and nonionic detergents, like NP-40 or Triton-X-100 to remove unbound proteins 
and nucleic acids from the affinity column. Imidazol competes with proteins for Ni2+-NTA 
binding sites and prevents at low concentrations (≥ 20mM) unspecific protein binding to 
Ni2+-beads while at high concentrations ( ≤ 100 mM) it leads to elution of His-tagged pro-
teins. 
The TG4- plasmid was transformed into BL21 (DE3) bacteria by chemical transformati-
on. A 50 ml LBKan oN- culture was set up at 37°C. The next day oN-culture was diluted to 
OD600= 0.3 in 37°C prewarmed LBKan. Protein expression was induced upon 1 mM IPTG 
and the culture grew for 6 hr to OD600= 0.8 at 25°C to increase protein yield (highest pro- 
tein expression occurs during exponential growth phase). 1 ml samples were taken (0, 2, 4, 
6h) to analyse protein synthesis in a time course experiment. The culture was spin down at      
6000 × g for 15 min and resuspended on ice in 10 ml/mg wet weight lysisbuffer using a glas       
pipet. The suspension was split in 50 ml Falcon tubes, complemented with 100 µg/ml lyso-
zyme and 1 µg/ml DNaseI and incubated on ice for 15 min. Cells were completely disrupted 
by sonification on ice at highest intensity (2 × 2 min) thereby preventing protein denatu-            
ration by spooming. Cell debries were separated by centrifugation for 15 min at 10.000 × g    
and the clear yellowish supernatant was filtered through 0,45 µm filter (Sartorius).           
For affinity purification, a column (Polyprep, Biorad) was filled with 0.5 ml well mixed 
Ni2+ agarose beads and equilibrated with 5 ml lysisbuffer. The filtered solution was applied 
to the column that was drained by gravity. The flow through was collected and reloaded          
once. Proteins that bound unspecifically to the beads were washed off under stringent con-
ditions by 5 ml Wash 1 buffer, 5 ml Wash 2 buffer and 5 ml Wash 3 buffer. 100 µl of each 
flowhtrough were kept for an analytic SDS-PAGE analysis. The fusion protein was eluted 
with 2.5 ml elution buffer. The flowthrough was reloaded twice to elute maximal protein 
amount. Protein concentration was estimated by Bradford. The column was washed with 
1M imidazol and stored with 70% EtOH at 4°C.
To remove the His-tag of the TG4 protein, a TEV protease cleavage was performed oN at 30 
°C by addition of 40 U/ml enzyme (Invitrogen). Enzymatic cleavage occured at recognition 
sequence EBL�FZG located between the 6 × His- tag and the protein of interest, here TG4.          
Tag and cleaved off protein were separated by a second Ni2±affinity purification step. The-
refore the high imidazol concentration was reduced using a spin column (Vivaspin, 50000    
Da). The sample volume was reduced twice to 500 µl in a            swing bucket rotor at 4000 rpm 
and each time refilled with Wash 1 buffer.
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For the second affinity purification the Ni2+- NTA column was equilibrated with 10 ml 
Wash 1 buffer. The now „dialysed“ protein sample was applied and collected in the flow 
through whereas the 6× His-tag carrier remained on the Ni      2+column. To increase the pro-
tein yield the flow through was reloaded once. After concentration measurement by Brad-
ford, protein was diluted to a 1 mg/ml stock solution aliquoted and stored at -20°C. 5 mg of 
purified TG4 protein were sent to BioScience, Göttingen (Ritschlweg2, 37085 Göttingen, 
Tel: 0551-25248; e-mail: Bioscience@T-online.de) for rabbit immunization. 
Lysisbuffer: 20 mM Tris pH 8.0, 10 mM imidazol pH 8.0, 150 mM 
NaCl, 0.2% NP-40, 2 mM β-Mercaptoethanol ( 1:10000) 
or 5 mM DTT/ DTE, 1 µM PEFAC or 200 µM PMSF
Wash 1 buffer: = Lysisbuffer without 0,2% NP-40
Wash 2 buffer: = Washbuffer 1 with 1 M NaCL
Wash 3 buffer: = Washbuffer 1 with 30 mM imidazol 
Elution buffer: = Washbuffer 1 with 330 mM imidazol, 10% glycerol 
Storage buffer: 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM DTT, 10% 
glycerol
PMSF: proteinase inhibitor 200 mM stock
PEFAC: proteinase inhibitor 100 mM stock
1 M IPTG isopropyl b- D-thiogalactopyranosid
Ni2+ agarose beads: Quiagen, binding capacity of 5 -10 mg/ ml beads       
Polyprep chromatographie 
column
Biorad
2.2.7.3 Purification of rabbit polyclonal antibody
Crude blood serum was tested after 3 (1st bleeding), 6 (2nd bleeding) and 9 weeks (3rd blee-
ding) for its antibody content by immuno detection (Western blot, see 2.2.7.4). Protein 
samples used to test antibody specificity were purified antigen TG4 protein, whole embryo 
extracts that were further separated into membrane and soluble protein fraction as well as 
bacterial lysate. The 2nd bleeding was used to extract TG4 antibody by affinity purification          
using AminoLink Plus Immobilisation Kit (Pierce) according to the manufacturers two-step 
protocol.
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Co�alent binding of the antigen to agarose beads
The first purification step consisted in covalent binding of the antigen, here 6 × His- tag 
TG4 protein, to the gel matrix of a supplied column. The matrix is composed of cross- lin-
ked 4% agarose beads that were activated to show reactive aldehyde groups reacting with 
primary amines of the protein. The resulting intermediate, a Schiff Base, is reduced to form 
a stable secondary amine linkage. 
Tris competes as primary amine with amino groups of the linked protein for reactive al-
dehyde groups thereby reducing binding capacity. To reduce Tris amount in the protein 
storage buffer, 2 ml TG4 protein (= 10 mg) were diluted 1:3 in coupling buffer pH 10. Af-
ter equilibrating the column with coupling buffer pH 10, the protein sample was applied     
and gently mixed in the closed column for 4 hrs. The liquid was drained by gravity and 
unbound protein was washed of with 5 ml coupling buffer pH 7.2. The covalent linkage 
between loaded protein and aldehyde groups was induced by the addition of 2 ml coupling 
buffer pH 7.2 + 40 µl of NaBH    3CN that serves as reducing agent for the reductive alkyla-
tion of amines. The reaction was performed by gentle rocking oN at 4°C. The alkylation 
was stopped upon washing the column with 4 ml of quenching buffer containing high Tris 
concentration. To block free remaining binding sides the column was treated with 2 ml 
quenching buffer pH 7.2 + 40 µl NaBH   3CN. The blocking was finished by washing uncou-
pled protein of the beads with 2 × 15 ml Wash solution, followed by a wash of 5 ml Wash 
solution including NaN3. 
Affinity purification of antibody 
In the second step the antibody was affinity purified by specific binding to the linked pro-
tein. The column was equilibrated with 6 ml sample buffer. The rabbit serum (15 ml) was 
filtered (0.45 µm), concentrated using a VivaSpin column to 5 ml, diluted 1:1 in sample 
buffer, incubated batchwise with the agarose matrix at RT for 1 hr, which was then reloaded 
to a column. The agarose was washed with 12 ml sample buffer prior to elute the antibody 
in 1 ml fractions with 8 ml elution buffer. The low pH of samples was neutralised by adding 
50 µl neutralisation buffer pH 9 to every aliquot.     
Protein concentration was measured by Bradford and the fractions of interest were pooled. 
For antibody storage, elution buffer was exchanged to storage buffer by reducing twice the 
volume to 100 µl using a VivaSpin column. The sample was diluted 1:1 in 100% Glycerol 
and stored at -20°C.
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Coupling buffer pH 10: 0.1 M NaCitrate, 0.05 M NaCO3, store 4°C
Coupling buffer pH 7.2: 0.1 M phosphate, 0.15 M NaCl
Quenching buffer pH 7.4: 1 M TrisHCl pH 8, 0.05% NaN3
Wash solution: 1 M NaCl, with and w/o 0.05% NaN3, 
Sodium Cyanoborohydride Solution: 5 M NaBH3CN dissolved in 0.01 M NaOH 
Sample buffer: 0.025 M Tris pH 7.2, 0.15 M NaCl,
Elution buffer: 0.1 M glycine•HCl, pH 2.5
Neutralization buffer: 1 M Tris pH 9
Storage buffer pH 7.5: 1×PBS, 1mg/ml BSA, 0.05 NaN3, 50%v/v 
Glycerol
2.2.8 Eukaryotic cell culture
2.2.8.1 Culturing, media and solutions   
To start a new cell culture a cell suspension aliquot was taken from the liquid nitrogen 
tank, washed in 100% MetOH to prevent Mycoplasm contamination, thawed quickly at 
37°C and poured in 20 ml prewarmed DMEM+. Cells adheared at 37°C and 5% CO2 for 
4 hr when medium was exchanged to fresh DMEM+ to eliminate toxic DMSO from the 
freezing media. The here used HeLa and NIH 3T3 cells are adherent cell types that grow 
as monolayer in a cell culture tissue flasc. If cell density becomes too high cell proliferation 
is inhibited and cells die. To keep optimal growth conditions, cells that covered confluent 
80- 90% of the flasc (75 cm2) were diluted down in a new culture bottle. 
Therefore media was decanted and cell layer washed twice with 1× PBS. Cells were detached 
from the cultur flasc surface by trypsination using 2.5 ml 1× Trypsin- EDTA. Peptidase 
damage of cells was inhibited by addition of 10 ml DMEM+. An homogenous cell suspen-
sion was achieved by carefully pipetting up and down. Cell density was estimated elec-
tronically in the “Casy cell counter” by diluting 100 µl cell aliquot in 10 ml Casy solution. 
For general purpose, 1× 106 cells were transferred to fresh 20 ml DMEM+ and grown at 
37°C. For cell transfection experiments 2.5× 105 cells were transferred to 20 ml DMEM+ 
and grown at 37°C
Eagle´ s MEM-media (MEM-) BioWhittacker, Europe
MEM powder 10.4 g/l, 2.38 g/l HEPES, 2.2 g/l NaHCO3 
Dulbecco's Modified Eagle 
Medium (DMEM- ):
BioWhittacker, Europe
DMEM powder 10.4 g/L, 2.2g/l NaHCO3, 
MEM or DMEM+ DMEM, + 10% (v/v) FCS, + 50 µg/ml Gentamycin 
100% Fetal Calv Serum (FCS) Biochrom KG; heat inactivation at 56°C for 45 min.
100 ml aliquotes stored at -20°C.
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Gentamycin [10 mg/ml] Biochrom KG; against Gram negative bacteria, store at 
4°C
10× Trypsin-EDTA BiochromKG; 0.05% (w/v) Trypsin, 0.02% (w/v) EDTA
dilute 1:10 in 1× PBS; 50 ml aliqoutes stored at -20°C
Media and solutions were sterilized using disposable filture cups (Sarstaedt) under the ster-
ile hood and 5 ml tested at 37°C for 4 days to exclude microorganism contamination. Store 
at 4°C.
Longterm storage of eukaryotic cells 
For longterm storage of cell culture aliquots the trypsinised cell supspension was spin 
down for 5 min at 2000 g and the pellet was washed with PBS. The cells were resuspended 
in PBS, cell density estimated as described and 1-3 x 106 cells/ ml were resuspended in 
freezing buffer and aliquoted in 1.8 ml cryotubes. To allow a slow but efficient freezing 
process, tubes were wrapped in paper and frozen at -80°C oN prior to store aliquotes in 
liquit nitrogen. 
freezing media DMEM (NIH 3T3) or MEM (HeLa), 20% (v/v) FCS, 10% 
(v/v) DMSO
2.2.8.2 Transient cell transfection 
Transfection of plasmid DNA into eukaryotic cells was performed using the lipofectamin 
2000 reagent (Invitrogen) according to the manufacturers protocol. One day before trans-
fection, cells were washed with 1× PBS, trypsinized and diluted to 3× 105 cells/ 2 ml media-/ 
well ( 10cm2). The well contained 4 cover slides (Ø 10 mm) for cell adheson. The transfec-
tion mix was prepared and applied to the cells after 24 hr.  
 
 Tube 1: 7.5µl lipofectamin/ 250 µl media- , mix and incubate at RT for 5 min 
 Tube 2: 4µg plasmid DNA/ 250µl media-
Solutions were mixed and incubated at RT for 20    min for micell formation. Meanwhile cells 
were washed with 1× PBS and supplied with media- . The transfection mix was added to 
the medium and cells were grown 18, 24, 36, 48 and 72 hr for fixation.  
Lipofectamin 2000 Invitrogen; 1 mg/ml, store at -20°C
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2.2.9 Immunofluorescent (IF) protein detection
2.2.9.1 IF in eukaryotic cells
Cover slides with transfected cells were washed with 1× PBS and taken out from the well 
onto parafilm (cells facing up). Cells were fixed with 3% PFA, permeabilised with 0.5% Tri-
ton-X-100, blocked against unspecific antibody binding with 3% BSA and incubated with 
corresponding first and secondary antibodies that were coupled with fluorescent dyes. An-
tibody incubation was done in a wet chamber in the dark.  Cells nulcei were DAPI stained 
prior to moviol mounting. Samples were stored at -20°C till confocal microscope analysis. 
step buffer time temp repeat
1 200 µl 1× PBS wash RT 3 ×
2 200 µl 3% PFA 40 min RT 1 ×
3 200 µl 1× PBS wash RT 3 ×
4 100 µl 0.5% Triton -X-100 15 min RT 1 ×
5 200 µl 1× PBS wash RT 3 ×
6 100µl 3% (w/v) BSA/1× PBS 15 min RT 1 ×
7 25 µl 1st antibody✴ 1 hr 37°C 1 ×
8 200 µl 1× PBS wash RT 3 ×
9 25 µl 2nd antibody✴ 1 hr 37°C 1 ×
10 1× PBS wash RT 3 ×
11 DAPI nuclei staining 10 min RT 1x
12 mounting in moviol
✴Dilutions were done in 3% BSA. 
3% paraformaldehyde (w/v) Sigma, dissolve in 1× PBS, store at -20°C
0.5% Triton-X-100 (v/v) dilute in 1× PBS, store at 4°C
3% BSA (w/v) Sigma, dissolve in 1× PBS at 37°C, store -20°C
1× PBS 140 mM NaCl, 2.5 mM KCl, 8 mM Na2HPO4, 1.5 mM 
KH2PO4
DAPI 1000× stock in 1x PBS, store at -20°C
2.2.9.2 IF in animal caps
After cutting animal caps stage 9 (0.8×MBS/ 0.8%agarose dishes in 0.8×MBS) let them       
round up before fixing them in MEMFA. 
step buffer time repeat
1 MEMFA for 1hr at RT (or oN 4°C) 1×
2 1× PtW (5ml Tween /1l PBS) 10 min 3x
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3 1st antibody 2hr at RT (or oN 4°C) 1×
4 1× PtW 10 min 3x
5 2nd antibody 1hr atRT 1×
1× PtW 20 min 1× 
1× PBS 10 min 1× 
DAPI in 1× PBS 10min 1×
PtW to avoid stickiness
After immunodetection, animal caps were kept in the dark at 4°C in 1× PtW for confocal 
microscopy.
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Initiation of organ development in the gastrointestinal tract demands area restricted spe-
cification of progenitor cells in the gut epithelium. In mouse, the two transcription factors 
HNF1β and HNF6 were reported to play an essential role in context of pancreas specifi-
cation in the gut tube (Haumaitre et a., 2005). On this background, the first part of this 
study focused on the characterisation and functional analysis of the transcription factor 
HNF1β in context of pancreas development. The transcription factor HNF6 was not previ-
ously identified for Xenopus laevis, hence the second part concentrated on the isolation and 
expression of HNF6 and presents first functional data upon its extopic expression in the           
endoderm. Concerning the urge for novel pancreas specific genes for descriptive analysis            
of organogenesis, the third part of this study described the identification and functional 
characterisation of a novel protein, named malectin, that was identified in a pancreatic 
cDNA library screen of Xenopus laevis.
3.1 Characterisation of HNF1β   during pancreas de�elopment
3.1.1 Expression profile of HNF1β during embryogenesis
In order to characterize HNF1β function during pancreas development analysis of its spa-        
tial distribution was refined, in particular for the developing endoderm (figure 3.1.1).
As previously described by Demartis et al   . (1994), endodermal HNF1β expression was evi-
dent at the onset of gastrulation in the involuting vegetal hemisphere (figure 3.1.1, 10 and 
10.5) that formed the endodermal germlayer. In accordance with earlier reports, HNF1β 
transcripts were cleary detected in the dorsal endoderm slighty expanding into the ven-
tral endoderm. With gastrulation, HNF1β expression domain was translocated to the ven-       
tro-anterior region of the endoderm (figure 3.1.1, 11). At stage 10.5, HNF1β transcription        
also started in two broad wedge-shaped domains within the neural ectoderm flanking the 
midline, where expression rapidly increased (figure 3.1.1, 10.5 to 13). As neurulation pro-       
ceded, these HNF1β positive domains shifted foward to the anterior region of the embryo 
(figure 3.1.1, 13 to 20) and narrowed into bilateral regions within the neural folds, which               
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converge anteriorly and fuse to the neural tube (figure 3.1.1, 14, S1, 16). In contrast to previ-        
ous reports (Vignali et al., 2000), mesodermal gene activation of HNF1β was first detected 
at stage 16 in the lateral plate mesoderm, giving rise to the presumptive pronephric tissue 
(figure 3.1.1, 16). 
At stage 14, endodermal HNF1β transcripts were evident in the dorso-anterior archenteron 
roof (figure 3.1.1, S1), the presumptive dorsal pancreatic domain, as well as in the ventro-
anterior endoderm, including cells of the early liver diverticulum and cells that acquire 
ventral pancreatic cell fate (figure 3.1.1, 14 not shown, see 20). While neural HNF1β expres-
sion decreased at stage 22 (Demartis et al., 1994), its transcription strongly increased in the 
pronephric anlage and within the endoderm, where transcripts were found in a antero-
posterior gradient and in the posteriorly located proctodeum (figure 3.1.1, 22). Transversal    
sections confirmed that this strong HNF1β expression was located within the endoderm 
and was excluded from the sourrounding meso- or ectoderm (figure 3.1.1, S2; Demartis et     
al., 1994). 
With proceeding gut tube patterning, HNF1β expression was confined to the ventral fore-
gut epithelium and to the caudal tip of the endoderm, the proctodeum (figure 3.1.1, 26 and             
S3). In contrast to previous studies, transversal sections revealed here, with the beginning 
of pancreatic budding from the foregut epithelium at stage 34, HNF1β transcription not 
only occurred in the ventro-anterior gut tube but in particular in the the dorsal gut epi-
thelium, “hidden” behind the strong pronephric HNF1β-expressing domain (figure 3.1.1, 
34, S4). Estimating from the position within the endoderm, this dorsal HNF1β expression 
domain most likely marked the dorsal pancreatic epithelium while ventral signals were 
confined to the liver and the ventral pancreatic regions. As in general, staining of the yolky 
endoderm represented a technical challenge; it cannot be excluded that HNF1β expression 
also occurred in the foregut domain in between the pancreatic analgen, representing the 
prospective duodenal epithelium. Broad HNF1β expression in the foregut resembled the 
Figure 3.1.1 Expression pattern of HNF1β during Xenopus laevis development. HNF1β expression was 
analyse� by W�ISH usin�� embryos of �ifferent �evelopmental sta��es as �in�i��ate� in ea��h panel�. The 
plasmi� p�LFB3 �Vi��nali et al., ��000� was use� as a template for in vitro trans��ription of �i��oxy��enine la-
bele� asRNA. Early sta��e 10- 11 embryos were �isse��te� prior W�ISH to improve hybri�isation. The re� 
arrow hea� at sta��e 10 an� 10.5 point to the �orsal blastopore lip. Sta��e 13 to 16 shows �orsal view of early 
neurula sta��e embryos, positione� with anterior re��ion to the top. White arrow at sta��e 14 points to the 
neural ��roove. From late neurula sta��e ��0 onwar�s, embryos are shown in lateral position with the hea� to 
the left. Asterisk marks en�o�ermal HNF1β expression. Embryos were embe��e� after W�ISH in ��elatine-
albumine for transversal vibratome se��tionin�� �30 µm, S1- S4�. Exa��t position of the se��tion is in�i��ate� as 
white �ashe� line in the ima��e of the ��orrespon�in�� embryo. Sta��e 39v presents a ventral view of sta��e 
39 embryo in�i��atin�� weak hepati�� an� stron��er ��all bla��er expression of HNF1β �bla��k an� re� arrow 
hea� respe��tively�. Abbreviations: �ar� ar��henteron roof, ���b��� ��ir��um blastoporal ��ollar, ��e� �orsal en�o-
�erm, ��p� �orsal pan��reas, �en� en�o�erm, �le� lateral en�o�erm, �li� liver, �lpm� lateral plate meso�erm, 
�n��� noto��hor�, �ne� neural e��to�erm, �nt� neural tube, �p�� pro��to�eum, �pn� pronephros, �sm� somiti�� 
meso�erm, �w�� wolfian �u��t, �ve� ventral en�o�erm, �vp� ventral pan��reas. 
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gastrointestinal transcript distribution that was reported for zebrafish and mouse and in-
dicated a conserved expression profile in vertebrates (Haumaitre et al., 2005; Sun and Hop-
kins, 2001). After neurulation, neural HNF1β expression dramatically regressed whereas, 
mesodemal transcription was detected in the proximal and distal tubules of the differenti-
ating renal anlage. In late tadpole stages, HNF1β transcription is predominantly seen in the 
excretory system, namely the developing proximal nephrostomes and the caudal extending 
wolfian duct as well as in the liver and gall bladder. Transcription in the pancreas remark-
ably decreased (figure 3.1.1, 39 and 39v).
The refined expression pattern of HNF1β clearly demonstrated early dorsal endodermal ex-
pression that was spatially retracted during subsequent development to the ventral foregut 
endoderm, including the liver. In addition, on transversal sections it was demonstrated for 
the first time, that HNF1β was also expressed in the ventral as well as the dorsal pre-pan-
creatic endoderm by the onset of pancreas formation at stage 34. Therefore it was of further 
interest to elucidate the necessity of HNF1β in respect to pancreas development in Xenopus 
laevis.
3.1.2 Functional characterisation of HNF1β during pancreas de�elopment
To investigate the role of the transcription factor HNF1β during pancreas development 
in Xenopus laevis loss- and gain- of- function experiments were performed. In the loss- 
of- function approach, HNF1β protein synthesis was inhibited by injection of antisense         
morpholino oligonucleotides that were targeted to the prospective endoderm. In the en-
doderm, their specific binding to HNF1β mRNAs repressed protein translation. Effects on           
endodermal organogenesis, in particular the pancreas, that were caused by HNF1β protein 
knockdown were investigated by analyzing changes in RNA levels of pancreas specific pro-
teins. Changes in transcript levels were monitored by whole mount in situ hybridisation 
(WMISH) or semiquantitative RT-PCR. 
For the gain of function approach, increase in HNF1β activity was achieved by artificially      
overexpressing the transcription factor in the endoderm. This was achived by microinjec-
tion of in vitro transcribed HNF1β sense „capRNA“. Analogous to the loss- of- function         
approach, HNF1β capRNA was targeted to the prospective endoderm and effects on en-
dodemal organogensis were determined by changes in RNA levels of pancreatic marker       
genes, using WMISH and semiquantitative RT-PCR. 
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3.1.2.1 Knockdown of HNF1β leads to pancreatic hypoplasia 
Verification of efficient translational inhibition by morpholino oligonucleotides
Depletion of HNF1β was achieved by injection of antisense morpholino oligonucleotides 
directed against two different sites of the HNF1β mRNA. HNF1β-Mo1 was designed to 
target the conserved 5´ end of the HNF1β-ORF beginning with the translation initiation 
site ATG. In order to prove specificity for morpholino induced phenotypes, a second mor-
pholino was designed. This HNF1β-Mo2 was directed against the 5´ UTR region of HNF1β 
coding sequence (figure 3.1.2). Due to its pseudo-tetraploid genome, some proteins are 
coded by a second gene copy, so called pseudoallele. As consequence Xenopus laevis ex-
presses in addition to regular proteins their functionally redundant pseudo allelic partner. 
Pseudoallel-transcripts differ in their nucleic acid sequence, in particular in the 5´ untrans-
lated regions (5´ UTR). 
Also for HNF1β, EST sequences for pseudoalleles were identified by EST database search, 
demonstrating a three nucleic acid difference compared to the wild type HNF1β-mRNA 
sequence. Theoretically, these mismatches could impair proper binding of the HNF1β-Mo2 
to pseudoallelic RNA targets thereby allowing protein translation of the redundant HNF1β 
variant and consequently increase the probability of an incomplete HNF1β protein knock-
down. However, according to information from the manufacturer, it is rather unlikely that 
three mismatches prevent morpholino bining (http://www.gene-tools.com). Efficient inhi-
bition of protein translation by recognising an HNF1β mRNA target was determined in 
Figure 3.1.2 Position and sequence of HNF1β- specific morpholinos. (A) The s��heme in�i��ates the posi-
tion of the two HNF1β spe��ifi�� morpholinos �HNF1β-�o1 an� HNF1β-�o��, blue bars� relative to the ��o�in�� 
sequen��e �C�S� of HNF1β �NCBI: N�_ 0010�7��16; ��rey bar�. Numbers state the nu��lei�� a��i� position with 
+1 be��innin�� at the translation initiation site AT�. (B) Sequen��es of HNF1β-�o1 an�- �o�� �blue� are state� 
below the s��heme. HNF1β-�o1 tar��ets the be��innin�� of the �RF at the translation initiation site AT� ���rey, 
un�erlaye� in re��. HNF1β-�o�� tar��ets the 5´UTR re��ion overlappin�� the AT�. EST �atabase sear��h in�eti-
fie� a pseu�oallele �NCBI: BU903744� that showe� three mismat��hes ��ompare� to the HNF1β-C�S. Last, 
the sequen��e of the unspe��ifi�� stan�ar� ��ontrol morpholino is state� �Co�o; �eneTools�.
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in vitro and in vivo approaches (figure 3.1.3). For this purpose, the 5´ end sequence of the        
HNF1β coding sequence (CDS) complementary to the HNF1β-Mo1 and HNF1β-Mo2 se-
quence, was fused upstream and in frame to the coding sequence of the green fluorescent 
protein (GFP; HNF1β-5´ end-GFP; Collart et al., 2005). 
In vitro, translational inhibition upon morpholino binding was tested in a radioactive 
combined transcription and translation assay („hot“TNT (hTNT), figure 3.1.3, A). The 
HNF1β-5´ end-GFP plasmids served as template for in vitro transcription of capRNA that 
was directly used as template for in vitro translation. In the transaltion process 35S-me-
thionine was incooperated in to the synthesised protein which allowed autoradiographic    
detection of the translation product (figure 3.1.3., A). As seen in the autoradiogram of the       
Figure 3.1.3 Determination of knockdown efficiency of HNF1β- specific morpholinos. (A) In vitro: ��om-
bine� trans��ription an� translation assay �hTNT� was performe� to reveal re��o��nition of tar��et sequen��e 
by HNF1β-�o1 �lane1- 4� an� HNF1β-�o�� �lane 6-10�. Autora�io��ram shows translation pro�u��t of the 
rea��tion. Table below states the ��omposition of ea��h rea��tion for ea��h lane. 300 n�� of HNF1β-5´en�-�FP 
��onstru��t were use� in ea��h rea��tion alone, or in ��ombination with �ifferent amounts of HNF1β-�o1 or 
HNF1β-�o�� or unspe��ifi�� ��ontrol morpholino �Co�o; +++= 0.5 pmol; ++ = 0.�� pmol; + = 0.1 pmol�. Weaker 
ban� in the se��on� Co�o rea��tion is �ue to a loa�in�� mistake (B) In vivo: HNF1β -5´en�-�FP ��apRNA was 
in vitro trans��ribe� an� inje��te� into the animal pole of a two ��ell sta��e embryo �bla��k bar� alone ���apRNA, 
100 p���� E� or in ��ombination with �ifferent amounts of HNF1β- �o1, HNF1β- �o�� or Co�o �15 p����E, 10p����E 
an� 5p����E as state� in ea��h panel�. After ��4 hr bin�in�� effi��ien��y was s��ore� a����or�in�� to �FP fluores��en��e. 
The presen��e of either morpholino effi��iently blo��ks HNF1β -5´en�-�FP translation, whereas inje��tion of 
Co�o �oes not impair protein synthesis. Spe��ifi��ity of HNF1β - �o1 an� HNF1β- �o�� to its tar��et sequen��e 
was also ��onfirme� by wil� type �FP fluores��en��e �e�FP�, by ��oinje��tin�� e�FP ��apRNA �100 p����E�.
6 7 8 9 10
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hTNT, in vitro translation of the HNF1β-5´ end-GFP fusion protein remained unaffected        
in the absence of morpholinos. Addition of the first morpholino, HNF1β- Mo1, efficiently        
repressed protein translation in a concentration dependend manner, as addition of low 
amounts (here, 0.5 pmol/ reaction) did not completely impaire HNF1β-5´ end-GFP synthe-
sis (figure 3.1.3, A, lane 4). The second morpholino, HNF1β-Mo2, blocked HNF1β protein 
translation in all concentrations tested. Addition of an unspecific standard control mor-      
pholino (CoMo), directed against human β-globin- pre- mRNA, did not abolish HNF1β 
protein synthesis in the in vitro assay. 
In order to determine knockdown efficiency in vivo, the HNF1β- 5´ end-GFP encoding ca-      
pRNA was in vitro transcribed and 100 pg coinjected with either HNF1β-Mo1 or HNF1β-  
Mo2 into two-cell stage embryos (figure 3.1.3, B). After 24 hr, effective inhibition of protein              
synthesis in presence or absence of morpholinos was monitored by loss of GFP fluorescence        
in the embryo. In contrast to the in vitro assay, the lowest amount of 5 ng of HNF1β-Mo1 or   
HNF1β-Mo2 inhibited protein translation of the HNF1β-5´ end-GFP protein. Conversely, a    
three fold higher dose of the unspecific CoMo (15 ng/E) did not prevent HNF1β-5´ end-GFP 
protein translation. Target specificity of HNF1β-Mo1 and HNF1β-Mo2 were further confir-
med by coinjecting wildtype GFP capRNA (eGFP, 100pg/E) with 15 ng of HNF1β- Mo1 or   
HNF1β- Mo2. As expected GFP fluorescence was not abolished in this experiment, proving 
selectivity of HNF1β-Mo1 and HNF1β-Mo2 for HNF1β mRNA target. Although both ex-
periments cannot exclude off traget effects or predict the extent to which expression of the 
endogenous HNF1β protein is inhibited, they prove recognition of the morpholino target 
sequence and provide strong evidence that translational inhibition occurs in the embryo. 
In order to achieve high knockdown efficiency of HNF1β protein translation HNF1β-Mo1 
and HNF1β-Mo2 were coinjected into the embryo and effects on pancreas development 
were investigated by analysis of pancreatic marker genes. 
Inhibition of HNF1β reduced expression of pancreatic marker genes 
After confirming specificity of HNF1β-Mo1 and HNF1β-Mo2 to the target sequence both        
morpholinos were coinjected (0.5 pmol each) to knockdown HNF1β protein translation   
within the embryo. To target the prospective endoderm, morpholinos were injected radi-
ally into the vegetal pole of a four-cell stage embryo. In order to reveal the role of HNF1β 
during pancreas organogenesis, embryos were cultured till early tadpole stage and effects 
on pancreas development were analysed by investigating changes in pancreas specific mar-
ker gene expression. In order to exploit the role for HNF1β in pancreas specification, ex-
pression of the pancreatic progenitor markers XlHbox8 and Xp48 were tested. To reveal 
effects on endocrine or exocrine cell fate specification, transcription levels of the earliest 
endocrine specific gene insulin and of the exocrine specific gene XPDIp were determined 
(figure 3.1.4).  
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Expression of the first pancreatic progenitor marker XlHbox8 is initiated at stage 28 in 
the foregut. XlHbox8 is one of the earliest genes that is specifically expressed in the pro-
spective ventral and dorsal pancreatic epithelium while it additionally marks the duodenal 
progenitor cells (Wright et al., 1989). At stage 32, XlHbox8 expression was still confined 
to the ventral and dorsal pancreatic anlage as well as the intermediate duodenal region of          
all uninjected control embryos (figure 3.1.4, A, white arrow head, black bracket and black 
arrow respectively). At this stage the dorsal pancreatic anlage begins to evaginate from 
the gut epithelium into the surrounding mesenchyme. The majority of embryos that were 
injected with 0.5 pmol of unspecific control morpholino (88%) demonstrated no altera-
tion of XlHbox8 expression (figure 3.1.4 B, E). Only 12% (2/16) showed a size reduction 
of the XlHbox8 expressing domain in the anterior endoderm. In HNF1β-Mo1+2 injec-
tion, pancreatic XlHbox8 expression was not detectable in 98% of the embryos at stage 32,             
Figure 3.1.4 Knockdown of HNF1β reduces expression of pancreatic marker genes. HNF1β protein trans-
lation was inhibite� upon ��ombine� inje��tion of HNF1β spe��ifi�� antisense morpholinos HNF1β-�o1+�� 
�ea��h 0.5 pmol��E�. Corre��t mi��roinje��tion was tra��e� by ��oinje��tion of β-��ala��tosi�ase ��apRNA �50p���� E�. 
Embryos were ��ulture� till ��ontrol siblin��s rea��he� �esire� �evelopmental sta��e an� analyse� for pan��re-
ati�� marker ��ene expression by W�ISH. Embryos are shown with in a lateral view with the hea� to the left 
�A- I� an� from a ventral view �J- L�. Analyse� marker ��enes are state� to the left. Sta��es are state� as small 
numbers to the bottom left in A, �, �, J. Effe��ts on marker ��ene expression were ��ompare� to effe��ts in 
embryos inje��te� with unspe��ifi�� ��ontrol morpholino �Co�o, 1pmol��E; B, E,H, K�. White arrow hea�s point 
to the ventral pan��reati�� anla��e �A-I�, bra��kets size the �orsal pan��reati�� ru�iment �A-I�, re� arrow hea� 
points to the presumptive �orsal pan��reati�� �omain �C�. In panel J-L, the white arrow hea� points to the 
fuse� pan��reati�� or��an that shows altere� morpholo��y by protrusion formation in its exo��rine ��ompart-
ment; obje��tive enlar��ment 60×; �st� stoma��h. n= states the total number of embryos analyse� for ea��h 
marker. Per��ent values in bra��kets in�i��ate the amount of embryos showin�� the presente� phenotype. 
Inset in L showes morpholo��i��al affe��te� pan��reati�� lobe. 
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most of them still maintaining weak duodenal expression XlHbox8 expression between 
the presumptive pancreatic domains (figure 3.1.4, compare B and C). By the time of pan-          
creatic budding at stage 34, control embryos and CoMo injected embryos (8/ 10= 80%)         
showed regular XlHbox8 transcription in the pancreatic and duodenal territories (figure         
3.1.4 , D). The remaining 20% of CoMo injected embryos revealed a slight size reduction 
in the ventral pancreatic expression domain. In contrast, 98% of HNF1β- Mo1+2 injected   
embryos presented weak increase in XlHbox8 expression in the dorsal pancreatic endo-
derm as compared to HNF1β-Mo1+2 injected embryos at stage 32, though it was spatially 
restricted to a smaller territory (figure 3.1.4, compare D,E and F). Increased transcription 
level was also represented by stronger duodenal XlHbox8 expression althoug it did not       
exhibit the level of regular XlHbox8 expression seen in control embryos. Only 18% (2/16) 
presented regular XlHbox8 expression while the ventral pancreatic XlHbox8 expression      
was still undetectable in 82%. This result indicated that HNF1β was required within the         
endoderm to activate XlHbox8 expression in the pancreatic and duodenal epithelium.          
The second pancreatic progenitor marker that was analysed in HNF1β depleted embryos 
was Xp48. As known from its expression profile, Xp48 expression was evident in the gut 
epithelium at stage 28 (Afelik et al., 2006). In contrast to XlHbox8, Xp48 is exclusively ex-
pressed in the ventral and dorsal pancreatic epithelium where its expression peaked with 
pancreatic budding at stage 34. As seen in control embryos the ventral Xp48 positive epi-
thelium extends ventro-posterior along the liver diverticulum (figure 3.1.4, G; white ar-    
row and bracket respectively). Despite a minimal reduction of the ventral Xp48 expressing          
region in 86% of injected embryos, the CoMo did not alter Xp48 expression (figure 3.1.4,  
H). Caudal extension of Xp48 expression in the ventral as well as in the dorsal pancreatic                
region was remarkably reduced in 83% of HNF1β-Mo1+2 injected embryos (figure 3.1.4, I;            
bracket). This result demonstrated that HNF1β was also required for Xp48 expression in 
the pancreatic region and only 17% (2/12) remained unaffected. Hence, HNF1β activity 
in the endoderm seems to influence Xp48 expression. In contrast to XlHbox8 expression, 
HNF1β knockdown did not completely impair Xp48 gene activation in the pancreatic epi-
thelium providing evidence for a distinct regulatory mechanism for Xp48 gene induction 
in the endoderm. 
As reported from a previous study (Afelik et al., 2006), both pancreatic progenitor markers 
are required to induce pancreas formation in the gut endoderm. The majority of the pan-
creas is composed of the exocrine tissue. In Xenopus laevis the first exocrine differentiation 
marker is the enzyme XPDIp whose transcripts demark the territory of the pancreatic 
lobes from stage 39 onwards. At stage 43, the pancreatic lobes are fused to one organ and 
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the branching epithelium exibits strong proliferative activity that promotes size increase 
and organ morphogenesis. To investigate whether reduced expression of pancreatic pre-
cursor genes as XlHbox8 and Xp48 in HNF1β depleted embryos was a transient effect 
or whether lack of their activity affects subsequent pancreatic growth, the organ size was 
estimated in HNF1β-Mo1+2 injected embryos by the size of XPDIp expressing territory at 
stage 43. In 100% of uninjected embryos or CoMo- injected embryos organ size was unaf-         
fected (figure 3.1.4, J and K), whereas 50% of HNF1βMo1+2 injected siblings showed an 
obvious size reduction of the fused pancreatic organ at stage 43. Size reduced organ showed 
morphological divergence forming small protrusions rather than a condensed exocrine 
tissue structure (figure 3.1.4, L, inset). Decrease in XPDIp positive territory together with 
the observed impaired expression of pancreatic progenitor markers XlHbox8 and Xp48 
suggested that HNF1β was required in the gut endoderm for pancreas specification as well 
as for organ outgrowth and differentiation. On this background it was of further interest 
to investigate effects of HNF1β on endocrine cell differentiation. 
At stage 32, few cells that lay scattered in the dorsal pancreatic epithelium initiate insulin 
expression. Gene expression of insulin is detectable in the dorsal endoderm from stage 32 
onwards (Kelly and Melton, 2000). The endocrine hormone insulin is therefore the first 
marker gene for endocrine cell differentiation in the pancreas. These early insulin-express-
ing cells migrate along within the pancreatic epithelium and accumulate anteriorly in the 
dorsal pancreatic rudiment at stage 36 (Kelly and Melton, 2000). So far, it remained ob-
scure how or when these first endocrine cells are specified in the doral gut region. 
Interestingly, embryos that were injected with HNF1β- Mo1+2 demonstrated a reduced size 
of insulin-expressing region (figure 3.1.5, A). Determination of the cell number of insulin-
postive cells per embryo revealed that HNF1β-Mo1+2 injected embryos had less insulin 
positive cells than uninjected control or CoMo- injected embryos. At stage 34, scattered 
insulin positive cells that are located in a caudal extending area of the dorsal gut endoderm 
move anterior along with the evaginating bud clustering in the dorsal rudiment. Reduction 
in insulin cell number and the size of insulin expressing region could arise from slight dif-
ferences in developmental staging or a naturally occuring variation in cell position.
In order to specify effects on insulin expression, the exact number of insulin positive cells 
in the dorsal gut epithellium was determined and compared between uninjected control 
embryos, control morpholino injected embryos and embryos injected with HNF1β Mo1+2 
(figure 3.1.5; B). As presented in the graph, injection of HNF1β specific morpholinos si-           
gnificantly reduced the average number of insulin-expressing cells to 15 cells per embryo, 
compared to 23 cells in uninjected control embryos or to the average number of 20 cells 
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in CoMo- injected embryos. 90% (18/ 20) of HNF1β-Mo1+2 injected embryos contained         
less insulin positive cells than the average value of uninjected controls and 75% (15/ 20) of 
HNF1β-Mo1+2 injected embryos presented less insulin positive cell than the average value          
of CoMo injected embryos. CoMo injected embryos also appeared to be slightly impaired         
in activation of insulin expression compared to uninjected control embryos (57% , 11/19) 
however to less extend than HNF1β- Mo1+2 injected embryos.    
The decreased number of insulin positive cells was also evident in the smaller range of in-
sulin positive territory within the dorsal gut epithelium, comparing HNF1β-depleted em-
bryos with CoMo-injected or uninjected controls (figure 3.1.5, C). 80% of HNF1β-Mo1+2 
injected embryos showed a size reduction in comparison to CoMo- injected siblings. Al-
though the downregulation of insulin expression was so far not quantified by real-time 
RT-PCR, the decreased cell number in association with a decrease in expression domain 
argued for significance of effect of HNF1β depletion on insulin expression in the dorsal en-
Figure 3.1.5 Knockdown of HNF1β leads to reduced insulin expression. (A) After W�ISH, insulin expres-
sion was analyse� in sta��e 36 embryos after removin�� the overlayin�� noto��hor� an� surroun�in�� tissues. 
White line marks the insulin expressin�� re��ion whose size was �etermine� by morpho��eneti�� measure-
ments. Two in�epen�ent experiments were performe� an� the total number of embryos �n� was use� for 
quantifi��ation. (B) Columns in�i��ate the avera��e number of insulin positive ��ells ��ounte� in the �orsal ��ut 
epithelium of a sta��e 36 embryo. Error bars in�i��ate the stan�ar� �eviation. ��ontrol embryos �CE�= ��3±5; 
��ontrol morpholino inje��te� embryos �Co�o�= ��0 ± 4; HNF1β-�o1+�� inje��te� embryos �HNF1β-�o1+���= 
15± 6. *: p-value < 0.0001; **: p-value = 0.0046 �p-value from unpaire� two-taile� stu�ents t-test ��al��ulate� 
usin�� free available online software graphpad�. (C) Columns in�i��ate the avera��e number of pixels per 
insulin-expressin�� re��ion. Pixel number was quantifie� for ea��h re��ion usin�� the software Ima��eJ. Values 
are ��iven as mean ± stan�ar� �eviation of the mean CE= 74�1± 1340; Co�o= 5 96� ± 1319; HNF1β-�o1+��= 
3�11± 1���9�. *: p- value < 0.0001; **: p-value < 0.0001 �p-value from unpaire� two- taile� stu�ents t-test 
��al��ulate� usin�� free available online software graphpad�.
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doderm. Using the same batch of embryos for injections, these results also argued against 
a natural occuring variance in insulin positive cells or a variance due to developmental 
stage difference. In an attempt to confirm morpholino induced repression of pancreas for-
mation, HNF1β-WT capRNA was coinjected with HNF1β-Mo1+2 (Vignali et al., 2000). 
However, the rescue experiments failed due to 100% lethality of injected embryos.
In summary, depletion of HNF1β caused reduction of XlHbox8 and Xp48 expression, a re-           
duced amount of insulin positive cells as well as pancreatic hypoplasia evident in a smaller 
expression domain of XPDIp.
Obviously, HNF1β activity was not only curcial for activation pancreatic progenitor genes 
XlHbox8 and Xp48 but also for activation of differentiation markers as insulin. These data   
suggested that HNF1β is required in the endoderm for pancreas specification and endocri-       
ne differentiation.
3.1.2.2 Induction of HNF1β expands expression of pancreatic marker genes 
To further investigate the requirement of HNF1β for pancreas development, the transcrip-
tion factor activity was upregulated in the endoderm by microinjection of HNF1β encod-
ing capRNA. For this purpose, the HNF1β-ORF (1683 bp) was isolated by RT-PCR from            
total RNA extracts of stage 39 embryos and cloned into the pCS2+ expression vector (fi-
gure 3.1.6, A; Vignali et al., 2000). This construct coding for the wildtype HNF1β protein 
(HNF1β-WT) served as a template for in vitro transcription of sense „capRNA“ that was 
injected into embryos in a different amounts, ranging from 500 to 10 pg/ embryo. To target 
increased HNF1β expression within the endoderm, HNF1β-WT capRNA was coinjected 
with β-galactosidase capRNA radially into the vegetal pole of four-cell stage embryos. Em-
bryos were grown to tailbud stage 33 in order to investigate changes on RNA expression 
levels of pancreatic marker genes as the pancreatic progenitor markers XlHbox8 and Xp48, 
the exocrine marker XPDIp and the endocrine marker insulin. 
From previous studies, focusing on the mesoderm inducing activity of HNF1β, it was ex-
pected that ectopic endodermal expression of HNF1β (1 ng- 500pg/ E) in Xenopus laevis 
would not affect embryonic development (Vignali et al., 2000). Surprisingly, in this study,        
vegetally injected embryos (500 pg/ E) revealed severe gastrulation defects resulting in high           
embryonic lethality (data not shown) and serious embryonic malformations in surviving 
embryos at stage 34 (figure 3.1.6, B).   
The most striking difference observed between the HNF1β overexpression analysis and 
the overexpression performed in the earlier study, is that overactivation of HNF1β upon 
capRNA injection did not result in any obvious phenotype. Sequence comparison of the 
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Figure 3.1.6 Phenotypes induced upon ectopic expression of HNF1β in the endoderm. (A) S��hemati�� 
�rawin�� of the HNF1β-WT ��onstru��t, in��lu�in�� the HNF1β-�RF �16�6 bp�. The trans��ription fa��tor HNF1β 
��onsists of an N-terminal �NA bin�in�� �omain �bla��k bar� that is ��ompose� of a �imerisation �omain ���� 
an� two �NA bin�in�� motifs �P�U-A an� P�U-B� an� a C-terminal transa��tivation �omain �TA, ��rey bar; 
Wu et al., ��004�. Numbers below the bar in�i��ate the nu��leoti�e position in the HNF1β ��o�in�� sequen��e. 
(B) HNF1βWT ��apRNA was in vitro trans��ribe� an� inje��te� ra�ially into the ve��etal pole of four ��ell sta��e 
embryos in an amount ran��in�� �500- 10 p����E�. Corre��t lo��alisation of inje��te� ��apRNA was tra��e� by β- 
��ala��tosi�ase stainin��. Embryoni�� malformations, in�u��e� upon HNF1β-WT inje��tion, were ��lassifie� into 
three ��roups: the stron�� phenotype �re�u��e� hea� stru��tures: small eyes an� forehea�, short trunk �bla��k 
arrow�, ventro-anterior en�o�erm expansion �bla��k arrow hea��, the mil� phenotype �less axis shortenin��, 
anterior en�o�erm enlar��ement� an� normal phenotype that was in�istin��uishable from ��ontrol embryos 
at sta��e 34 �not in�i��ate� in the panel�. The ��raph represents the per��enta��e of embryos that showe� 
stron��, mil� or normal phenotype �epen�in�� on the inje��te� amount of HNF1β-WT ��apRNA �p����E�. Num-
bers on top of the ��olumns state total number of embryos from two in�epen�ent experiments �table 3.1 
�The le��en� shows the ��olour ��o�e of the three phenotype ��roups. (C) Effe��t on pan��reas �evelopment 
upon e��topi�� a��tivation of HNF1β in the en�o�erm was investi��ate� by analysis of ��ene expression of the 
pan��reati�� pro��enitor marker �lHbox� at sta��e 33. Inje��te� amounts of HNF1β-WT ��apRNA are in�i��ate� 
in ea��h panel. Total number of embryos n for ea��h sample: ��ontrol, 500 p����E= 3��; 100 p����E= 39, 50 p����E= 
3��, 10 p����E= 4��. Embryos inje��te� with 500p����E HNF1β-WT ��apRNA showe� a broa� homo��enous expan-
sion of �lHbox� expression towar�s the ��au�al tip of the embryo. Ventral an� �orsal pan��reati�� expression 
�omains are marker with white an� bla��k arrow hea� respe��tively. The posterior boun�ary of �lHbox� 
expression in the �uo�enum is pointe� out by bla��k arrow. Note that �lHbox� expansion is ��on��entration 
�epen�ent �100- 10p����E�, showin�� e��topi�� territories in �istin��t lo��i of the posterior ��ut tube at low ��on-
��entrations �re� arrow hea��.
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obtained construct from R.Vignali that was efficiently used for WMISH analysis, with the 
here isolated HNF1β ORF identified insertion of a thymidine nucleotide at position 1414. 
This point mutation results in an HNF1β mutant containing a DNA binding region but 
lacking a functional transactivation domain. This was most probably the reason for the 
absence of an embryonic phenotype.
Embryonic malformations were classified into three phenotype-groups: strong, mild and 
normal. The strong phenotype was predominantly obtained upon injection of high amounts 
of HNF1β-WT capRNA (500 pg/ E). It was characterised by reduced head and trunk struc-           
ture as well as anterior endoderm expansion. The milder phenotype still showed enlarge-     
ment of the anterior endoderm however less trunk deformations and defects in head for-
mation. The normal phenotype was undistinguishable from control embryos at stage 34. 
These deformation were concentration dependent as they became less severe with decreas-
ing amount of injected HNF1β-WT capRNA (figure 3.1.6; graph, table 3.1).
To specify the apparent endodermal malformations for pancreas development, injected 
embryos were analysed for changes in RNA levels of the pancreatic marker gene XlHbox8 
by WMISH (figure 3.1.6, C). Its expression was strongly upregulated in the pancreas as well 
as in the duodenal region and its expression expanded posteriorly upon HNF1β overex-
pression. This effect decreased in a concentration dependent manner as seen by injection of 
lower capRNA concentration (100 and 50 pg/ E). Injection of 500 pg HNF1β-WT capRNA      
caused not only a strong malformation phenotype but it also increased lethality of injected 
embryos up to 100% (data not shown). Injection of 100 pg HNF1β-WT capRNA lead pre-
dominantly to a mild phenotype and lethality decreased to 50%. 
Contradictory to the previous report (Vignali et al., 2000), injections performed in this 
study demonstrated that ectopic expression of HNF1β in the whole endoderm, including 
regions where endogenous HNF1β expression is low, affected embryogenesis of Xenopus 
laevis. Enlargement of the anterior endoderm was associated with caudal expansion of the 
endogenous XlHbox8 expression domains, namely the pancreas and the duodenum. Inter-
estingly the homogenous expansion of XlHbox8 towards the posterior end was dependent 
HNF1β-WT n strong mild normal
500 pg/E 42 51% (22/42) 49% (20/42) 0%
100 pg/E 125 28% (35/125) 60% (76/125) 12% (14/125)
50 pg/E 109 7% (8/109) 65% (71/109) 28% (29/109)
10 pg/E 111 0% 27% (30/111) 73% (81/111)
β-gal 500 pg/E 64 0% 4% (2/64) 96% (61/64)
Table 3.1 Phenotypes induced upon ectopic expression of HNF1β in the endoderm Table states total 
number of embryos �n� obtaine� from from two �ifferent experiments an� the per��enta��e of embryos 
showin�� stron��, mil� or normal phenotype. 500p����E β-��ala��tosi�ase en��o�in�� RNA were inje��te� to ex-
��lu�e unspe��if�� effe��t by mi��rominupulation of the embryo. 
73
Results
on the level of ectopic HNF1β expression. High HNF1β capRNA concentration lead to 
homogenous extension of the XlHbox8 expressing region, implying an HNF1β induced 
expansion of the endogenous expression domain. Low concentration revealed additional 
XlHbox8 positive cells in additional distinct territories of the posterior intestine. Combin-
ing the reduction of XlHbox8 gene expression in the HNF1β loss of function experiment 
with the reverse complement result in the HNF1β gain of function approach, it was pos-
tulated that HNF1β is an upstream regulator of the pancreatic progenitor gene XlHbox8 
within the endoderm. Although, it remained unclear whether it was a direct or indirect 
regulatory mechanism. 
The transcription factor HNF1β is expressed already at gastrula stage in the involuting 
endoderm. High levels of HNF1β activitiy in the early embryo was lethal and caused severe 
embryonic malformations implying an early function during emrbyogenesis. Therefore it 
was of further interest to determine the exact time point for HNF1β requirement in the 
endoderm, in particular regarding later pancreas formation from the gut tube.
To adress this question, a time point inducible HNF1β protein was generated by fusing the 
HNF1β-ORF to the ligand binding domain of the human glucocorticoid receptor (GR-    
LBD, figure 3.1.7; Gammill and Sive, 1997). In the cell, heat shock proteins (Hsp) bind to               
the GR domain keeping the fusion-protein in an inactive state in the cytosol. After addi-
tion of the steroid hormone dexamethason (Dex), Hsps dissociate, thereby releasing the 
transcription factor that can translocate to the nucleus. 
To confirm obtained data of HNF1β loss-and gain of function, the HNF1β coding sequence 
was also fused to the repressor domain of the Engrailed transcription factor from Dro-
sophila (EngRP) in combination with the GR-LBD. This HNF1β- EngGR fusion protein 
maintained a dominant repressor activity and was inducible upon Dex application. Since       
the transcription factor HNF1β is known to function as positive regulator, its transforma-
Figure 3.1.7 HNF1β constructs used for gain- and loss of function approaches. The HNF1β-�RF was PCR 
amplifie� out of the pCS��+ HNF1β-WT ��onstru��t an� fuse� to the li��an� bin�in�� �omain of the ��lu��o-
��orti��oi� re��eptor ��R-LB��. A��tivity of the HNF1β-�R fusion protein was a��tivate� by appli��ation of 1x 
�examethason �+�ex�. In a��ition, a��tivity of HNF1β fun��tion was represse� or enhan��e� by fusin�� the 
HNF1β-�RF to the repressor �omain of the en��raile� trans��ription fa��tor �En��-R�, �10bp, re�� as well as 
to the a��tivation �omain of the viral trans��ription fa��tor VP16 �VP16-A�, ��50bp, ��reen� in��lu�in�� the �R- 
LB�. HNF1β-En���R maintains a �ominant ne��ative a��tivity whereas HNF1β-VP16�R maintaine� a stron�� 
a��tivator a��tivity.
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tion into a dominant negative repressor by EngGR fusion depleted its endogenous func-
tion. As consequence, injection of HNF1β-EngGR capRNA was expected to cause a similar   
reduction of pancreatic marker expression as observed upon HNF1β- Mo1+2 injection. A 
similar approach was performed in the previous study by the group of Vignali (Vignali et 
al., 2000). Although in their study, the HNF1β transactivation domain was not fused to the 
EngRP domain but replaced it, and it was not fused to the GR-LBD.
To confirm effects upon ectopic activation of HNF1β in the endoderm, transcription fac-
tor activity was also increased upon injection of HNF1β-VP16GR capRNA. Here, HNF1β 
activity was additional enhanced by fusion to the dominant activator domain of the viral            
transcription factor VP16 (VP16-AD). 
Ectopic expression of the pancreatic progenitor marker XlHbox8 provided evidence for an 
activating role of HNF1β during pancreas development. To determine the time window 
for HNF1β necessity, the hormone-inducible HNF1β-GR protein was overexpressed in the 
endoderm. Therefore HNF1β-GR capRNA (75 pg/E) was radial injected into the vegetal     
pole of four-cell stage embryos. HNF1β function was activated upon Dex-treatment by the 
end of gastrulation stage 13 and at the onset of gut tube patterning stage 20. Analogous to 
HNF1β-Mo1+2 injection, effects on pancreas specification were determined by analyzing 
changes in transcription of the pancreatic markers XlHbox8 and Xp48, XPDIp and insu-          
lin.
In control embryos XlHbox8 was detected in the ventral and dorsal pancreatic territory as 
well as in the intermediate duodenal region (figure 3.1.8, A). 50% of HNF1β-GR injected 
embryos that were not activated by Dex-treatment (-Dex) showed regular XlHbox8 tran-
scription in the endogenous expression domains. 44% revealed a slighty caudal expansion 
of the endogenous XlHbox8 positive regional and a weak ectopic expression in the ventro-
posterior region of the endoderm (figure 3.1.8, B) that was clearly seen in the remaining 2%           
(appendix; figure 8.1). 
Upon early Dex mediated activation of HNF1β in the endoderm, embryos showed enlarge-   
ment of the anterior endoderm that was similar to the mild phenotype in HNF1β-WT in-
jections. In 15% (4/26) this posterior expansion was homogenous thoughout the endoderm 
and endogenous expression domains were not clearly distinguishable. In addition, these 
embroys showed within the homogenous transcript distribution few smaler territories that 
were positioned to the ventroposterior region of the embryo, similar as in embryos without 
Dex treatment. In 70% the origin of the posterior expanding XlHbox8 expressing region 
was defined to the ventral and in particular to the dorsal pancreatic expression domains. 
After removing the overlaying notochord, it was observed that this dorsal pancreatic     Xl-
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Figure 3.1.8 Changes in pancreatic marker gene expression upon ectopic activation of HNF1β . HNF1β 
was e��topi��ally a��tivate� in the en�o�erm by inje��tin�� HNF1β-�R ��apRNA �75p����E� ra�ially into the ve��-
etal pole of a four- ��ell sta��e embryo. HNF1β a��tivity was in�u��e� at late ��astrula sta��e 13 an� prior or��an 
formation at sta��e ��0 by appli��ation of �examethason �+�ex 13, +�ex��0�. Uninje��te� ��ontrol embryos 
were also treate� with �ex. Corre��t mi��roinje��tion was tra��e� by ��oinje��tin�� β-��ala��tosi�ase ��apRNA. 
Embryos were ��ulture� till ��ontrol siblin��s rea��he� �esire� sta��e an� analyse� by W�ISH for ��han��es in 
pan��reati�� marker ��ene expression �in�i��ate� to the left�. n= total number of embryos. Numbers in bra��k-
ets in�i��te� per��enta��e of embryos showin�� the most frequent phenoype as in�i��te� in the panel. 
↑= in��rease� expression; ↓= �e��rease� expression. White arrow hea�: ventral pan��reati�� expression �o-
main, bra��ket: sizes the early �orsal pan��reati�� expression �omain; bla��k arrow: �uo�enal �lHbox� expres-
sion; re� arrow: extopi�� territories of �lHbox� expression; bla��k arrow hea�: �orsal pan��reati�� lobe. �: 
�orsal expression �omains of �lHbox� in uninje��te� ��ontrol embryo. N: -�ex embryos; �: expan�e� �orsal 
�lHbox� expression alon�� the mi�line of +�ex13 embryo. 
Hbox8 expansion did not occur in a broad territory of the epithelium but it was rather 
spatially restricted to the central and most dorsal region, expanding caudally along the 
midline (figure 3.1.8, M-O). Later induction at stage 20 did not activate XlHbox8 expres-         
sion to such an extent, however 72% of examined embryos revealed an ectopic XlHbox8 
positive territories in a distinct ventro-posterior region comparible to embryos without 
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Dex (figure 3.1.8, D). Embryos treated at stage 26 did not show posterior induced XlHbox8              
transcription and resembled untreated embryos (not shown). The vast distribution of Xl-          
Hbox8 transcription in the endoderm in early HNF1β activated embryos resembled the 
induction obtained in embryos that were injected with HNF1β-WT capRNA. 
Expression of the second pancreatic precursor marker Xp48, that was restricted to the 
ventral and dorsal pancreatic rudiments, was not affected to the same extent than it was 
seen for XlHbox8 expression although some early treated embryos (figure 3.1.8; G, E) sho-
wed a slight increase in the ventral pancreatic expression domain. As the difference was 
remarkably small, this increase in Xp48 transcription could derive from naturally occu-
ring differences during bud formation rather than a specific effect upon ectopic HNF1β 
expression. 
In order to investigate the role of HNF1β for later pancreas development, injected embryos 
were examined for alteration in XPDIp expression, representing the first exocrine differen-
tiation marker in Xenopus laevis. Against the expectation, ectopic endodermal activation 
of HNF1β resulted in 80% of the embryos in a decreased ventral and dorsal pancreatic ru-
diment, compared to uninduced embryos as well as control embryos. Reduced pancreatic 
size was also obtained upon later HNF1β induction at stage 20. Together with the loss of 
function data it was concluded that HNF1β was required but not sufficient to drive pancre-
atic outgrowth and differentiation. 
As for the loss of function approach it was of further interest to analyse changes in ex-
pression of the first endocrine marker insulin. In comparison to embryos without Dex, 
HNF1β-GR injected embryos that were early activated at stage 13, revealed an increase 
in insulin positive cells that were located more posteriorly in a larger insulin expressing 
domain (figure 3.1.9 A; +Dex13). Interestingly, in few embryos insulin positive cells were 
found in more distal regions of the dorso-lateral endoderm. On the background of previous 
studies in Xenopus laevis, this was the first time observed, that early insulin expression 
was ectopically induced in the dorsal endoderm upon misexpression of a transcription 
factor, thereby providing evidence, that HNF1β plays a crucial role in endocrine cell fate 
determination within the dorsal pancreatic anlage. Specificity of the effect for the early in-
crease of HNF1β function in the endoderm, was confirmed since activation at stage 20 did 
not augment the amount insulin-positive cells to such an extend. It was noteworthy that 
the number of insulin expressing cells in +Dex13 embryos did not only increase but also 
mislocated more posteriorly so that insulin positive cells were found in a larger territory 
expanding posteriorly within the dorsal endoderm. Later HNF1β activation did not result   
in an increase of insulin-positive cells nor in obvious mislocation of insulin positive cells 
(figure 3.1.9, A; +Dex20). Induction of HNF1β activity at stage 26, prior to pancreas speci-           
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fication by XlHbox8 and Xp48 expression did not alter insulin activation in comparison to 
untreated embryos. Analogous to HNF1β- Mo1+2 injection, the effect on cell number and           
region size was quantified.
The observed increase of insulin-positive cells in WMISH, was reflected in the quantifica-
tion of cell number and morphogenetic quantification of insulin expressing domain in 
injected embryos after early and late ectopic HNF1β activation as well as in untreated con-
trols without Dex, (figure 3.1.9, B and C). To reduce the possibility of natural occuring vari-
ances in insulin expression or differences according to embryonic staging, insulin positive 
Figure 3.1.9 Ectopic activation of HNF1β leads to induced insulin expression.
(A) Embryos inje��te� with HNF1β-�R ��apRNA �75p����E� were analyse� for ��han��es in insulin expression 
by W�ISH. HNF1β a��tivity was in�u��e� upon �ex-treatment at sta��e 13, sta��e ��0 an� sta��e ��6 �+�ex13, 
+�ex��0, +�ex��6�. Insulin expression was analyse� in sta��e 36 embryos after removin�� the overlayin�� noto-
��hor� an� surroun�in�� tissues. White line marks the insulin expressin�� re��ion whose size was �etermine� 
by morpho��eneti�� measurements. Two in�epen�ent experiments were performe� an� the total number 
of embryos �n� was use� for quantifi��ation. Early a��tivation of HNF1β at sta��e 13 promote� en�o��rine ��ell 
fate in the �orsal en�o�erm an� in�u��e� e��topi�� insulin expression in the �orso-lateral re��ions �re� arrow 
hea�s�. �5% �17����0� of +�ex13 embryos obtaine� more or the same amount of insulin positive ��ells that 
the avera��e number of -�ex embryos. �ut of these �0%, ��3% �4��17� reveale� e��topi�� insulin expression in 
more �istal lo��i of the �orso-lateral en�o�erm. (B) Columns in�i��ate the avera��e number of insulin posi-
tive ��ells ��ounte� in the �orsal ��ut epithelium of a sta��e 36 embryo. In total ��0 embryos were analyse� 
for ��han��es in insulin expression. Error bars in�i��ate the stan�ar� �eviation. ��ontrol embryos �CE�= ��4±4; 
-�ex= ���±5; +�ex13= 33±6, +�ex��0= ��7±5, +�ex16= ��6±5; Error bars in�i��ate stan�ar� �eviation. *p-
value < 0.0001; **p-value=0.006� �p-values from unpaire� two-taile� stu�ent´s t-test was ��al��ulate� usin�� 
online available software graphpad�. (C) �vera��tivation of HNF1β in��reases the size of insulin expressin�� 
�omain. �orpho��eneti�� quantifi��ation was �one on ima��es taken of W�ISH-embryos. Quantifi��ation was 
�one usin�� Ima��eJ software. Early a��tivation of HNF1β lea� to enlar��ement of insulin expressin�� re��ion 
��ompare� to CE an� untreate� embryos �-�ex�. Avera��e pixel numbers: CE= 5656 ± 176�; -�ex= 731� ± 
13��5; +�ex13= 1036�1 ± ��645; +�ex ��0= 7�11 ± 169�; +�ex��6= 7067 ± 1374. Error bars in�i��ate stan�ar� 
�eviation *p-value < 0.0001; **p-value < 0.0001 �p-values from unpaire� two-taile� stu�ent´s t-test was 
��al��ulate� usin�� online available software graphpad�.
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cells were counted in a total of 20 embryos deriving from two independent experiments. 
Despite the slight increase of insulin positive cells that was already detected in HNF1β-GR 
injected but untreated embryos, cell number increased significantly upon early activation      
of HNF1β function (figure 3.1.9, B; +Dex13). 85% (17/20) of these embryos showed the same            
or higher number of insulin positive cells than the average value of 28, obtained in unin-
duced embryos. Interestingly, in 23% (4/17) few of these insulin positive cells escaped their 
posterior expanded expression domain and were mislocated in more posterior regions of 
the endoderm. Cell number increase upon later activation was less evident and comparable 
to injected but untreated embryos (figure 3.1.9, B).   
Not only cell number but also the size of insulin expressing region was measured and 
compared with uninduced and induced HNF1β function. As expected from the increase 
in insulin cell number, early HNF1β activation (figure 3.1.9, +Dex13) resulted in an ex-      
panded insulin-expressing region while expansion upon later HNF1β activation was not 
apparently enlarged as compared to uninduced embryos (figure 3.1.9, C). In addition few      
embryos showed ectopic insulin positive cells in the dorso- lateral region. Data obtained  
upon ectopic expression of HNF1β in the endoderm argued that HNF1β not only regulated 
XlHbox8 activation but it was also involved in endocrine cell specification. 
As HNF1β injected embryos exhibit a smaller pancreatic bud,based on XPDIp expression, 
it was concluded that HNF1β regulates formation of the pancreatic organ but not organ 
outgrowth. HNF1β function in the endoderm was required in the dorsal pancreatic epithe-
lium to induced XlHbox8 expression which promotes endocrine at the expense of exocrine 
cell differentiation. Since overexpression caused a reduction of XlHbox8 in the ventral 
foregut, it was speculated that HNF1β plays a different role in the ventral pre-pancreatic 
endoderm, maybe by influencing development of the adjacent liver. 
Together, overexpression data demonstrated that HNF1β positively regulated XlHbox8 
and insulin expression whereas it did not affect Xp48 gene expression. These findings im-
ply a function in pancreas specification as well as in cell differentiation. Data from ectopic 
overexpression are in accordance with data from HNF1β depletion. In addition time point 
specifiation provided evidence that HNF1β function plays a role already during gastrula-
tion.
In an attempt to confirm the data obtained in loss and gain of function studies of HNF1β, 
the dominant repressor protein HNF1β- EngGR and the activator protein HNF1β- VP-
16GR were injected into embryos and resulting effects on pancreas development monito-
red by WMISH analysis of XlHbox8 (figure 3.1.10, appendix figure 7.1). 
The fusion protein HNF1β- EngGR has a strong repressor activity, antagonising endoge-
nous activity of HNF1β- WT. Injection into embryos, caused a similar reduction of dor-
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Figure 3.1.10 HNF1β positively regulates XlHbox8 expression. HNF1β ��o�in�� sequen��e was fuse� to the 
�ominant repressor �omain of the trans��ription fa��tor en��raile� �HNF1β-En���R� or the �ominant a��tiva-
tion �omain of VP16 trans��ription fa��tor �HNF1β-VP16�R�. Both proteins were a��itionally fuse� to �R-LB� 
to allow in�u��tion of trans��ription fa��tor a��tivity by �ex at sta��e 13 �+�ex10.5�. n= states total number of 
embryos of one experiment. Number in bra��kets in�i��ate amount of embryos in per��ent showin�� present-
e� phenotype. Inje��tion of HNF1β-En���R ��apRNA ��ause� a �e��rease in �lHbox� expression of inje��te� 
embryos �100p����E� that were treate� with �examethason, in parti��ular in the �orsal pan��reati�� re��ion �C; 
white arrow�. 47��71 �66%� of inje��te� but untreate� embryos �-�ex� showe� re��ular expression of �lHbox�. 
In the remainin�� ��4��71 �33%� �lHbox� trans��ripts were �eplete�. A��tivation of HNF1β fun��tion by inje��tin�� 
100p����E HNF1β-VP16�R ��apRNA �100p����E� ��ause� an in��rease in �lHbox� expression �F; +�ex13�. Note 
that also the unin�u��e� fusion protein ��ause� �lHbox� expansion ��ompare� to ��ontrol �E�. 
sal pancreatic XlHbox8 expression at stage 30 as observed for translational inhibition of 
HNF1β (figure 3.1.10, A-C). The ventral pancreatic XlHbox8 transcription was not im-          
paired. This results supported the idea, that HNF1β played a different role in dorsal versus 
ventral pancreas specification. Enhancing HNF1β function in the endoderm upon injec-
tion of capRNA, encoding the transcriptional activator HNF1β-VP16GR, phenocopied Xl-
Hbox8 induction of ectopic expressing of HNF1β-WT or HNF1β-GR at early activation 
upon Dex treatment. Apart from the ectopic ventro-posterior expression, the dorsal Xl-         
Hbox8 positive domain was also slightly expanded towards the anterior domain of the 
embryo. This change in Xlhbox8 expression phenocopied the effect caused upon RA treat-
ment (Chen et al., 2004).
In summary, the data obtained in the loss- and gain of function appproaches argued that 
the transcription factor HNF1β played a multifunctional role in the endoderm: (1) it is ne-
cessary but not sufficient to promote pancreas formation in the endoderm (2) it is necessa-
ry and sufficient to promote early endocrine cell differentiation in the dorsal pancreas (3) it 
played a role in specifying the position of the pancreatic anlage along the anteror-posterior 
axis of the gut tube. 
Interestingly a similar induction of XlHbox8 and insulin gene expression was reported 
in a previous study Dissecting the role of retinoic acid (RA) in organogenesis (Chen et. 
al, 2004). Embryos treated with RA showed a posterior expansion of the dorsal XlHbox8 
expression domain whereas ventral and duodenal regions remained unaffected. Also the 
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insulin expressing domain was posteriorly shifted. The number of insulin positive cellsin-
creased at stage 36. In contrast, treatment with the synthetic chemical compound BMS453, 
RA receptor (RAR) antagonist, induced the reverse phenotype, a decreased XlHbox8 RNA         
expression as well as a reduction of insulin positive cells. In this context it was tempting to 
investigate the relationship between HNF1β and RA signalling. 
3.1.3 Requirement of RA- signalling for HNF1β expression
3.1.3.1 HNF1β expression is responsi�e to RA- signalling
A previous study reported that RA signalling is required already during gastrula stage to 
determine a pancreatic precursor cell population in the forming endoderm. RA is syn-
thesised by the enzyme RALDH2 that is expressed at gastrula stage in the mesoderm. RA 
induces directly and indirectly expression of its downstream target genes in the neigh-
bouring tissues. At gastrula stage, the transcription factor HNF1β is expressed adjacent to 
RALDH2 in the involuting mesendoderm (compare figure 1.3 with figure 3.1.1) making it 
a suitable candidate to be activated by RA signalling. To investigate the influence of RA on 
HNF1β expression in the endoderm, embryos were treated at blastula stage 9 for 1 hr with 
5µM RA or 1µM BMS453. BMS453 is a synthetic retinoid, classified as arotinoid (Schulze 
et al., 2001) that antagonises RA on RAR. Embryos were fixed at stage 10.5, 25, 33 and 36 
and analysed for changes in HNF1β RNA levels using WMISH and semiquantitative RT-
PCR.
Expression in control embryos was consistent with the expression pattern as previously de-
scribed in this study, although in this experiment staining of targeted HNF1β RNA was in 
general weaker (figure 3.1.11). HNF1β expression is detectable in the neural ectoderm and 
endoderm where it persited till tailbud stage 33. HNF1β was also detected in the develop-
ing nephric system from stage 16 onwards (figure 3.1.11, B). Due to technical limitations, it 
was difficult to stain for targeted HNF1β transcripts in the yolky endoderm (figure 3.1.11, 
S1- S6).
At stage 33, the onset of pancreatic budding from the gut epithelium, the broad endoder-
mal transcript distribution gets restricted to the prospective liver and pancreatic region 
(figure 3.1.11, C, S2). In contrast to its strong meso-and endodermal expression, neuronal 
HNF1β expression is decreased (figure 3.1.11, S2). As the pancreatic organ differentiation 
proceeds, expression of HNF1β is clearly detectable in the liver, the developing kidney as 
well as the proctodeum (figure 3.1.11, D). 
Compared to control embryos, RA treated siblings showed a strong HNF1β activation in 
the neural ecoderm as well as the involuting endoderm, evident as stained rim edging the 
yolk plug (figure 3.1.11, E). Strong increase in HNF1β expression in ecto-and endoderm as 
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Figure 3.1.11 HNF1β expression is responsive to RA- signalling. Embryos were treate� at late blastual 
sta��e 9 for 1 hr with 5µ� RA or 1µ� B�S453 an� ��ulture� till �evelopmental sta��es in�i��ate� to the ri��ht 
of ea��h panel. Embryos were fixe� an� staine� for HNF1β expression by W�ISH. p�E�T-LFB3 was use� 
as template for �i��oxi��enin labele� asRNA. Note, that stainin�� is in ��eneral weaker than shown in HNF1β 
expression pattern fi��ure 3.1.1. At sta��e 10.5 the �orsal blastopore lip is represente� as bla��k line. Asterisk 
marks the en�o�erm. From tailbu� sta��es on embryos are shown in a lateral view with hea� to the left. 
Tailbu� sta��e embryos were embe��e� in ��elatine albumine for transversal se��tionin�� �30µm, S1-S6�. Po-
sition of the se��tion in the embryo is in�i��ate� by a white �ashe� line. In se��tions, a bla��k �ashe� line sur-
roun�s the en�o�erm �S1-S6�. In S�� an� S6 the bla��k line also marks the bor�er between liver an� ventral 
pan��reas. If ��ompare� to ��ontrol embryos �A-��, RA treatment lea�s to broa� expansion of HNF1β expres-
sion to in the neural e��to�erm as well as meso- an� en�o�erm �E- H� in parti��ular in the �orsal en�o�erm 
as pointe� out with bla��k arrow hea� in S��, 4, 6. In ��ontrast, inhibition of RA si��nallin�� by B�S453 lea�s 
to a re�u��tion of HNF1β expression �I-L�. Effi��ien��y of ��hemi��al treatment is ��onfirme� by morpholo��i��al 
�efe��ts as seen in the absen��e of hea� stru��tures upon RA treatment an� e�ema formation upon B�S453 
treatment. Abbreviations: ��e� �orsal en�o�erm, �en� en�o�erm, �li� liver, �ne� neural e��to�erm, �nt� neural 
tube, �p�� pro��to�eum, �pn� pronephros, �ve� ventral en�o�erm, �vp� ventral pan��reas, �w�� wolfian �u��t. 
well as in the forming nephric system was evident during subsequent development (figure 
3.1.11, stage 25, F). The pronephric capsule as well as the developing Wolfian duct were in-
creased in size and expanded posteriorly. Also, induced HNF1β RNA levels upon RA treat-
ment allowed transcript detection throughout the endoderm, also in transversal sections 
(figure 3.1.11, S3, S4). At stage 33, HNF1β transcripts were reduced in the ventro- anterior 
endoderm. Transversal section revealed that in particular, the previously undetectable 
HNF1β transcription became evident in the dorsal gut epithelium. This result indicated 
that HNF1β activation especially in the dorsal region was responsive to RA signalling (fig-
ure 3.1.11; S4). In the latest stage analysed, HNF1β expression in the ventro- anterior region 
was too weak to estimate an RA induced effect on endodermal HNF1β transcription (figure 
3.1.11; H). In accordance with a previous study (Cartry et al., 2006) persistent activation of 
RA signalling at stage 36 was evident in the increase in pronephric size, that was marked 
by HNF1β expression in comparison to control embryos (figure 3.1.11; H).
A complement approach to investigate the requirement of RA for HNF1β expression in 
the endoderm was performed treating embryos with the RAR antagonist BMS453. Treat-
ment with BMS453 caused reduction of HNF1β expression from gastrula stage onwards in 
the ectoderm. Due to weak endodermal staining it was not possible to estimate whether 
endodermal HNF1β expression was also affected in comparison to control (figure 3.1.11 
I- L; S5, S6). Effective BMS453 treatment was however confirmed regarding the disrupted 
formation of the mesoderm derived kidney (figure 3.1.11, K, L, black arrow; Cartry et al., 
2006). At later stages (figure 3.1.11; L) BMS treated embryos developed large edema in the 
ventro-anterior endoderm. In reverse complement to RA treatment the diminished renal 
anlage was detected by the dramatically reduced HNF1β expression that was restricted to 
the most anterior region of the excretory system.
Altogether, these findings indicated that HNF1β expression was responsive to RA signal-
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ling in the endoderm, already at gastrula stage and that its expression was especially in-          
duced in the presumptive dorsal pancreatic epithelium. Therefore, HNF1β might be RA 
downstream target, activated at gastrula stage and possibly mediating early RA signalling 
that is required for pancreas development. It was therefore of further interest to investigate 
how HNF1β expression was activated by RA- signalling in the forming endoderm.
3.1.3.2 HNF1β responds to RA- signalling in the endoderm
According to the previous study by Chen et al. (2004) pancreatic precursor cells were de-
termined by RA in the dorsal region of the involuting vegetal hemisphere. A more recent 
study by the same group showed that RA acts directly and indirectly on the endoderm 
where activation of differential expressed of RAR receptors regulate later pancreas specific 
gene expression in the dorsal versus the ventral endoderm. 
With the onset of gastrulation, HNF1β transcription was evident in the forming endoderm, 
adjacent to the expression domain of the RA synthesizing enzyme RALDH2 (compare fig-
ure 1.1.4 and figure 3.1.1). This observation aroused the interest to investigate whether RA    
was required for endodermal gene expression of HNF1β. In order to investigate the necessi-
ty for RA on isolated endoderm, changes in HNF1β transcription were analysed in vegetal 
explants upon activation and inhibition of RA signalling. RA signalling was acitvated by 
culturing explants in RA while reduced RA singnaling activity was achieved by treating 
explants with BMS453. 
Whole vegetal explants were Dissected by the with of gastrulation by removing the sur-
rounding ecto-and mesodermal germlayers (figure 3.1.12). After dissection, explants were      
treated RA or BMS453 and cultured till approximatly stage 17. Total RNA was extracted 
and analysed for changes in marker gene expression by semiquantitative RT-PCR (figure 
3.1.12, B). HNF1β transcripts were detected in untreated control embryos and untreated 
whole vegetal explants. As expected from the result of WMISH, upon activation of RA           
signalling HNF1β expression was increased in whole embryos as well as in isolated ex-
plants (figure 3.1.12). As HNF1β was detectable in the absence of exogenous RA, the onset              
HNF1β expression did not appear to depend on RA signalling. In addition it was reported 
that HNF1β expression was initiated right after MBT, meaning before RA synthesis. Ne-
vertheless, this experiments indicated that HNF1β transcription in the endoderm was     
promoted by RA- signalling during gastrulation. The pan- mesodermal marker brachury 
(Xbra) was analysed to assure mesoderm free explant preparations that would exclude in-
structive mesoderm derived signals that promote HNF1β activation within the endoderm. 
In comparison to control embryos, Xbra expression in the isolated explants is remarkably 
low approving proper tissue isolation. The still detectable Xbra expression is in accordance 
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with previous studies revealing autonomous mesoderm gene activation in early endoderm 
explants (Gamer and Wright, 1995). 
Vegetal explants differentially express certain genes along the anterior-posterior axis of 
the forming endoderm such as Cerberus (Bouwmeester et al., 1996; Zorn et al., 1999) that 
is expressed in the early dorsal endoderm at gastrula stage, that translocates towards the 
anterior region during subsequent embryo elongation. Transcripts of the anterior endo-
dermal marker Cerberus were present in low amounts in total embryonic extracts whereas 
they were enriched in the endoderm thereby confirming effective endoderm preparation. 
Cerberus expression was unaffected upon RA treatment. Conversely, inhibition of RA sig-
nalling by BMS453 treatment caused a strong downregulation of HNF1β transcription in 
treated embryos as well as in isolated explants (figure 3.1.12). Mesoderm contamination 
was excluded according to vanished Xbra detection. Cerberus transcripts were enriched 
in endoderm explants again confirming proper explant preparation. These data confirm 
the idea that HNF1β expression within the endoderm was regulated by RA signalling. 
However, the fact that HNF1β transcription was not completely abolished by inhibition of 
RA signalling indicates that additional signals within the endoderm, as for instance GATA 
transcription factors (Afouda et al., 2005) are responsible to maintain minimal HNF1β 
expression. 
Figure 3.1.12 HNF1β expression in the endoderm is responsive to RA signalling. (A) Requirement of 
RA si��nallin�� for HNF1β expression in the en�o�erm was analyse� by semiquantitative RT-PCR. Ve��etal 
explants were �isse��te� at the onset of ��astrulation sta��e 10 �st 10, �orsal blastopore lip is lo��ate� to the 
ri��ht, re� lines with sissors in�i��ate se��tione� area�. After �isse��tion, explants were treate� for 1 hr with 
5µ� RA or 1µ� B�S453, retransferre� to 1× �BS an� ��ulture� for ��4 hr at 16°C. (B) Total RNA was extra��te� 
of treate� an� untreate� embryos ���ontrol embryos CE; CE+ RA; CE +B�S� an� whole explants �WE, WE+ 
RA, WE + B�S� an� use� for analysis of ��ene expression by semiquantitative RT-PCR. Analyse� ��enes are 
sate� to the left. �li��onu��leoti�es use� were: HNF1β-RT for��rev �56°C, 30 ×�, the meso�ermal marker �bra 
��bra-for��rev; 56°C, 33 ×�, �orsal en�o�ermal marker Cerberus �Cerberus-for��rev; 57°C, ��� ×� an� the house-
keepin�� ��ene Histone H4 to equalize RNA amounts �Histone H4 for��rev�
A
B
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3.1.3.3 HNF1β expression responds to RA- signalling in the dorsal and �entral   
 endoderm
At early gastrula stage HNF1β expression was predominantly confined to the dorsal terri-        
tory of the involuting endoderm. Pan et al. (2007) revealed that RA is sufficient to induce 
pancreatic gene expression in the dorsal but not the ventral endoderm. Concerning HNFβ 
as RA downstream target to mediate RA signalling for later pancreas organogenesis. It was 
of further interest to exploit whether RA differentially activated HNF1β expression in the 
dorsal versus the ventral endoderm. To adress this question, changes of HNF1β expression 
were specified in early endodermal explants that were dissected into dorsal and ventral 
halfs, that were afterwards treated with 5µM RA or 1µM BMS453. 
HNF1β RNA levels did not remarkably differ between untreated control embryos, untreat-
ed dorsal or untreated ventral endoderm explants (figure 3.1.13, stage 10). Upon RA treat-
ment HNF1β expession was increased in control embryos and dorsal endoderm explants 
while HNF1β expression in the ventral endoderm only slightly differed from untreated 
ventral explants. Analysis of Xbra RNA levels confirmed mesoderm free tissue explants. 
The anterior endodermal marker gene Cerberus was expected to be enriched in the dorsal 
endoderm, compared to whole embryos and ventral endoderm explants indicating that 
enrichment of endodermal transcripts was less efficient as in the previous WE explant 
preparation and in the preparation of the BMS453 treatment. The pancreatic precursor 
gene XlHbox8 is autonomously expressed in the anterior endoderm at mid-neurula stages 
(Gamer and Wright, 1995) and was shown to be activated upon RA treatment (Chen et al., 
2004). In accordance to previous studies (Pan et al., 2007) the pancreatic precursor marker 
XlHbox8 was not detected in isolated dorsal endodermal explants and was only expressed 
upon exogenuos RA treatement, indicating that these explants adopted pancreatic fate. 
XlHbox8 was also detectable in ventral endodermal explants, that gives rise to the more 
posterior gut endoderm, contradictory to earlier reports (Pan et al., 2007), indicating that 
segregation of dorso-ventral endoderm was difficult by the onset of gastrulation. However, 
also in ventral endodermal tissue, XlHbox8 expression was elevated upon RA treatment 
indicating that chemical treatment was efficient and specific for gene activation.
Vice versa, inhibition of RA signalling using the RAR antagonist BMS453 repressed HNF1β 
transcription in whole embryos and remarkable in the dorsal and ventral endodem. Coact-
ing mesoderm derived signals were excluded according to weak Xbra expression. Cerberus 
was weakly detected in whole embryonic RNA extracts while in endodermal RNA ex-
tracts, in particular the dorsal endoderm, Cerberus transcripts were enriched. Accord-
ing to XlHbox8 gene induction upon RA treatment, inhibition of RA signalling in BMS 
treated explants repressed XlHbox8 transcription confirming efficient chemical treatment 
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and specific effects on gene activation. Although these findings remain to be quantified by 
realtime RT-PCR these results clearly demonstrated that endodermal HNF1β expression 
was under control of RA- signalling. 
In summary, the data obtained in the first part of this study cleary demonstrated that 
HNF1β was expressed in the early endoderm where it was coexpressed with the pancreatic         
progenitor markers XlHbox8 and Xp48 within the dorsal and ventral prepancreatic epithe-
lium by the onset of organogenesis. 
It was further shown, that HNF1β expression in the endoderm was under control of RA 
signalling as HNF1β transcription levels were elevated upon RA treatment and decreased 
upon BMS453 treatment. In tailbud stages 25 to 33, this increase in HNF1β expression 
occured in particular in the dorsal gut epithelium. At this stage the dorsal gut epithelium 
including pancreatic progenitor cells marked by the first pancreas specific genes XlHbox8 
and Xp48. These XlHbox8- Xp48 positive cells give rise to all exocrine and endocrine cell 
types of the mature pancreas. 
Loss and gain of function experiments indicated that HNF1β was necessary and sufficient 
to induce XlHbox8 expression in the pancreatic region and to promote differentiation of 
insulin positive cells in the dorsal gut endoderm. In contrast the expression of Xp48 was 
Figure 3.1.13 HNF1β expression in the dorsal and ventral endoderm is responsive to RA- signalling. 
(A) S��hemati�� �rawin�� of explant preparation. Explants were �isse��te� at sta��e 10-10.5 an� separate� 
into ventral �VE� an� �orsal halfs ��E� a����or�in�� to the position of the �orsal blastopore lip �re� lines�. 
After �isse��tin��, explants were treate� for with 5µ� RA or 1µ� B�S453 for 1hr an� than transferre� to 1x 
�BS. After ��4 hr, total RNA extra��ts were isolate� an� use� for ��ene expression analysis by semiquantita-
tive RT-PCR. CE: whole ��ontrol embryos sta��e 17. (B) Left panel shows ��han��es in marker ��ene expression 
in whole embryos �CE�, �orsal explants ��E� an� ventral explants �VE� upon a��tivation of RA si��nallin�� by 
RA treatment �+�. RA in�u��es HNF1β to the same exten� in the �orsal as well as the ventral en�o�erm. 
HNF1β usin�� oli��onu��leoti�es �HNF1β-RT-for��rev; the pan-meso�ermal marker �bra ��bra-for��rev�; the 
anterior en�o�ermal marker Cerberus �Cerberus-for��rev� an� the pan��reati�� pro��enitor marker �lHbox� 
��lHbox�-for��rev�. The ri��ht panel shows ��han��es in marker ��ene expression upon inhibition of RA si��nal-
lin�� by B�S453 treatment �+�. �ifferen��es of Cerberus an� �lHbox� trans��ript level between both experi-
ments are �ue to �ifferin�� quality of RNA preparations.
A
B BMS453
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only weakly affected upon HNF1β depletion, supporting the idea that Xp48 and XlHbox8 
are differentially regulated in the gut epithelium. In this regard, the second part of the study 
focused on isolation and characterisation of the Xenopus laevis homologue of the tran-
scription factor HNF6, that was reported as upstream regulator of Ptf1a/p48 in mouse. 
3.2 Isolation and characterisation of HNF6/ onecut-1 in Xenopus laevis
Studies in mouse indicated that in addition to HNF1β, the transcription factor onecut-1, 
also called HNF6, functions as activator for gene expression of the first pancreatic progeni-
tor genes XlHbox8 and Xp48 in the gut epithelium (Jaquemin et al., 2003a). In contrast to 
HNF1β, HNF6 has not been identified in       Xenopus laevis. In order to study its function in 
pancreas organogenesis, in particular as upstream regulator of XlHbox8 and Xp48, Xeno-
pus laevis HNF6 homologue was isolated and its detailed expression profile was generated.           
Finally, first functional studies were initiated by ectopic protein expression in the endo-     
derm and the resulting effects on pancreas development were monitored by changes in         
marker gene expression of Xp48 and Trypsin. 
3.2.1 Isolation of an onecut transcription factor 
To isolate the HNF6 homologue from Xenopus laevis, three nucleotide databases (NCBI,    
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi, Altschul et al., 1997; Ensemble, http://www.
ensembl.org/index.html; JGI, http://genome.jgi-psf.org/Xentr4/Xentr4.home.html) were 
screened for available sequence information of Xenopus using the mouse HNF6 DNA se-
quence (NCBI: NM008262). Several EST-sequences (for instance NCBI: CX397211) and a        
full length HNF6 coding sequence were annotated for Xenopus tropicalis (NCBI: BC135775) 
but no sequence information was availabe for Xenopus laevis. Since the sequence identity 
between Xenopus tropicalis and Xenopus laevis is generally high, this full length sequence 
served as template to design specific oligonucleotides that were used to isolate the entire 
Xenopus laevis HNF6 coding sequence using 3´RACE- and 5´ RACE-PCR methods. 
Regarding the time point of induction of XlHbox8 and Xp48 gene expression in the pre-
pancreatic endoderm, total RNA was extracted from a mix of stage 28 to stage 34 embryos 
and used for 3´RACE and 5´ RACE cDNA synthesis. For the following PCR step, Xeno-
pus specific primers were used to isolate a 3 e´nd and 5´ end fragments including sequence 
information of the coding region. These amplified PCR fragments were subcloned into 
pGEMT-E vector, analysed by sequencing and compared to the Xenopus tropicalis sequen-
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ces subsequently. While the 3´ end, including the translational stop codon TGA, was isola-            
ted in a 3´RACE-PCR using the XHNF6 3´RACE primer, the 5´  end could not be isolated 
by 5´ RACE-PCR although different combinations of oligonucleotides (XHNF6-5´ RACE 
1- 3) were used. 
In a second attempt to isolate a 5´ end sequence of Xenopus laevis HNF6, a Xenopus lae-
vis λ- Zap Express cDNA head library (Hollemann et al., 1996) was screened using the 
vector specific primer CMV_for and the Xenopus specific oligonucleotide CX397211_rev. 
Obtained PCR fragments were subcloned into pGEMT-E. Subsequent sequence analysis 
resulted in one sequence of 573 bp with high sequence homology to the Xenopus tropicalis 
onecut-1 sequence. This isolated   Xenopus laevis sequence included the translation initia-
tion side ATG. The missing intermediate domain of the coding sequence (between ATG 
and TGA) was isolated using Xenopus laevis specific oligonucleotides matching the ATG 
and TGA sides (Xl_HNF6-5´ ClaI; Xl_HNF6-3´XhoI). Finally, all three obtained fragments 
were used to compose the entire Xenopus laevis coding sequence including 265 bp of 5´ un-
translated region (5´ UTR), an ORF of 1482 bp and a 3´UTR of 220 bp (figure 3.2.1). The  
coding sequence was translated into corresponding amino acids that resulted in a protein 
of 492 aa with a calculated weight of 54 kD (MacMolly software, figure 3.2.2). This protein 
was aligned to sequences of known HNF6 homologues from other species in order to con-
firm its HNF6 identity.
3.2.2 The Xenopus laevis onecut protein corresponds to HNF6/ onecut-1 
The name of the onecut transcription factor family is based on the first identified cut pro-
tein from Drosophila melanogaster (Blochlinger et al., 1988). All onecut family members    
contain a characteristic C-terminal DNA binding domain, composed of one CUT motif 
Figure 3.2.1 Isolation of an onecut transcription factor from Xenopus laevis. S��hemati�� �rawin�� of the 
the isolation of the ��o�in�� sequen��e �blue� of the Xenopus laevis one��ut protein that was ��ompose� of 
three isolate� sequen��es: the 5´ en� of the ��o�in�� sequen��e, in��lu�in�� the translation initiation site AT� 
an� ��65 bp of the 5´UTR was isolate� from a Xenopus laevis λ- �ap Express ���NA hea� library �HL, bla��k�. A 
3´ en� fra��ment, in��lu�in�� the translational stop ��o�in T�A an� ��ontainin�� ����0 bp of the 3´UTR, was isolat-
e� by 3´RACE-PCR out of sta��e ���-34 total RNA extra��t �3´RACE, white, oli��onu��leoti�e: HNF6-3´RACE�. The 
�RF of 14��� bp was amplifie� by RT-PCR out of sta��e ���-34 total RNA extra��t usin�� the oli��onu��leoti�es 
mat��hin�� the translation start �AT�� an� stop �T�A � si�es �re�, �l_HNF6-5´ClaI; �l_HNF6-3´�hoI�. 
(1482 bp)
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and one downstream HOMEOBOX motif. In contrast, the N-terminus differs between 
onecut family members classifying them into three subgroups: onecut-1, 2 and 3 (OC-1, 2 
and 3). 
To assign the here identified Xenopus laevis protein to one of these subgroups, the amino 
acid sequence was compared to onecut family members of other organism (alignment soft-
ware: CLC Free Workbench, appendix figure 7.4). Sequence comparison with eukaryotic    
homologues revealed that the isolated Xenopus laevis protein was closely related to onecut-
1/ HNF6. 96% of the Xenopus laevis HNF6 (XHNF6) protein residues were identical to 
Xenopus tropicalis and 79% were identical to the mouse and human onecut-1. The zebrafish 
homologue showed 75% identical amino acids. While the N-terminus differed strongly      
between different organism, the C-terminal DNA binding site showed remarkable high 
conservation of amino acid sequence in the CUT and HOMEOBOX domain (table 3.2). 
As reported from studies in mouse, HNF1β and HNF6 were both responsible for activa-
tion of the pro-pancreatic transcription factors Pdx1 and p48 in the developing murine gut 
tube. In general, regulation of gene expression by transcription factors occurs directly by 
binding to specific promotor sites of the target gene. Therefore regulator and downstream 
target must be expressed at the same time and in the same tissue. 
In order to investigate the differential role of XHNF6 and HNF1β to direct pancreatic de-
velopment in Xenopus in particular regarding the onset of pancreatic preogenitor marker 
Xp48, a detailed expression profile of HNF6 was generated and compared to the expression 
of the co-regulator HNF1β and their postulated downstream targets XlHbox8 and Xp48.
3.2.3 Comparati�e expression analysis of XHNF6 within the endoderm 
3.2.3.1 XHNF6 expression precedes the onset of pancreatic marker genes
In order to be an usptream regulator of Xp48, XHNF6 should be coexpressed with its 
downstream target. To elucidate the role of XHNF6 during pancreas development in Xe-
nopus laevis it was therefore necessary to determine its temporal and spatial expression 
pattern. 
Using semiquantitative RT-PCR on RNA that was extracted from different developmental 
stages, first HNF6 transcription was detected at stage 15 (figure 3.2.3). From there onwards 
HNF6 expression level remained constant till end of neurulation. From there on, Transcript 
levels slightly increased during tadpole stage 26 until stage 42. In contrast, HNF1β tran-
scription was already detectable during gastrulation stage 10.5 showing increasing tran-
scription levels by stage 12 (see also figure 3.1.1; Vignali et al., 2000; Demartis et al., 1994). 
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In respect to HNF1β, a splice variant HNF1β-B, lacking 26 amino acids in the DNA bind-
ing domain, was previously identifed in humans (Wu et al., 2004). It was speculated that 
also in Xenopus laevis such an HNF1β variant exists and that it might play a redundant role 
during organogenesis (HNF1β-∆26; Wu et al., 2004). Sequence information from humans 
indicated that splicing occurred in the region of intron II. To find out whether Xenopus 
laevis also expressed an HNF1β-∆26 splice variant, the second intron was amplified from 
genomic DNA of Xenopus laevis. Based on this intron II sequence, oligonucleotides were 
designed that would detect both HNF1β variants. Amplification during RT-PCR would re-
sult in two fragments: one fragment corresponding to the wildtype HNF1β fragment (317 
bp) and the alternatively spliced fragment (239 bp).However only the large fragment was 
amplified by RT-PCR indicating that only one HNF1β variant exists in Xenopus laevis. 
Further, XHNF6 expression levels during development were also compared to gene tran-
scription of its potential downstream targets XlHbox8 and Xp48. XlHbox8 is known to be 
weakly transcribed in the anterior endoderm from stage 12 onwards (Gamer and Wright, 
1995), here seen as a faint band at stage 15 (figure 3.2.3). Its expression strongly increases 
by the time of regionalisation of the primitive gut, where XlHbox8 becomes predominant 
in the pre-pancreatic and duodenal epithelium at stage 28. This expression profile was very 
similar to the temporal gene induction observed for XHNF6 that also revealed higher tran-
script levels what matches with the increase in expression level of XlHbox8 during gut tube 
organism identical/ total
amino acids
total 
% identity 
% identity CUT 
(aa 282- 362)
% identity 
Homeobox
(aa 414- 468)
X. tropicalis (AAI35776) 473/ 493 96 100 100
M. musculus (NP_032288) 396/ 465 79 100 100
H. sapiens (NP_004489) 396/ 465 79 100 100
Z. onecut (NP_956867) 372/ 461 75 99 98
M. onecut 2 (NP_919244) 270/ 505 54 99 92
M. onecut 3 (NP_6131972) 205/ 490 41 98 83
H. onecut 2 (NP_004843) 264/ 485 52 99 91
H. onecut 3 (XP_944823) 211/ 494 42 98 83
D. melanogaster (NP_524842) 167/ 1081 32 90 82
Table 3.2 Sequence homology between isolated XHNF6 and onecut proteins. Name of or��anism an� 
sequen��e a����ession number is state� to the left. The amount of i�enti��al amino a��i�s to total resi�ue 
number of the homolo��ue is ��ompare� �se��on� ��olumn�. Amount of i�enti��al resi�ues ��ompare� to 
�HNF6 is ��al��ulate� as per��enta��e �thir� ��olumn�. The one��ut �NA bin�in�� �omain is ��ompose� of the 
CUT an� H��E�B�� motif that is hi��hly ��onserve� between all one��ut family members.Per��enta��e ��al-
��ulate� �fourth an� fifth ��olun� in�i��ate motif i�entity ��ompare� to the CUT �aa �����- 36��� an� H��E�B�� 
�aa 414- 46�� �omain of �HNF6 �fourth an� fifth ��olumn�. Strikin��ly, the �NA bin�in�� sites of all one��ut-1 
homolo��ues are 100 % i�enti��al to Xenopus laevis. 
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patterning (figure 3.2.3, stage 26). As known from previous studies, the second pancreatic 
progenitor marker Xp48 is detectable by the end of neurulation (stage 20) with increasing 
amounts at stage 26 (figure 3.2.3). Shortly after first detection of XHNF6 transcripts. Also 
Xp48 expression levels increased, like XHNF6 and XlHbox8, by stage 26 representing the 
time point of pancreas specification in the foregut endoderm (Afelik et al., 2006). XHNF6 
transcription was persistent by the time of endocrine and exocrine cell differentiation as 
seen in comparison to the expression of the earliest endocrine gene insulin and the earliest 
exocrine differentiation marker XPDIp (Afelik et al., 2004; Kelly and Melton 2000). 
Despite the marginal transcript level of XlHbox8 at stage 15, these data demonstrated that 
XHNF6 expression preceded the onset of pancreatic marker gene expression. As already 
mentioned, synchronized expression of the activator and downstream target in time and 
tissue is required for direct gene activation. The RT-PCR experiment determined the time 
but not the place of XHNF6 transcription. In order to specify the spatial transcript dis-
tribution, a detailed spatial expression pattern was generated for XHNF6 during Xenopus 
laevis embryogenesis, and its transcript distribution was compared to expression domains 
of XlHbox8 and Xp48 by the onset of pancreatic budding at stage 34. 
3.2.3.2 XHNF6 is expressed in the neural tissue and anterior endoderm 
Spatial distribution of XHNF6 was analysed by WMISH using a digoxyxgenin labeld asR-
NA targeting the entire coding sequence of XHNF6. As shown in (figure 3.2.4 A) XHNF6 
expression is first evident at stage 16 in two small elongated territories orthogonal to the 
Figure 3.2.3 XHNF6 preceds expression of pancreatic marker genes. In�u��tion of �HNF6 expression was 
��ompare� to the onset of expression of liver an� pan��reati�� marker ��enes by semiquantitative RT-PCR. 
Total RNA was extra��te� from embryos of �ifferent �evelopmental sta��es as state� on top of ea��h lane. 
�li��onu��leoti�es use� for RT-PCR rea��tion were: �HNF6: C�397��11-for�� rev; HNF1β-RT for�� rev; HNF1β-∆��6 
for�� rev; �lHbox�-RT-for�� rev; �p4�-RT-for�� rev; Insulin RT-for�� rev; �P�Ip-RT-for�� rev. Histone H4 amplifi��a-
tion was use� to equalize RNA amounts. H��� was use� as ne��ativ ��ontrol. 
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midline of the anterior embryonic region. Dissection of the embryo revealed that the stai-
ning was in the ectodermal layer. Two faint lines of expression expanded to the posterior 
end. Position and shape of the anterior expression domains resembled the site of Krox20 
transcription that marks prospective hindbrain regions rhomdomere 3 and 5 and the mi-
grating neural crests that become the third branchial arch (Bradley et al., 1993). The two           
caudal expression lines represent the presumptive closing neural tube. It was noteworthy 
that initial Xp48 transcirption was activated in similar neural territories by the end of 
neurulation. 
At stage 20, XHNF6 expression is found in the forming mid- and hindbrain region, the 
closing neural tube and the lateral migrating neural crest cells which give rise to the lateral 
line placodes (Schlosser and Northcutt, 2000; figure 3.2.4, B). First endodermal expression      
became weakly detectable at stage 24 in the ventro-anterior endoderm (figure 3.2.4, C, D,    
asterisk). At this stage, XHNF6 was also found in the optic anlage and the migrating neurla               
crest cell were it was segregated into the distinct lateral placodes (figure 3.2.4 C). By stage 
34, the two romdomeres patterned the hindbrain region that was passing over into the 
mid-and forebrain territory. However, its expression was strictly end persistent excluded 
from intermediate structures as the midbrain-hindbrain boundary (figure 3.2.4 G,J, M, 
Q). Transversal sections located XHNF6 expression in the eye to the presumptive retinal 
pigment epithelium and retina resembling expression of the retinal marker Otx2 (figure 
3.2.4 , S1; Viszian et al., 2000). Neural expression was confined to differentiating neurons 
located in the intermedial and marginal zone of the spinal cord. The endodermal XHNF6 
transcription was elavated in the ventro anterior endoderm marking the liver diverticulm. 
Ventro-anterior expression was extending towards the dorso-anterior region marking the 
presumptive ventral and dorsal pancreatic domain. Here, XHNF6 transcription was re-       
stricted to the prospective liver and ventral pancreas (figure 3.2.4, E, H; transversal section 
S1 and S2), living up to its name as „liver enriched hepatic nuclear factor 6“. 
During subsequent development the neural crest placodes further differentiated into di-
stinct anlagen. The neural XHNF6 transcription persisted ubiquitously in differenting cells 
of the ventral spinal cord. At this stage HNF6 expression was excluded from the lens tis-
sue, but its retinal staining was not defined to any restricted retinal zone or layer (figure 
3.2.4, S3,S4; Viszian et al., 2000 ). Although it was not evident from transversal sections,             
in whole embryos endodermal XHNF6 transcription was clearly seen in the forming liver 
and the ventral pancreatic domain expanding to the dorsal gut endoderm. From the posi-
tion within the embryo it was estimated that XHNF6 and Xp48 are coexpressed in same 
territories during embryogenesis in the neural as well as endodermal territories (Dullin et 
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Figure 3.2.4 Expression pattern of HNF6 during Xenopus laevis development. Spatial �istribution of 
HNF6 trans��ripts �urin�� �evelopment was analyse� by W�ISH usin�� embryos of �ifferent �evelopmental 
sta��es. The �HNF6-p�E�T ��onstru��t en��o�in�� the entire �RF, serve� as template to trans��ribe �i��oxy-
��enine labele� asRNA. �HNF6 trans��ripts were �ete��te� from sta��e 16 onwar�s in the neural e��to�erm, 
the presumptive romb�omeres, the mi��ratin�� neural ��rest ��ells an� the ��losin�� neural tube. From sta��e 
��4, �HNF6 trans��ription is first visible in the ventro-anterior en�o�erm �asterisk�, where it ��ets spatially 
resti��te� to the liver, ventral pan��reas an� to the ��all bla��er at later ta�pole sta��e 41. Sta��e 16 embryo 
is positione� anterior to the top �A�. Late neurula an� tailbu� sta��e embryos are positione� laterally with 
anterior to the left �B-R�. �: ventral view of embryo sta��e ��5 in C �asterisk in�i��ates the anterior en�o�erm�.
F, I, L, P: show enlar��e� hea� re��ions of the embryo to the left - E, H, K, � respe��tively. �, J, �, Q: enlar��e� 
�orsal view of the mi�-brain-hin�brain re��ion �braket� of embryos to the left- E, H, K, � respe��tively. S1-S4 
transversal ��elatine albumine se��tions of the embryo to the left. Position of the se��tion is in�i��ate� in the 
embryo as white �ashe� line. N,R: ventral view of the embryo to the left K,� respe��tively. Abbreviations: 
��e� �orsal en�o�erm, �epI�� ��lossopharyn��eal epibran��hial pla��o�es, �ep�1� first va��al epibran��hial pla-
��o�es, �epVII� fa��ial epibran��hial pla��o�es, �fb� forebrain, ���b� ��all bla��er, �hb� hin�brain, �llp� lateral line 
pla��o�e, �li� liver, �mb� mi�brain, �mhr� mi�brain hin�brain re��ion, �mhb� mi�brain hin�brain boun�ary, 
�mn��� mi��ratin�� neural ��rest, �mz� mar��inal zone, �nt� neural tube, �pA�� antero-�orsal lateral line, �p�� 
mi��le lateral line pla��o�es, �p�l� olfa��tory bulb, �p�t� oti�� pla��o�e, �pP� posterior lateral line pla��o�es, 
�ov� opti�� vesi��le, �rb� rob�omeres, �re� retina, �v� mi��ratory primor�ia of the ventral trunk lines, �v�t� oti�� 
vesi��le, �ve� ventral en�o�erm.
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al., 2007; Afelik et al., 2006). With differentiation of head structures, XHNF6 expression 
is found in the outer region of the retina the presumptive pigment epithelium, although 
transversal sections are required to confirm the exact region within the pigment epitheli-
um. Endodermal expression in the liver is maintained whereas pancreatic expression faints            
and is not detectable by stage 37. At this stage XHNF6 transription in the liver margely 
decreases in the anterior liver diverticulum and gets spatially confined to the most dorsal 
edge of the liver diverticulum that segregates to the form the gall bladder (figure 3.2.4 K, N, 
O,R) which was clearly distinct in the ventroanterior endoderm by stage 41.
Analysis of transcript distribution in whole embryos revealed that HNF6 was expressed 
in the neural tissue, the neural crest and in the endoderm. This expression was coincident 
with the expression profile observed in mouse (Rausa et al., 1997). The similar expression 
pattern favored the idea that XHNF6 played a conserved role during pancreas develop-
ment. In context of this study, it was very intersting to observe that XHNF6 expression in 
the anterior endoderm was evident at stage 24, before the onset of Xp48 in the pancreatic 
epithelium. This anterior endoderm included the bipotential cell population that eventual-
ly gives rise to liver and ventral pancreas. This was in agreement with expression profiles in 
mice increasing expression during subsequent development in this domain, in particular 
by the onset of pancreatic budding by stage 33, provided evidence for a functional role of 
HNF6 in liver and pancreas development. 
3.2.3.3 XHNF6 is expressed in the �entral and dorsal pancreas
The spatial expression pattern of XHNF6 demonstrated that by the onset of pancreatic 
budding (stage 33/34), it was transcribed in the anterior ventral endoderm. If HNF6 was 
indeed the postulated upstream activator of Xp48 in the regulatory cascade, both tran-
scription factors should be coexpressed in the ventral pancreas. At this stage the liver pri-     
mordium is located adjacent to the ventral pancreatic anlage in the gut epithelium. Before 
delamination from the gut tube, both primordia are marked by differential expression of 
organ specific genes as the hepatic transcription factor Hex (XHex) and the pancreatic 
transciption factor Xp48 (figure 3.2.5). 
In order to specify the region of XHNF6 expression in both organ primordia, its transcript 
distribution was compared to the spatial distribution of XHex and Xp48 RNA as well as 
the transcript localisation of pancreatic marker gene XlHbox8 and the anterior foregut 
marker gene HNF1β. Control embryos were stained by WMISH targeting the expression 
of the hepatic marker XHex (figure 3.2.5, A, S1), the anterior foregut marker HNF1β (figure             
3.2.5, B, S2), the identified XHNF6 (figure 3.2.5, C, S3), the pancreatic progenitor markers             
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XlHbox8 and Xp48 (figure 3.2.5 D, S4 and E, S5 respectively).       
XHex expression domains included the thyroid and proctodeum as well as the most ventral              
region of the anterior foregut, the liver diverticulum. In comparison, XHNF6 transcripti-
on was also detected more dorsally in the budding ventral pancreatic rudiments. The two 
XHNF6 positive regions adjacent to the dorsal side of the liver correlated with the location 
for Xp48 and XlHbox8 staining in the ventral pancreas (compare figure 3.2.5 C with D,E              
and S3 with S4, S5). However it remained unclear, whether XHNF6 was also expressed in          
the dorsal prepancreatic endoderm. 
In the dorsal pancreatic rudiment HNF1β expression was still detectable as faint staining 
whereas the dorsal endoderm seemed devoid of any XHNF6 transcripts (figure 3.2.5, com-
pare B and C, S2 and S3). Studies in mouse reported of XHNF6 transcripts in both organ          
primordia, therefore rising the question whether absence of XHNF6 transcription in the 
dorsal gut epithelium was real or whether it was due to technical limitions of the staining             
procedure as seen for the detection of low HNF1β RNA levels in the yolky endoderm. In 
order to overcome this technical constraint, XHNF6 gene expression within the endoderm 
was analysed by semiquantitative RT-PCR. 
3.2.3.4 XHNF6 and HNF1β are expressed in the dorsal endoderm
To focus on the XHNF6 transcript distribution in the endoderm, it was crucial to isolate 
the endoderm from other XHNF6 expressing tissues. As known from the generated spatial 
expression pattern (figure 3.2.5), the XHNF6 gene was activated in the head region and the 
neural tube. To determine exclusively endodermal XHNF6 transcript levels, other HNF6 
positive tissues were removed as depicted in the scheme (figure 3.2.6). Further, the isolated 
whole embryonic endoderm was dissected into its dorsal and ventral endodermal part. 
Total RNA of each fraction was extracted and used for semiquantitative RT-PCR analysis. 
XHNF6 gene activation was compared with transcript levels the anterior foregut marker 
HNF1β and insulin, that is exclusively expressed in the dorsal pancreatic rudiment. To 
assure that endoderm was devoid of neural tissue, cross- contamination was excluded by 
analysis of the neuronal differentiation marker n- tubulin. 
As expected, the anterior foregut marker HNF1β is expressed in the dorsal and ventral 
foregut whereas transcripts of the endocrine gene insulin were only detectable in the dor-
sal fraction thereby confirming proper isolation of dorsal endoderm. As just mentioned, 
detected XHNF6 expression could also originate from neuronal tissues, although this pos-
sibility was eliminated by the absence of the neuronal differentiation marker n- tubulin. 
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These data confirmed, that similar to mouse (Rausa et al., 1997), XHNF6 expression occu-
red in the ventral and dorsal endoderm.
3.2.3.5 Tissue distribution of XHNF6 in adult Xenopus laevis
Finally, to complete the detailed expression profile of XHNF6, its expression was exami-
ned in tissues of the adult frog by RT-PCR. In the adult, tissue distribution correlates with 
observed expression domains during development, namely the liver, the pancreas and the 
brain (figure 3.2.7). 
Altogether, the data obtained by the detailed expression study of XHNF6 revealed that 
it is activated early in the anterior endoderm, prior to the onset of XlHbox8 and Xp48. 
These findings support the idea that also in Xenopus laevis XHNF6 is involved in pancre-
Figure 3.2.6 XHNF6 is expressed in the dorsal and ventral endoderm by the onset of pancreatic budding.
�HNF6 expression was analyse� by semiquantitative RT-PCR on total RNA extra��ts of sta��e 34 embryos 
�CE�. To spe��ify its en�o�ermal expression the embryo was �isse��te� into whole embryoni�� en�o�erm 
�WEE�, whole �orsal embryoni�� en�o�erm �W�E� an� whole ventral embryoni�� en�o�erm �WVE�. H��� was 
use� as ne��ative ��ontrol. �HNF6 is expresse� similar to HNF1β in the W�E as well as in the WVE. In ��on-
trast insulin is just �ete��table in the area of the �orsal pan��reas. To ex��lu�e neuronal ori��ine for HNF6 
trans��ripts the neuronal �ifferentiation marker N-tubulin was teste�. Histone H4 serve� to equalize RNA 
amount. Primers use�: �HNF6: C�397��11-for�� rev; HNF1β-RT-for�� rev; Insulin RT-for�� rev; N-tubulin for��rev; 
Histone H4-for�� rev. 
st 34
X
Figure 3.2.5 XHNF6 is expressed in the ventral pancreas. Expression of �HNF6 was ��ompare� by W�ISH 
to expression of the liver pre��ursor marker �Hex, the anterior en�o�erm marker HNF1β as well as to its 
potential pan��reati�� �ownstream tar��ets �lHbox� an� �p4�. Transversal se��tions were performe� to re-
veal trans��ript �istribution in the en�o�erm at the onset of pan��eati�� bu��in�� sta��e 34. Whole embryos 
are positione� lateral with the hea� to the ri��ht. �evelopmental sta��e is in�i��ate� as number to the ri��ht. 
White line in�i��ate� postion of the se��tion shown un�erneith the whole embryo. Abbreviations: ���� �uo-
�enum, ��p� �orsal pan��reas, �li� liver, �ty� thyroi�, �pn� pronephros, �vp� ventral pan��reas, �p�� pro��to�eum, 
�hb� hin�brain, �nt� neural tube, �re� retina, �vz� ventri��ular zone. Asterisk marks the en�o�erm.
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atic organogenesis and underlines is potential role as upstream regulator of the pancreatic 
marker gene Xp48. 
3.2.4 Functional characterisation of XHNF6 during pancreas de�elopment
In order to study the role of XHNF6 during pancreas development, the coding sequence 
was cloned into the pCS2+ expression vector (XlHNF6_ClaI/ XlHNF6_ XhoI). The pCS2+/ 
XHNF6 construct, containing the entire ORF (1482 bp), was used for in vitro transcripti-
on of XHNF6 capRNA. In the previous study that underlined the requirement for Xp48 
expression to direct pancreatic cell fate in the foregut 800 pg capRNA were injected per      
embryo. Here, 750 pg HNF6 capRNA were directed to the endoderm by radial injection into 
the vegetal pole of a four-cell stage embryo. Embryos were cultured till late tadpole stages        
to analyse changes in pancreatic marker gene expression as Xp48 and the exocrine marker 
trypsin used to illustrate organ size.
Upon ectopic expression of XHNF6 in the endoderm, 90% showed an increase of the Xp48       
positive territory indicating an enlargment of the pancreatic lobes. The dorsal lobe ranged 
from it dorsal position nearly to the most ventral domain. Size expansion was in particular 
seen from the ventral side of the embryos (figure 3.2.8 B; B and C). The ventral pancreas 
evaginated from the gut epithelium as two distinct buds that are separated by the caudal 
tip of the liver diverticulum. Due to gut rotation movements, these two ventral buds come 
in apposition and fuse to give rise to the ventral panceratic lobe at stage 41. Upon XHNF6 
overexpression, the two ventral buds showed an increased staining intensity, enlarged ter-
ritory and they were connected to each other by a thin Xp48 positive stripe that was located 
posterior to the posterior liver tip. Increased Xp48 expression would consequently promote      
exocrine pancreas specification leading to an enlarged organ size (Afelik et al., 2006). 
To order to analyse XHNF6 function during development, embryos were injected with 
XHNF6 capRNA and cultured untill stage 43 and analysed for expansion of exocrine tissue 
using the exocrine enzyme trypsin (figure 3.2.8 A; C). At this stage, the pancreatic lobes 
Figure 3.2.7 XHNF6 is expressed in liver, pancreas and brain of the adult Xenopus laevis. �istribution 
of �HNF6 in the mature fro�� was analyse� by RT-PCR usin�� oli��onu��leoti�es C�397��11_for��rev on total 
RNA extra��ts from a�ult or��ans. Histone H4 was analyse� to equalize RNA amounts. Abbreviations: �in� 
intestine, ���b� ��all bla��er, �m� mus��le, �ki� ki�ney, �st� stoma��h, �li� liver, �he� heart, �pa� pan��reas, �lu� lun��, 
�br� brain. 
XHNF6
Histone H4
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Figure 3.2.8 Ectopic expression of XHNF6 promotes pancreas development. (A) Embryos were inje��te� 
with �HNF6 ��apRNA, ��ulture� till sta��e 39 an� analyse� for ��han��es in expression of its potential �own-
stream tar��et �p4� �750 p����E; A, B� as well as for ��han��es in or��an size a����or�in�� to the exo��rine ��ompart-
ment that was markes by the exo��rine enzyme trypsin. Compare� to ��ontrol, overexpression of �HNF6 
lea� to expan�e� �p4� expression �omain in the ventral as well as in the �orsal pan��reati�� anla��e �B, �; 
white arrow an� bla��k arrow respe��tively�. Small numbers to the left in�i��ate �evelopmental sta��e. n= 
total number of embryos; per��enta��e in bra��kets states number of embryos showin�� the presente� phe-
notype. In panel �, all 15 embryos presente� enlar��e� exo��rine ��ompartent of the pan��reas ��ompare� to 
��ontrol embryos �C�. 3 embryos ���0%� showe� e��topi�� trypsin expressin�� ��ells in the anterior fore��ut. (B) 
As seen in the ventral ��lose up view of two �HNF6 inje��te� embryos �B; C�, the �p4� positive re��ion was 
not only enlar��e� in the ventral pan��reati�� epithelium �vp� but also ventro-posterior expan�e� �re� arrow 
hea��. ��p� �orsal pan��reas �vp� ventral pan��reas. �st� stoma��h 
have already fused to one organ that is positioned underneith the stomach and duodenum 
due to gut rotation movements (figure 3.2.8 A; D). Since the exocrine compartment repre-
sents the majority of the pancreatic tissue, it was possible to judge pancreatic size accor-
ding to the trypsin expressing region. 100% of the injected embryos developed an enlarged 
pancreatic organ. In addition, 20% of these embryos not only showed enlarged pancreas 
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but also ectopic trypsin- positive regions in the anterior foregut. Since the pancreatic lobes 
fused it cannot be judged whether this additional trypsin positive tissue originated from 
the ventral or dorsal pancreatic rudiment. It was noteworthy that the trypsin positive regi-
ons were positioned in the neighbouring intestinal tissue of the endogenous Xp48 expres-
sion domain.
A recent study in Xenopus laevis revealed that the transcription factor Xp48 was also cru-
cial for endocrine cell differentiation (Afelik et al., 2006). Hence, it would be of interest to 
analyse effects on insulin gene activation upon ectopic HNF6 expression. 
In summary, the second part of this study focused on the isolation of the Xenopus laevis 
homologue XHNF6 that was suggested to function as a direct upstream activator of Xp48 
during pancreas development. On this background, both transcription factors have to be 
coexpressed in the endoderm at the same time and in the same location. A detailed expres-
sion pattern analysis revealed that XHNF6 transcription was initiated prior to the onset of 
Xp48 in the anterior foregut endoderm. XHNF6 positive region included the ventral and 
dorsal prepancreatic epithelium, indicating that XHNF6 could function as upstream regu-
lator of Xp48. Preliminary gain of function data obtained from ectopic XHNF6 expression 
in the endoderm resulted in an increased Xp48 positive region in the foregut endoderm 
as well as in an enlargement of the organ. It is a matter of course that loss of function ap-
proaches by XHNF6 depletion are necessary to confirm and further specify the function of 
XHNF6 on Xp48. Nevertheless, these preliminary data strongly support the idea that simi-
lar to mouse, XHNF6 also plays a crucial role in pancreas development of         Xenopus laevis.
3.3 Malectin, a no�el ER resident protein in Xenopus laevis 
As seen from the functional analysis of the transcription factors HNF1β and HNF6, these 
tissue specific genes are useful tools to study organogenesis, since they mark specifically 
the pancreatic organ and illustrate any developmental alterations. For this purpose, the 
identification of novel genes uniquely expressed in the pancreatic tissue would be a great 
advancement to improve the descriptive analysis of pancreas development. Based on this 
idea, the third aspect in this study focused on the characterisation of a putative pancreas 
specific marker gene in Xenopus laevis. 
In an attempt to identify new pancreas specific markers, a hybridization screen on tadpole 
stage embryos was performed using asRNAs generated from clones of an adult pancreas 
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cDNA library (Afelik et al., 2004). Among others, clone p150 (pancreas clone 150) showed 
expression in the pancreas at stage 41. Sequence analysis of the cDNA library clone pBK-           
CMV- p150 (3.6 kb, table 3.3) revealed an ORF of 828 bp coding for a protein of 276 aa. To              
obtain further informations on homologous genes, BLAST searches were performed with 
the full length nucleotide, ORF as well as protein sequence using the NCBI, Ensemble and 
JGI databases. Sequence comparisons revealed homologues in lower and higher eukaryo-
tes. Comparison of the protein sequences revealed a strikingly high amino acid similarity 
in vertebrates (figure 3.3.1). 
Pancreatic staining observed in late Xenopus laevis tadpoles and the high conservation of 
of up to 89% among vertebrates, prompted us to investigate the role of p150 during orga-
nogenesis. Since the p150 protein was functionally not yet described, its characterisation 
was approached in two different ways: (1) by characterising its biochemical properties, in-
cluding its protein structure and interaction partners, and (2) by analysing its role during 
embryogenesis of Xenopus laevis, in particular during pancreas development. 
The first aspect was intensively investigated by the group of Claudia Muhle-Goll (EMBL, 
Heidelberg) that collaborated by solving the p150 protein structure by NMR and perform-
ing biochemical interaction studies. According to their findings of specific interaction with 
the dissacharide maltose, the protein “p150” was renamed malectin as it will be further 
referred to in context of this study (Schallus et al., 2008). 
The second aspect concerned the functional relevance of malectin during pancreas devel-
opment. In this context, the late pancreatic expression pattern of malectin was determined 
in greater detail by acquisition of an expression profile during Xenopus laevis embryogen-
esis. This included the temporal characterisation of gene induction and spatial localisation 
Table 3.3: Sequence comparison of malectin with eukaryotic homologues. I�: NCBI a����session num-
bers; n.a.: not annotate�. %i�entity: in�i��ates the number of i�enti��al resi�ues in per��ent between Xeno-
pus laevis male��tin an� eukaryoti�� homolo��ues, also presente� in total numbers in bra��kets. *Similar to 
platelet-�erive� ��rowth fa��tor re��eptor alpha polypepti�e
organism nucleotide ID protein ID % identity
Xenopus laevis I NM_001091743/BC072149 AAH72149 -
Xenopus laevis II NM_001087063/ BC042341 AAH42341 96% (205/212)
Xenopus tropicalis CT030323 n.a. n.a.
Homo sapiens NM_014730 NP_055545.1/ KIAA0152 89% (221/247)
Dario rerio NM_001113618 NP_001107090 71% (199/279)
Mus musculus AK129066.1 BAC97876 86% (224/259)
Rattus norvegicus NM_001013983 NP_001014005 88% (219/247)
Canis familiaris XM_846298 XP_851391 87% (227/259)
Drosophila melanogaster NM_136243.2 NP_610087 40% (123/307)
Caenorhabditis elegans NM_066550.1 NP_498951 35% (98/276)
Onithorhynchus anatinus XM_001511731 XP_001511781.1* 88% (189/214)
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of transcripts and endogenous protein.
In order to reveal its role during pancreas organogenesis, loss- and gain of function ap-
proaches were also performed for malectin by injection of antisense morpholinos and of in 
vitro transcribed malectin capRNA. 
3.3.1 Malectin is an ubiquitously expressed protein
Malectin expression was analysed on the RNA level by WMISH and semiquantitative RT-
PCR as well as on the protein level by immunodetection. By WMISH, stage 1 to stage 13 
embryos showed a weak and diffuse staining that did not remarkably differ from unspecific 
background staining (not shown). Region specific expression of malectin transcripts was 
first observed at neurula stage 1 (stage 18 to 20) in the anterior neural ectoderm, the neural 
folds and the neural crest (figure 3.3.2 A; stage 18 and 20). At tadpole stage 32, malectin 
was broadly expressed including the neural crest placodes, otic vesicle, pronephros, the tail 
tip, the neural tube but also in the retina. Interestingly, at this stage malectin expression 
was upregulated in a distinct structure in the mid-dorsal head region, namely the hatching 
Figure 3.3.1 Sequence comparison of Xenopus laevis malectin with eukaryotic homologues. Ali��ne� 
eukaryoti�� protein sequen��es an� ��orrespon�in�� a����ession number are state� to the left. Small numbers 
to the ri��ht in�i��ate the amino a��i� position. Resi�ues �ifferin�� from a ��onsensus sequen��e are hi��hli��ht-
e� in re�. Protein fra��ment of Xenopus laevis male��tin whi��h was use� for stru��tural analysis by N�R is 
marke� by a blue bar �S��hallus et al., ��00��. Sequen��e analysis usin�� S�ART-tool pre�i��te� putative protein 
�omains: an N-terminal si��nal pepti�e �aa 1- ��5; re� bar�, an interme�iate pre�i��te� ��lobular �omain �aa 
��6- ��56, blue bar�, an� an hy�rophobi�� C-terminal transmembran �omain �aa ��56- ��76, yellow bar�. Note, 
that male��tin sequen��e ��ontains a ne��ative ��har��e� serial sequen��e of ��lutami�� a��i� �E� at aa ��30- ��4��. 
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gland (figure 3.3.2; A 32, inset). Malectin remained expressed in neural crest derivatives            
during subsequent development, while additional transcripts appeared in the differentia-
ting pancreas at stage 41.
To determine the exact time point of malectin transcription, the original clone obtained 
from the cDNA library screen (pBK-CMV-p150) was used to design malectin specific oli-
gonucleotides to analyse temporal malectin gene expression by semiquantitative RT-PCR 
(figure 3.3.2, B). In contrast to the WMISH, semiquantitative RT-PCR on total RNA ex-
tracts from stage V oocytes and different embryonic stages embryos (stages V, 0- 42) re-
vealed a presence of malectin transcripts already in oogenesis that persisted in at constant 
expression level throughout development. 
In order to detect the time course of protein synthesis, a malectin specific antibody was 
generated and used for immunodetection analysis of the malectin protein in different em-
bryonic stages (figure 3.3.2, B). According to the detailed sequence information obtained 
by the collaborating group of Claudia Muhle-Goll (SMART protein domoin prediction 
tool), it was suggested that malectin was a type I transmembrane protein (Schallus et al., 
2008). For this reason, membrane protein fractions of embryos with different stages were 
analysed for the presence of malectin protein. Embryos of different developmental stages 
were homogenised, and membrane debries pelleted. The malectin protein was specifically 
detected using a newly generated Xenopus laevis specific malectin antibody that was di-
rected against the intermediate lectin like domain of the protein (aa 30-254, see 2.2.10). 
This antibody detected very specifically one single protein band with an estimated size of 
30kD that matched the predicted size of malectin protein (30kD). This protein band was 
evident in all stages tested. Hence, it was demonstrated that also malectin protein was 
present from early embryogenesis onwards indicating a constant translational activity. 
Expression analysis of malectin in adult tissues of Xenopus laevis revealed an ubiquitous 
expression in all analysed tissues albeit with varying transcription levels (figure 3.3.2; C). 
Weak expression was detected in eye, kidney and the heart whereas muscle, gall bladder, 
stomach, liver and lung. Also the pancreas demonstrated high transcript levels. According 
to the specific expression of XPDIp that was detected in the pancreas and stomach tissue 
preparations (Afelik et al., 2004) it was excluded that the broad expression derived from 
cross contamination during the RNA purification procedure. 
Altogether, malectin expression was shown to be present throughout development in a 
rather ubiquituosly manner than in a germlayer specific way or in a spatially restricted 
territory.
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Figure 3.3.2: Spatial and temporal expression profile of malectin in Xenopus laevis embryos and adult. 
(A) Spatial �istribution of male��tin was analyse� by W�ISH. pBK-C�V-p150 full len��th ��lone was linearise� 
with BamHI an� �i��-labele� antisense RNA was trans��ribe� with T7-RNA-polymerase. From sta��e 1� on-
war�s, male��tin is expresse� in the anterior neuroe��to�erm �ne� an� neural ��rest �n��, white arrow hea�s�. 
At sta��e 3��, it is restri��te� to the retina �re�, oti�� vesi��le �ot�, epibran��hial pla��o�es �eb�, pronephros �pn� 
an� the tail tip �tp� as well as to the hat��hin�� ��lan� �h��, front view of the hea�, inset�. At sta��e 41, tran-
s��ripts are �ete��te� in the liver �li, frame� in re��, the a�ja��ent ventral pan��reas �vp, frame� in white� an� 
�orsal pan��reas ��p� as well as in bran��hial ar��hes �ba�, oesopha��us �oe� an� pro��to�eum �p��. (B) A��tiva-
tion of male��tin ��ene expression was �etermine� by semiquantitative RT-PCR on total RNA extra��ts an�            
by Westernbot on embryoni�� protein extra��ts. Total RNA amount was equalise� to 100 n����µl for 10µl rea��-
tion for ���NA synthesis. �H��� was use� as ne��ative ��ontrol. Histone H4 was use� equalise RNA amounts. 
�li��onu��leoti�es use� were p150��male��tin-RT_for�� p150��male��tin-RT rev, Histone H4-for�� Histone H4 rev; 
�P�Ip-for��rev. �ale��tin trans��ription is persistent throu��hout �evelopment as ��ompare� to pan��reas spe-
��ifi�� protein �isulfi�e isomerase ��P�Ip� that is initiate� at sta��e 39. �evelopmental sta��es �Nieuwkoop 
an� Faber, 1967� are in�i��ate� as numbers on top of ea��h lane. VI=sta��e VI oo��yte. For immuno�ete��tion     
analysis, membrane protein fra��tions were ��enerate� of �ifferent �evelopmental sta��es. 10 embryos were       
homo��enise� usin�� a syrin��e. The suspension was ��entrifu��e� to obtain membraneous ��ompartments 
whi��h were resolve� in ��0 µl sample buffer ��embryo. 10µl sample �0.5 embryo equivalents� were loa�e� 
per lane of a 1��.5% S�S-�el. After S�S-PA�E, proteins were transferre� onto a nitro��ellulose membrane. 
En�o��enous male��tin protein was �ete��te� usin�� a poly��lonal male��tin spe��ifi�� antibo�y �rabbit-anti-          
male��tin; 1:15000� an� the se��on�ary antibo�y ��oat-anti-rabbit-HRP �Santa Curz, 1:5000�. Numbers on top 
of the lanes in�i��ate� �evelopmental sta��es; BL = ba��terila lysate was use� as ne��ative ��ontrol, T�4= 
purifie� male��tin protein �aa 30-��0�� whi��h was use� as anti��en for rabbit immunisation. The ban� shift 
in sta��e 0 results from a ��el artefa��t (C) �ale��tin expression in a�ult tissues was anaylse� by RT-PCR. It 
shows ubiquitiuos �istribution in ��omparison to �P�Ip whi��h is �ete��te� only in pan��reas an� stoma��h.     
Abbreviations are not �efine� in A: ��all bla��er ���b�; heart �he�; intestine �in�; ki�ney �ki�; lun�� �lu�; mus��le                 
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The presence of malectin from the beginning of embryogenesis on to the mature amphi-
bian, together with its dispersed transcript localisation and late onset of expression in the        
pancreatic tissue, favored the idea that malectin rather maintained a general function du-    
ring embryogenesis than a restricted role during pancreas organogenesis. 
3.3.2 Malectin resides in the endoplasmic reticulum (ER)
The detailed analysis of the embryonic expression pattern of malectin was completed by 
studies on its intracellular localization. For this purpose, malectin was ectopically ex-      
pressed in the embryos as well as in eukaryotic cell lines, where its intracellular localisa-
tion was investigated by immunofluorescent detection of overexpressed malectin protein. 
For this purpose, malectin constructs were generated, which included a „flag- tag“ positi-
oned internally between the presumptive N- terminal signal peptide and the protein core 
(N- flag-malectin; figure 3.3.3; A), since N- terminal tags might be cleaved off with the             
N- terminal predicted signal peptide, and tags to the hydrophobic C- terminus could stay 
attached in a membrane compartment. In general, signal peptide serve to target a protein 
to and intracellular compartment or to drive its sorting and extracellular secretion. As 
the signal peptide of malectin was only a predicted protein domain, it was of interest to  
determine the significance of the signal peptide for intracellular localisation of malectin. 
To adress this question a deletion construct was generated where the tagged malectin was 
lacking the first 26 amino acids, the potential signal peptide (ΔN- flag- malectin). Correct 
protein synthesis of the wild type malectin, N- flag-malectin and   ΔN- flag- malectin were  
confirmed by immunodetection of in vitro synthesised proteins (nonradioactive TNT; not 
shown) as well as by detecting the in vivo synthesised proteins. For the later ones, capRNA 
that coded for N- flag- malectin or ΔN- flag- malectin was injected into the animal pole 
of Xenopus laevis embryos. At stage 10, embryos were homogenised and membrane pro-
tein fractions prepared which were analysed for N- flag- malectin or ΔN- flag-malectin 
by immunodetection using the malectin specific antibody as well as a flag-epitop specific 
antibody.
In uninjected control embryos, the malectin specific antibody recognised a single protein 
band (figure 3.3.3 B, lane 1). Estimating its size and detecting a protein band of similar size 
in the injected embryos, it was assumed that this lower band represented the endogenous 
malectin protein. Embryos injected with capRNA encoding either N- flag-malectin or ΔN-
flag- malectin showed a additional overlying bands that were missing in the uninjected 
control embryo (figure 3.3.3 B, lane 2 and 3). This experiment indicated that N-flag-malec-
tin and ΔN- flag- malectin were both translated in the embryo. While N- flag- malectin, 
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with a calculated molecular weight of 32 kD, was detected above the endogenous malectin, 
the ΔN-flag-malectin, with a calculated molecular weight of 29 kD, was also detected above 
the endogenous protein with a calculated weight of 30 kD. Detection of N-flag-malectin 
or ΔN-flag-malectin using a flag-epitope specific antibody, confirmed their identity as the 
protein extracts of control embryos did not reveal any detectable protein. Hence the size 
difference between the tagged and endogenous malectin proteins could only result from 
protein modification. It could not be excluded, that the endogenous protein undergoes 
posttransaltional processing, e.g cleavage of the signal peptide (figure 3.3.1; aa 1-25). This 
would result in a product with a calculated weight of 27.5 kD. However further experimen-
tal evidence as by injection of ΔN-malectin was not acquired. Nevertheless, this experi-
ment confirmed correct in vivo protein translation of N-flag-malectin or ΔN-flag-malectin 
and the constructs were used for subsequent analysis of the intracellular localisation of 
malectin. 
The analysis of intracellular localisation of malectin was approached in two different ways.          
The first approach was performed by bilateral microinjection of 100 pg capRNA that coded     
for N-flag-malectin or  ΔN-flag-malectin into the animal pole of two-cell stage        Xenopus 
laevis embryos. Animal cap explants were dissected at stage 8-9.        In vivo translated proteins 
were detected by immunofluorescent labeling in dissected animal caps (figure 3.3.4.; A). N- 
Figure 3.3.3 Malectin constructs generated for protein overexpression. (A) S��hemati�� �rawin�� of the 
fla��-ta����e� male��tin ��onstru��ts use� male��tin overexpression. �etaile� sequen��e analysis �S��hallus et 
al., ��00�� pre�i��te� that the wil�type �WT� male��tin ��ontains an N-terminal si��nal pepti�e �SP, aa 1-��6, 
re��, a ��onserve� le��tin- like �omain �LL�, aa ��7-��55, blue� an� a hy�rophobi�� C-termimnal �omain �H�, 
aa ��55-��76, yellow�. N-fla��-male��tin in��lu�es an a��itional fla��-ta�� �F; epitope ��K����K, ��reen� between 
the SP an� LL�. The ΔN- fla��- male��tin ��onstru��t la��ks the SP. (B) Corre��t protein translation of male��tin ��on-
stru��ts was ��onfirme� by immuno�ete��tion in vitro ��ata not shown� an� in vivo usin�� antibo�ies �ire��te� 
either a��ainst male��tin �rabbit- anti- male��tin 1:15000� or mouse- anti- fla����� �1:10000�. lane 1: uninje��te� 
��ontrol embryos, en�o��enous male��tin after SP ��leava��e ���7.5 k��; lane ��: N-fla��-male��tin �3�� k��; lane 3: 
ΔN- fla��-male��tin ���9 k��. �arker ��� ban�s in�i��ate� show 37k� an� ��5 k� �precision plus protein stand-
ard, Biora��.
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flag- malectin or ΔN- flag- malectin proteins were detected using an flag-epitope specific     
antibody followed by immunodetection using fluorescent dye-labeled secondary antibody. 
Images that were taken with a confocal microscope that was suitable for liquid incubation. 
Fluorescent protein detection revealed, that N-flag-malectin was not dispersed throughout     
the cytoplasm but clustered in small granular perinuclear structures. In contrast,  ΔN- flag-
malectin protein, that was devoid of the signal peptide, showed a rather diffuse cytoplasmic 
distribution, partially aggregating and partially translocated into the nuclear space (figure 
3.3.4; A, asterisk). This finding favored the idea that malectin protein was translocated to a          
cellular compartment with its signal peptide where it was integrated into the mebrane by 
its hydrophobic C-terminus. However, a more detailed specification of the organell was not 
achieved due to the technical limitations in the use of animal cap explants. 
Therefore, the second approach to identify the intracellular localisation of malectin made 
use of transient eukaryotic cell transfections. Plasmids coding for N-flag-malectin or          ΔN- 
flag- malectin were transfected in 3T3 mouse fibroblasts. Similar to the animal cap system,             
N- flag- malectin was concentrated in small territories in the cytoplasm as if it was accu-             
mulated in subcellular compartments. Co-detection of the ER-resident heat shock protein 
Hsp47, revealed partially overlapping localisation of N- flag- malectin and Hsp47 (figure      
3.3.4 B; A- C). This finding provided evidence for the localisation of malectin in the endo-            
plasmic reticulum (ER), although it did not exclude the possibility that the observed ER 
localisation was an overexpression artefact caused by artificial accumulation of the N- flag- 
malectin protein in the cell. Attempts to detect the endogenous protein using anti- malec-
tin antibody failed to technical difficulties. Deletion of the N- terminus of malectin did 
result in an unequal cytoplasmic distibution and partially forming cytolsolic aggregates 
(figure 3.3.4 B, D- E). As ΔN- flag- malectin (29 kD) did not exceed the exclusion size of the 
nuclear pore (30 kD) it was partiall diffusing into the nucleus (Schallus et al., 2008). 
To further support the idea of an ER residence for malectin, a time course experiment was 
performed (figure 3.3.3; B). N- flag- malectin overexpressing cells were fixed after 12, 24 
and 48 hr and the overexpressed N- flag- malectin was detected by immunofluorescence 
labeling. After 18 hr, fluorescent detection of N- flag- malectin was weakly observed in 
small perinuclear tubular structures that resembled the extensive membrane network of 
the ER. Over time, extended translated N- flag- malectin accumulated in the ER (24, 48 
hr) where it was arrested and partially aggregated in larger areas in the perinuclear rim 
and distinct loci of the cytoplasm (figure 3.3.3; B). Even after 48 hr, malectin protein was 
not translocated to the plasma membrane or showed cytoplasmic distribution. Instead, it 
remained confined to the ER. These results supported the idea, that malectin was an ER 
resident protein that was not translocated to the cell surface or secreted into the extracel-
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Figure 3.3.4 Malectin resides in the endoplasmic reticulum
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lular space. However, it did not exclude the possibility that malectin was synthesised in the 
ER but later translocated to a different membraneous compartment. 
Altogether, the permanent and ubiquitous expressionof malectin during development and 
in the adult organism in combination with is presumpted ER localisation implied a re-
gulating cell-autonomous role for malectin. As malectin was expressed in the pancreatic 
lobes at late tadpole stages (figure 3.3.2), and in context of the topic of this study, it was 
interesting to determine the effect on pancreas development resulting from depletion of 
malectin protein in Xenopus laevis embryos. 
3.3.3 Functional analysis of malectin in Xenopus laevis organogensis
Determination of knockdown efficiency of malectin specific morpholinos
In order to study functional relevance of malectin during embryogenesis in Xenopus laevis, 
loss- and gain of function approaches were performed. 
Loss of malectin function was achieved by translational inibition of malectin upon mor-
pholino injection. Two malectin specific antisense morpholinos (malectin- Mo1 and ma-
lectin- Mo2) were designed, targeting the region of translational initiation (figure 3.3.5). 
Efficiency of translational inhibition was tested in vitro and in vivo. 
Figure 3.3.4 Malectin resides in the endoplasmic reticulum. The intra��ellular lo��alisation of male��tin was 
analyse� in ��ell transfe��tion experiments. (A) N-fla��-male��tin an� ΔN- fla��-male��tin ��apRNA �100 p����E� 
were inje��te� into the animal pole of a two ��ell sta��e embryo. At blastula sta��e animal ��ap explants were 
�isse��te� an� left to roll up for 30 min. Caps, were fixe� in �E�FA, washe� in PBS��Tween, blo��ke� in 
3% BSA�� PBS an� use� for antibo�y stainin�� �1st antibo�y: mouse-anti-Fla�����; ��n� antibo�y: rabbit-anti-
mouse-Alexa595�. Ima��es were taken usin�� a ��onfo��al mi��ros��ope ��eiss LS� 510 �ETA, 63x; Carl �eiss, 
�berko��hen�. Asterisk in�i��ates the nu��lei. White arrow hea� points to stainin�� in the nu��lear rim. White 
bar in�i��ates size of ��0µm.(B) NIH-3T3 mouse fibroblasts were transfe��te� with 4µ�� plasmi� of fla��-ta����e� 
male��tin usin�� lipofe��tamin ��000 �Invitro��en�. After a ��4h- in��ubation, ��ells were washe� with PBS, fixe� 
with 3% PFA, permeabilize� usin�� 0.5% Triton-x-100 an� blo��ke� with 3% BSA��PBS. Antibo�ies use� were 
�ilute� 1:��00 in 3% BSA�� PBS: mouse- anti- ratHsp47 ��oBiTe���, ��oat- anti- mouse- Alexa 595 �Invitro��en�, 
rabbit- anti- Fla��- FITC �Si��ma�. Ima��es were taken usin�� a ��onfo��al mi��ros��ope �eiss LS� 510 �ETA, 63x 
�Carl �eiss, �berko��hen; A- E� an� a Lei��a �R� IRE�� TCS SP��, 63x �Lei��a, Bensheim; �- I� an� pro��esse� for 
presentation with A�obe Photoshop CS��. N-fla��-male��tin ���reen� is foun� in a membraneous ��ompart-
ment aroun� the nu��leus �A- I, asterisk�. Counterstainin�� usin�� an antibo�y a��ainst the ER resi�ent ��hap-
erone Hsp47 �re��, reveales that male��tin is ��olo��alise� in with the ��haperone in the ER �mer��e, enlar��e� 
inset�. �eletion of the N-terminal si��nal pepti�e results in a broa� ��ytoplasmi�� �istribution of male��tin. 
Note that ΔN- fla��- male��tin still a����re��ates in membraneous ��ompartments �ue to its C-terminal trans-
membrane �omain. (C) A time ��ourse experiment shows that N-fla��-male��tin protein a����umulates in peri-
nu��lear membrane or ��lustures in �istin��t territories within the ��ell �white arrow hea�s�. Note that it is not 
translo��ate� to the plasma membrane. Hours after ��ell transfe��tion are in�i��ate� in ea��h panel.
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In vitro, the morpholino binding efficiency was examined in a combined radioactive tran-
scription and translation assay. Addition of malectin-Mo1 to the in vitro reaction in dif-
ferent concentrations (50, 20 and 10 µM) efficiently repressed malectin translation in a           
concentration dependent manner, whereas addition of unspecific control morpholino did 
not inhibit protein translation. In contrast, addition of same amounts of malectin-Mo2 (50,  
20 and 10 µM) did not inhibit protein translation as efficiently as malectin-Mo1 as seen by            
a clear detectable band in the autoradiogram (figure 3.3.6; A).   
To analyse morpholino efficiency in vivo, the N- terminal coding sequence of malectin was 
fused in frame to the coding sequence of GFP that were subsequently used for capRNA 
transcription (N-p150-GFP, 5´ UTR-p150-GFP, figure 3.3.6; B). 100 pg of capRNA were          
coinjected with different morpholino amounts (100, 50 and 10 µM) into the animal pole 
blastomeres of a four-cell stage embryo. GFP fluorescence was analysed at stage 10. The 
presence of malectin-Mo 1 or malectin-Mo 2 inhibited translation of the GFP-fusion pro-
tein in all amounts tested, whereas expression of a wild type GFP was not affected (eGFP, 
figure 3.3.6; B). In contrast, injection of an unspecific control morpholino (CoMo) did not 
abolish translation of the GFP-fusion protein. These results showed specific morpholino 
binding to its target sequence and efficient inhibition of protein translation for malectin-
Mo1 and malectin-Mo2.
Misexpression of malectin in the embryo disrupts proper tissue formation 
As the major focus of this study was devoited to understanding of regulatory processes in 
the endoderm that eventually lead to pancreas formation, effects on malectin misexpres-
Figure 3.3.5 Position and sequences of malectin- specific morpholinos. (A) The s��heme in�i��ates the 
position of the two of male��tin spe��ifi�� morpholinos �male��tin-�o1 an� male��tin-�o��, blue bars� relative 
to the male��tin ��o�in�� sequen��e �C�S, NCBI: N�_001091743; ��rey bar�.Numbers state the nu��lei�� a��i� po-
sition with +1 be��innin�� at the translation initiation site AT�. (B) Sequen��es of male��tin- �o1 an� male��-
tin- �o�� �blue� are state� below the s��heme. �ale��tin- �o1 tar��ets the be��innin�� of the �RF, one ��o�on 
�ownstream of the translation initiation site AT� ���rey, un�erlaye� in re��. �ale��tin- �o�� tar��ets the 5´UTR 
re��ion overlappin�� the AT�. EST �atabase sear��h in�entifie� a pseu�oallel �NCBI: BJ06����0�� that showe� 
one mismat��h ��ompare� to the male��tin mRNA. A����or�in�� to �eneTool information, one mismat��h shoul� 
not impair morpholino bin�in��. 
112
Results
Figure 3.3.6 Determination of knockdown efficiency of malectin- specific morpholinos. �A) �orpholino 
bin�in�� spe��ifi��ity was analyse� prior to inje��tion by an in vitro ra�ioa��tive trans��ription an� translation 
assay �hTNT, Prome��a�. 300n�� pCS��±male��tin plasmi� serve� as template for in vitro trans��ription of ma-
le��tin mRNA, followe� by translation of male��tin protein with in��ooperation of 35S-methionine. A��ition of 
male��tin �o-1 �eplete� male��tin translational in a ��on��entration �epen�ent manner �+++= 0.05m�; ++ = 
0.03m�, + = 0.01m��. To test �o��, the 5´UTR of male��tin was fuse� to the �RF of my��-�FP � male��tin- �o��- 
�FP�. 300n�� plasmi� were use� in the hTNT rea��tion. Upon a��ition of male��tin-�o��, protein translation 
was less effi��iently blo��ke� in amounts teste�. In ��ontrast appli��ation of an unspe��ifi�� ��ontrol morpholino 
�Co�o� has no effe��t on protein synthesis. (B) Inhibition of protein translation was further teste� in vivo. 
The N-terminal SP was fuse� to �FP, male��tin- �o1-�FP. CapRNA of male��tin- �o1-�FP an� male��tin-    
�o��-�FP were in vitro trans��ribe� an� inje��te� into animal pole of �enopus embryos �100 p����E� alone or    
with �o in �ifferent amounts �0.1- 0.01m��. Bin�in�� effi��ien��y was s��ore� the next �ay a����or�in�� to �FP            
fluores��en��e. In both ��ases ��oinje��tion of �o inhibits protein synthesis. Note that in ��ontrast to hTNT, ef-            
fi��ient inhibition is also evi�ent for �o��. �li��onu��leoti�e spe��ifi��y a��ainst male��tin is further ��onfirme� 
by �FP fluores��en��e in embryos that were ��oinje��tion with �o an� e�FP ��apRNA �100β���� E�. In ��ontrast      
��oninje��tion of Co�o �oes not interfer with male��tin-�o1-�FP or male��tin-�o��-�FP protein synthesis.         
sion were primarily examined in the prospective endoderm. For this purpose, 100 µM of      
malectin-Mo1 was radially injected into the vegetal pole of a four-cell stage embryoand 
traced by coinjection of β -galactosidase encoding capRNA. Embryos were cultured till    
stage 41, when endodermal expression of malectin was evident in the hepatic and pancre-
atic tissue. Effects on liver and pancreas formation were monitored by expression analysis 
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of organ specific marker genes as the pancreas specific XPDIp (Afelik et al., 2004) and the 
hepatic transcription factor XHex (figure 3.3.7; Newman et al., 1997).   
Malectin-Mo1 injected embryos showed an bulby enlargement of the anterior endoderm, 
gut coiling defects and dramatically reduced pancreatic (91%) and hepatic lobes (63%, fi-
gure 3.3.7; A-C) as it was demarked by expression domain of XPDIp and Hex. As small or-
gan rudiments were still detectable, it was excluded that the loss of pancreatic and hepatic 
structures was due to default marker gene detection. This finding indicated that inhibition 
of malectin function in the endoderm affected liver and pancreas formation by the time of 
its endogenous expression. General unspecific side effects caused by microinjection were 
controlled by injecting a standard control morpholino (CoMo, 1.6 pmol). In contrast, in 
57% of control morpholino in�ected embryos sho�ed no reduction in organ si�e, either for            
pancreas not for the liver. The remainig 43% �ere only slightly reduced and not rudimen-
tary as seen in malectin-Mo1 in�ected embryos. In order to ectopically express malectin in 
embryos 100pg/E of malectin capRNA was injected into control siblings and cultured till 
late tadpole stage 40 and organogenesis analysed with organ specific markers. 
Ectopic expression of malectin in the endoderm lead to similar pleiotophic morphological 
defects in the anterior endoderm associated with loss of hepatic and pancreatic domains. 
In addition, mesoderm derivatives as tunk and anterior head structures were severely af-
fected. 
Altogether, inhibtion or ectopic activation of malectin in the endoderm revealed a rather 
heterogenic effect that did not only disturbed formation of one particular organ but rather 
the general formation of the entire endoderm. Since malectin was detected throughout 
Figure 3.3.7 Misexpression of malectin affects endoderm development. Inhibition of male��tin by 
male��tin-�o1 inje��tion �1.6 pmol��E� as well as e��topi�� expression by ��apRNA inje��tion �100p���� E� lea�s 
embryoni�� malformations in the anterior en�o�erm. W�ISH was performe� usin�� or��an spe��ifi�� marker 
��enes as �P�Ip markin�� the panreas an� �Hex markin�� the liver lobe. xP�Ip positive �omain was severely 
affe��te� upon male��tin-�o1 inje��tion �A- C, white arrow hea��. Also the hepati�� �Hex psotive re��ion was 
re�u��e� �E- �, white arrow hea��. n= total number of embryos. Numbers is bra��kets state the number of 
embryos in per��ent, presentin�� the shown phenotype. Arrow �own in�i��ate� re�u��tion of marker ��ene 
expression. ��ata not shown�. �p� pan��reas, �li� liver, �p�� pro��to�eum. 
114
Results
development and was only at later stages evident in the endoderm, it is obscure when and 
how malectin plays a role in endoderm formation. 
The third part of this study focused on the characterisation of a putative pancreas specific 
marker gene that showed later pancreatic expression and a high amino acid conservation 
between vertebrate homologues. Unlike expectations a detailed expression profile revealed 
a constant and rather ubiquitous gene activation during development. Intracellular locali-
sation assays revealed an ER residence of malectin. Togehter with the pleiotrophic develop-
mental effects upon malectin misexpression it was suggested that malectin played more of 
general role during embryogenesis than specifically for pancreas development. 
In summary, this study has shown that HNF1β is expressed in the ventral and dorsal pan-        
creatic anlagen. HNF1β is required but not sufficient to induce pancreas development in           
Xenopus laevis. This result is similar to data obtained from mouse and zebrafish. Converse-
ly to mouse and zebrafish, knockdown of HNF1β in Xenopus laevis did not result in either 
a depletion of Xp48 expression nor in a complete loss of pancreas. 
It was also shown, that HNF1β is required and sufficient to induce early endocrine cell 
differentiation. This is the first time, that a transcription factor regulates the early onset of 
insulin gene expression within the dorsal pancreatic rudiment. It remains obscure whether 
late endocrine cell differentiation is affected and if HNF1β promotes directly or indirectly
endocrine cell differentiation.
HNF1β is responsive to RA in the early endoderm. Herewith it was shown for the first 
time, that early HNF1β expression was responsive to RA in the endoderm and not only in              
the ecto- or mesoderm. Regarding the possibility of HNF1β linking early RA- signalling 
and late pancreas formation, it still remains unclear whether HNF1β mediates directly or  
indirectly the RA induced signal.    
The isolated XHNF6 is expressed in the dorsal and ventral endoderm. HNF6 is therefore 
coexpressed with its potential downstream targets Pdx1/XlHbox8 and Ptf1a/p48. Upon 
overexpression, XHNF6 promotes pancreas development. It remains to be investigated 
when and how XHNF6 is required for pancreas specification and cell differentiaion in 
Xenopus laevis. 
Malectin is an ubiquitously expressed ER resident protein that maintains a rather general 
role than a specific function during organogenesis. Considering its role in the N-glycosyl-
ation pathway, it would be intriguing to reveal its putative function in regulation of signal-
ling pathways, as BMP and Wnt, involved in embryogenesis.
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Defects in pancreas organogenesis are the cause of severe clinical conditions including 
diabetes type I, which is characterised by absence or dysfunction of insulin producing 
β-cells. It is therefore of high interest to determine regulatory factors that are involved in 
pancreas development and the differentiation of β-cells. Pancreas specification in the ante-
rior foregut epithelium is controlled by a complex cross- talk of transcription factors. From 
studies in the mouse, it was suggested that the homeobox transcription factor HNF1β and 
the onecut protein HNF6 participate in this specification process by activating the pancre-
atic progenitor genes Pdx1/XlHbox8 and Ptf1a/Xp48 in the pre-pancreatic gut epithelium 
(Haumaitre et al., 2005). 
In addition to these transcription factors, it was also shown that instructive signals from 
the surrounding tissues, such as RA- signalling, are required to direct pancreatic cell fate 
(Martin et al., 2005; Molotkov et al., 2005). Continuative studies in Xenopus laevis revealed 
that in amphibians, RA plays a crucial role in controlling dorsal pancreas prepatterning 
already during gastrulation when the germ layers are formed (Chen et al., 2004). It was 
revealed that early RA- signalling is crucial for endocrine at the expense of exocrine cell 
differentiation. But how these early RA induced prepatterning events are linked to the 
actual onset of pancreatic precursor gene expression or early induction of endocrine diffe-
rentiation markers as insulin remain obscure. 
In this regard, this study focused on the analysis of regulatory mechanisms that occur 
between gastrulation in the early embryo and the induction of XlHbox8 and Xp48 expres-
sion in the pancreatic endoderm. In general, gene activation is regulated by transcription 
factors that function in a hierarchical cascade of upstream regulators and downstream 
targets. Knockout studies in the mouse have identified two upstream candidates for regu-
lation of Pdx1/XlHbox8 and Ptf1a/p48 expression, namely HNF1β and HNF6 (Haumaitre 
et al., 2005; Jaquemain et al., 2003a). 
This study focused on the functional characterisation of HNF1β and HNF6 during pan-
creas development of Xenopus laevis. As in Xenopus, the HNF6 was not yet identified, the 
HNF6 homologue was isolated, analysed for its expression during embryogenensis and 
tested for its potential to activate pancreatic gene transcription. In order to investigate the     
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functional roles of HNF1β and HNF6 on pancreas development, gain-and loss of function 
approaches were performed. HNF1β function was investigated by protein knockdown as        
well as by ectopic protein expression in the context of pancreas development. Resulting ef-
fects on organogenesis were monitored by expression analysis of pancreas specific marker 
genes. 
The fact that HNF1β was reported as RA target gene in the neural tissue (Pouilhe et al., 
2007, Hernandez et al., 2004) rised the interest to study the requirement of RA for HNF1β 
expression within the endoderm (Demartis et al., 1994). 
Intensive research on pancreatic specification and cell differentiation demands the identifi-
cation of new pancreas specific marker genes as tool to mark segregating cell types. Hence, 
as a minor aspect, this study focused on the characterisation of a novel pancreas expressed 
protein, named malectin. 
4.1 The requirement of HNF1β for pancreas de�elopment 
In Xenopus laevis, HNF1β was extensively discussed regarding mesodermal kidney deve-
lopment (Bohn et al., 2003) and it was reported to contribute as GATA4-5-6 downstream 
target to early endoderm formation in Xenopus laevis (Afouda et al., 2005). However, its 
function in respect to endoderm organogenesis, as it was investigated in mouse or ze-
brafish (Haumaitre et al., 2005; Lokmane et al., 2008; Sun and Hopkins, 2001), was rather      
neglected for the Xenopus system.
To adress the question of HNF1β function during endoderm organogenesis, here in respect 
to pancreas formation, it was necessary to refine the previous reported spatial and tem-
poral expression patterns in the endoderm. Detailed expression analysis was achieved by 
WMISH on embryos of different developmental stages (figure 3.1.1). Transversal sections 
clearly traced HNF1β expression to the early endoderm including the the dorsal region, 
where it became progressively restricted to the anterior foregut, including liver and pro-
spective pancreas. This observation was in accordance with previously published expres-
sion patterns (Demartis et al., 1994; Vignali et al., 2000; Afouda et al., 2005). But for the 
first time, it was clearly shown, that HNF1β was not only expressed within the anterior 
endoderm, but in particular in the ventral and the dorsal pre-pancreatic regions. This de-
tail in the HNF1β expression profile was remarkable in order to explore the importance of 
HNF1β during pancreas development in Xenopus laevis. 
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Pancreas development in Xenopus laevis begins with the region-specific expression of the 
pancreatic progenitor markers XlHbox8 and Xp48 in the foregut. Studies from mouse 
described HNF1β as upstream regulator for Pdx1/XlHbox8 and Ptf1a/48 (Haumaitre et 
al., 2005). HNF1β expression was activated in the foregut from developmental stage E8.5, 
preceding the onset of Pdx1/XlHbox8 and Ptf1a/Xp48 espression. At stage E9.5 the three 
transcription factors were coexpressed within the pre-pancreatic epithelium (Haumaitre 
et al., 2005). 
In this study, it was also demonstrated for Xenopus laevis, that endodermal HNF1β expres-
sion preceded the onset of its suggested downstream targets XlHbox8 and Xp48. HNF1β 
not only proceded but it also overlapped with XlHbox8 and Xp48 expression domains by 
the onset of pancreatic budding (figure 3.1.1; figure 3.2.4). This match in temporal and spa-
tial gene activation of HNF1β and XlHbox8 and Xp48 in the territory of the prospective 
pancreas argued for a regulatory link between these transcription factors in specification 
and differentiation of the pancreas, as it was hypothesised from studies in mouse.
4.1.1 HNF1β is necessary for pancreas specification 
To define the necessity for HNF1β in pancreas development in Xenopus laevis, downregu-
lation of protein function was performed by HNF1β specific antisense morpholino injec-
tion. Morpholinos were targeted to the whole endoderm by radial injection into the vegetal 
pole. Downregulation of HNF1β protein in Xenopus laevis embryos leads to pancreatic 
hypoplasia, based on XPDIp expression (figure 3.1.4). The smaller pancreatic organ showed 
morphological abnormalities as protrusions of the exocrine compartment. The pancreatic 
progenitor marker XlHbox8 that is normally expressed strongly in the duodenal and pan-
creatic epithelium from stage 28 onwards, was severely reduced in its pancreatic expression 
upon HNF1β depletion. First, pancreatic XlHbox8 expression was detectable in the dorsal 
pancreatic rudiment by stage 34 while the ventral rudiment was still devoid of HNF1β 
transcripts. 
Expression of the second pancreatic marker gene Xp48 was also downregulated upon 
HNF1β depletion by stage 34, in particular in the ventral pancreas. Although it was not 
repressed to the same extend than XlHbox8 (figure 3.1.4). Reduction of both pancreatic 
progenitor genes suggested that HNF1β was necessary for pancreas specification in the gut 
epithelium. Unlike the complete pancreatic agenesis seen in HNF1β-deficient mice (Hau-
maitre et al., 2005), HNF1β-depleted Xenopus laevis embryos still generated a small pan-
creatic organ that seemed to derive from dorsal and ventral lobes (figure 3.1.4). Under the 
constraint of the technical limitations in protein knockdown upon morpholino injections 
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(Eisen and Smith, 2008), generation of a hypoplastic complete pancreas could also derive 
from an partial knockdown of HNF1β within the endoderm (figure 3.1.3). As known from 
recent overexpression studies a combined activation of XlHbox8 and Xp48 is required to 
specify pancreatic cell fate in the foregut region (Afelik et al., 2006). The occurancy that 
ventral XlHbox8 expression was inhibited by morpholino injection by stage 34 made it 
rather unlikely that Xp48 expression was evident due to an incomplete HNF1β knockdown 
in the endoderm of Xenopus laevis (reviewed in Eisen and Smith, 2008). It was concluded 
that Xp48 might be regulated by an additional factor within the pancreatic epithelium. 
Ergo, the remnant XlHbox8 protein induced in the dorsal pancreatic region in combina-
tion with the remaining Xp48 protein might be sufficient to make the anterior foregut 
competent to adopt pancreatic cell fate and to generate a small organ. A recent study by 
Stanger et al. (2007) revealed that the number of pancreatic progenitor cells determines 
organ size affecting exocrine and endocrine tissue in mouse. 
These results are in agreement with studies in HNF1β-deficient mice, reporting that lack 
of HNF1β leads to pancreatic hypoplasia (Haumaitre et al., 2005). The ventral prospective 
pancreatic region was devoid of Pdx1 and Ptf1 expression resulting in total absence of the 
ventral pancreatic bud. In the dorsal pancreas, Pdx1 was initiated and budding occured, 
however, outgrowth and morphogenesis were impaired. Consequently, the dorsal pancre-
atic remnant regressed and disappeared by E13.5 and the epithelium was devoid of any 
endocrine cells. The delayed onset of dorsal Pdx1 and p48 expression indicated a main-
taining rather than inducing activity of HNF1β for Pdx1 and p48 transcription within 
the pancreatic epithelium and thereby promoting outgrowth and morphogenesis. In ac-
cordance it was proven, that size reduction upon HNF1β depletion was based on impaired 
proliferation (Haumaitre et al., 2005). 
To exclude incomplete protein knockdown, a second approach to inhibit HNF1β function  
was performed by repressing endogenous HNF1β activity by its fusion to the engrailed re-        
pressor domain (Vignali et al., 2000). This repressor construct has a similar reducing effect 
on XlHbox8 repression in the foregut domain as morpholino injections, in particular the 
dorsal endoderm. In contrast to previous studies (Vignali et al., 2000), it was not possible        
to rescue the repression of XlHbox8 expression by ectopic expression of HNF1β within the 
endoderm. Coinjection of HNF1β and HNF1β- Mo1+2 resultet in high lethality instead. 
This data confirmed that HNF1β was necessary to activate XlHbox8 in the pancreatic en-          
doderm but it still remained unclear whether HNF1β directly or indirectly promoted Xl-      
Hbox8 activation. As no binding studies were done for HNF1β binding to the XlHbox8            
promotor, data from the mouse system argue for a direct activation of XlHbox8 by HNF1β 
(Gerrish et al., 2001).
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4.1.2 HNF1β is not sufficient for pancreas formation
To analyse if HNF1β is sufficient for pancreas formation, the reverse complement experi-
ment was performed to characterise its regulatory capacity during pancreas development. 
Ectopic HNF1β activation within the endoderm was achieved by overexpression of HNFβ           
encoding capRNA, as wild type, constitutive active HNF1β- VP16 fusion or time point 
inducible GR fusion. Injection was done radially into the vegetal pole of Xenopus laevis 
embryos targeting the HNF1β protein to the whole endoderm. 
In all cases, pan-endodermal induction of HNF1β activity resulted in an posterior exten-
sion of XlHbox8 in the endoderm (figure 3.1.8; appendix 7.1). This XlHbox8 expansion was 
either seen as homogenous expansion with decreased transcript levels in the endogenous 
XlHbox8 expression domains or XlHbox8 positive regions were still evident in the dor-
sal and ventral pre-pancreatic endoderm. In this case, expression extended towards the 
caudal tip in the dorsal rudiment and the ventral expression was ectopically detected in 
ventro-posterior regions. This increased XlHbox8 expression was most evident upon early 
activation of HNF1β protein after gastrulation. Later time-points of hormone treatment re-
sulted in less, and rather region specific XlHbox8 epression. The dorsal expression domain 
was still expanded however approaching its regular size in the dorso-anterior foregut. The 
ventral pancreatic expression domain was rather reduced and XlHbox8 expression was de-
tected in discrete loci of the ventro-posterior gut endoderm (figure 3.1.8, appendix 7.1. A). 
If HNF1β is required for XlHbox8 activation, ectopic HNF1β activation in more posterior 
regions could be the cause for ectopic XlHbox8 expression in these posterior domains. 
This result clearly demonstrated that HNF1β was sufficient to initiate XlHbox8 expression 
within the endoderm and argued for a direct activating role of HNF1β for XlHbox8 expres-
sion. Furthermore, the discrete XlHbox8 positive loci in the posterior endoderm that were 
induced upon late-stage treatment provided evidence for a cell fate conversion of poste-
rior intestinal cells into ventral pancreatic or duodenal tissue. It remained to be examined 
whether detected expansion of XlHbox8 expression in the posterior intestine is indeed pre-
pancreatic endoderm or whether XlHbox8 positive cells in the intestine undergo cell-fate 
conversion into other XlHbox8 expressing endodermal tissues as stomach or duodenum. 
The later idea was supported by the fact, that posterior regions obtained upon HNF1β ac-
tivation, did not result in additional pancreatic territories based on the exocrine tissue 
marker XPDIp (figure 3.1.8). 
Otherwise, lack of extra pancreatic lobes in XlHbox8 overexpressing embryos was reason-
able according to reports in chicken, showing that ectopic activation of Pdx1 in chicken 
endodermal explants. PDX1 induced multiple pancreatic protrusions in the posterior gut 
endoderm however Pdx1 was not sufficient to drive pancreatic organ growth and differen-
tiation of pancreatic cell lineages (Grapin-Botton et al., 2001). Absence of pancreatic tissue 
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would be in agreement with a recent study in Xenopus laevis, showing a combined expres-
sion of XlHbox8 and Xp48 was necessary to direct pancreatic cell fate in the endoderm 
(Afelik et al., 2006). In addition, two reasons argued additionally for a pancreas specific        
XlHbox8 expansion in the dorsal and ventral endoderm: (1) dorsal XlHbox8 expansion 
occured in a small remarkable rim along the dorsal midline (figure 3.1.8), and (2) the XlH-
box8 expansion in the ventral region was spatially restricted to the most ventro-posterior 
domain resembling an interrupted extension from the endogenous ventral domain.      
As induction of ventro- posterior ectopic XlHbox8 expression was associated with a reduc-
tion of ventro- anterior XlHbox8 expression, it was suggested that HNF1β might have an 
additional function in A-P patterning of the gut tube (figure 3.1.8). Interestingly, a similar     
ventro- posterior expansion of XlHbox8 was observed in a recent study elucidating the role 
of Wnt- signaling in anterior endoderm patterning (McLin et al., 2007). In this study, in-
hibition of Wnt-signaling was required to permit posterior cell fate conversion of posterior 
intestine into XlHbox8 positive pancreatic endoderm, providing evidence for a regulatory 
mechanism between HNF1β and Wnt- signalling. 
While ectopic expression of HNF1β in the endoderm caused an expansion of pancreatic 
progenitor gene XlHbox8 it did not obviously affect expression of the second pancreatic 
progenitor marker Xp48 (figure 3.1.8). The occurancy that Xp48 expression domain was 
only slightly reduced upon HNF1β depletion and not remarkably affected upon ectopic 
HNF1β expression favors the idea of a differential regulation of Xp48 by another upstream 
regulator within the pre-pancreatic epithelium.
First promotor analysis in mouse revealed a contradictive HNF1β binding site in the Xp48 
promotor (Haumaitre et al., 2005) supporting the idea that HNF1β directly reguated Xp48 
activation in mouse. So far, preliminary promotor analysis of the Xenopus tropicalis Xp48 
promotor though did not reveal HNF1β target sequences (Lennart Opitz, personal commu-
nication) favoring the idea of an alternate transcriptional activator, for instance HNF6. 
Interestingly, ectopic activation of HNF1β within the endoderm pertubed pancreas de-
velopment. This effect was evident in the diminuished ventral and dorsal pancreatic lobes 
(figure 3.1.8). In general, size reduction can occur due to apoptosis, impaired specification, 
inhibited proliferation, induced differentiation or cell fate conversion. 
Although no experimental prove was obtained, size reduction due to apoptosis was rather 
unlikely based on observations in HNF1β-deficient mice, which did not reveal an increase 
in apoptotic cells within the foregut domain (Haumaitre et a., 2005). Decrease in pan-
creatic size could result in pertubed differentiation into pancreatic progenitor cells by a            
delayed cell cycle exit of proliferating foregut. Ungoing epithelial cell proliferation would 
reason the increase in endodermal cell mass and would explain impaired differentiation 
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processes and would explain the enlargement of the ventro-anterior endoderm that was 
observed in the mild phenotype of HNF1β overexpressing embryos (figure 3.1.6). Inhibited  
cell cycle exit and pertubed pancreas organogenesis were observed for ectopic activation 
of Notch-signalling in the proliferating pancreatic epithelium in mouse (Hald et al., 2003; 
Murtaugh et al., 2003). By overactivation of Notch- signaling, it was shown that pancreatic 
precursor cells maintained their proliferative stage and repressed differentiation leads to 
size reduced pancreas formation. In agreement, depletion of HNF1β, which showed a con-    
fined expression to the foregut epithelium, revealed impaired endoderm outgrowth and 
expansion that was evident by a decrease in proliferating cells (Lokmane et al., 2008). In 
this study, impaired specification of pancreatic precursor cells was excluded as XlHbox8 
expression was strongly increased. 
In addition, Pdx1/XlHbox8 was shown to act antiproliferative in gastric cancers and was           
reported as a negative regulator of the expression of the mitotic gene C-Myc (Ma et al., 
2008; Chen et al., 2007). Therefore, it is rather possible that high levels of Pdx1/XlHbox8 
in the gut, as obtained in this study upon HNF1β activation, promote cell-cycle exit and            
impaired proper proliferation and outgrowth of the branching pancreatic epithelium. This 
hypothesis is supportet by observations that loss of C-Myc expression in the pancreatic 
epithelium leads to reduced proliferation of epithelial and acinar precursor cells. Advanced  
cell-cycle exit comes along with an increase in endocrine cell differentiation (Nakhai et al.,   
2008; Zhou et al., 2007). Similar, endocrine differentiation was observed upon inhibition 
of Notch signaling (Jensen et al., 2000). 
In Xenopus laevis endocrine cells are exclusively specified in the dorsal pancreatic anlage at 
stage 32. Size reduction of the dorsal pancreatic rudiment could therefore result from ex-
tensive endocrine cell differentiation. This idea was supported by an increase in XlHbox8 
expression that came along with an increased number of insulin positive cells expressed 
in the dorsal gut epithelium which were posteriorly mislocalised and appeared in distant 
caudal regions of the gut endoderm. However, it was contradictive to previous results that 
never described an obvious alteration in this early endocrine gene expression upon ectopic 
expression of Xp48 or XlHbox8 (Afelik et al., 2006). 
As HNF1β is known to be involved in anterior-posterior patterning in the ecto-and meso-
derm it could also be that it played a similar role in A- P axis formation in the endoderm. 
By the time of gut tube patterning at stage 20-22, HNF1β is expressed in an anterior-pos-
terior gradient and was later also confined to the liver diverticulum. Studies in mouse rev-
elead that HNF1β was required for liver and bile duct specification (Lokmane et al., 2008; 
Coffinier et al., 2002). In Xenopus laevis, the liver diverticulum lays anterior and adjacent 
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to the ventral pancreas. Therefore, it could be that induced activation of HNF1β caused 
cell fate conversion of ventral pancreatic cells into hepatocytes in the foregut endoderm or 
shifting the position of the ventral pancreas towards the posterior gut endoderm.
Differences in XlHbox8 gene activation in the ventral and dorsal gut epithelium also sup-
ported the idea of a differing regulatory system that might be responsible for segregation 
of ventral pancreas and the adjacent liver (Deutsch et al., 2001). However, this aspect de-
mands further analysis using hepatic and posterior endodermal marker genes. In sum-
mary it was concluded that HNF1β is required but not suffcient onto induce pancreatic 
formation within the endoderm. 
4.2 The requirement of HNF1β for endocrine cell differentiation
In mouse, the majority of endocrine cells derive from the branching pancreatic epithelium 
at E13 in a process of massive endocrine cell differentiation named secondary transition. 
This step in pancreatic development is definded by the onset of expression of the pro-endo-
crine gene Ngn3. Ngn3 positive cells subsequently differentiate into all endocrine cell types 
of the mature pancreas. However, few glucagon and insulin positive cells are spotted in the 
early intestinal gut epithelium during primary transition and appeared in the pancreatic 
epithelium prior the onset of the endocrine precursor gene Ngn3 (Gradwohl et al., 2000). 
Their real origin remained obscure. 
In Xenopus laevis the pro-endocrine gene Ngn3 has not been described so far. Hence, the 
insulin is the earliest endocrine differentiation marker that is expressed exclusively within 
the dorsal pancreatic anlage from stage 32 onwards (Kelly and Melton, 2000). It was sug-
gested that these early endocrine cells correspond to the endocrine cells of the primary 
transition in mouse. It remains obscure how differentiation of these early endocrine cells 
is regulated. In a later differentiation wave at stage 45 a second group of insulin producing 
endocrine cells differentiates in the pancreatic epithelium. These cell were demonstrated to 
depend on XlHbox8 and Xp48 expression in the organ specification process (Afelik et al., 
2006). As reported, ectopic activation of either XlHbox8 or Xp48 alone, or in combination,              
did not result in any obvious increase of early insulin expressing cells. Inhibition of both   
keyregulators by antisense morpholino knockdown did not affect cell number of early in-
sulin positive cells. But they remained clustered in the dorso- anterior endoderm due to 
gut coiling defects. However, late endocrine cell differentiation was pertubed (Afelik et al., 
2006). As late endocrine differentiation was impaired it was postulated that early and later 
endocrine cell specification is differentially regulated, with the early differentiation beeing 
independent of both pancreatic progenitor markers. Similar observations in mouse and 
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zebrafish indicated that early endocrine gene activation was independent from Pdx1/Xl-
Hbox8 and Ptf1a/p48 whereas late endocrine differentiation was pertubed (Burlison et al., 
2008, Lin et al., 2004). 
Is HNF1β necessary and sufficient for endocrine cell differentiation?
In this study, Hnf1β depletion caused a significant reduction of early insulin positive cells 
(figure 3.1.5) that was associated with a decrease in Xhlbox8 and Xp48 expression in the 
dorsal pancreas. It was not analysed whether late hypoplastic pancreas of HNF1β depleted 
embryos was also devoid of late endocrine cells. 
Recent studies from mouse and Xenopus laevis support the idea that early endocrine cell 
differentiation is independent of Pdx1/XlHbox8 and Xp48 (Afelki et al., 2006; Burlison et 
al., 2008). In Xenopus laevis, XlHbox8 and Xp48 depleted embryos revealed impaired gut 
coiling and in addition cluster formation of insulin positive cells in the anterior foregut 
but apparently revealed no alteration in the number of insulin positive cells (Afelik et al., 
2006). Here, HNF1β depletion upon morpholino injection also induced gut coiling defects 
(not shown) that could explain the reduced range of insulin positive region in the gut epi-
thelium. However, quantification of insulin positive cells not only demonstrated a reduced 
size of expansion but a significant reduction in cell number. The reverse complement phe-
notype obtained upon ectopic activation of HNF1β argues for a real decrease in insulin 
transcription. 
In an attempt to further quantify putative changes in insulin expression between control 
and HNF1β morpholino injected embryos, insulin transcription levels were determined 
using semiquantitative RT-PCR on RNA from whole embryo endoderm (not shown). In 
this one time experiment though levels of insulin transcription were not apparently altered 
as expected from the finding by WMISH. Hence, further quantification of insulin repres-
sion using realtime PCR is strongly recommended to confirm the idea of HNF1β inducing 
insulin gene activation and to determine to which extend the level of insulin transcription 
is affected upon HNF1β downregulation. 
In the reverse complement study, ectopic activation of HNF1β within the endoderm caused 
a strong increase in insulin positive cells suggesting that HNF1β was sufficient to activate 
insulin expression within the dorsal endoderm (figure 3.1.9). One possibility would be that 
HNF1β activates insulin directly on the promotor. But HNF1β was only weakly expressed 
in the dorsal endoderm at the time point of early endocrine differentiation peaks. Thereby 
rising the question of an intermediate regulator. Ectopic HNF1β function in the posterior      
region caused an posterior induction of XlHbox8. Interestingly, the XlHbox8 positive ter-
ritory was confined along the midline. This extending dorsal pancreatic XlHbox8 positive 
epithelium overlapped with the region of insulin positive cells that were also mislocated to 
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more posterior regions of the endoderm. As mentioned, Pdx1 originally reported as Insu-    
lin promoting factor 1 (Ipf1) in mouse, directly activates insulin expression and is required 
for β-cell generation (Jonsson et al., 1995; Watada et al., 1996; Gannon et al., 2008). Hence, 
posterior increase in XlHbox8 and insulin expression suggests that also in Xenopus laevis 
insulin expression is regulated by the transcription factor XlHbox8. 
In HNF1β -/- mice, reduced Pdx1/XlHbox8 expression inhibited pancreatic branching and 
outgrowth and also impaired endocrine cell differentiation (Haumaitre et al., 2005). Also 
studies in zebrafish report that Pdx1/XlHbox8 repression pertubed pancreas specification 
and endocrine differentiation (Song et al., 2006) that was also seen in human MOD�5 pa-
tients (Wang et al., 2004). Hence, the other possibility for induction of early insulin tran-
scription in Xenopus laevis proposes that it is not HNF1β that directly activated insulin 
gene expression but rather XlHbox8 as HNF1β downstream mediator. 
Contradicting previous reports of unaffected early insulin expression upon XlHbox8 mor-
pholino injection (Afelik et al., 2006), first data obtained in this study upon XlHbox8 mor-
pholino injection (data not shown) favor the idea that XlHbox8 is required for this early 
insulin expression in the dorsal epithelium. As dorsal XlHbox8 expression was driven by 
HNF1β, this transcription factor cross talk could provide a regulatory mechanisms explan-
ing early induction of insulin expression exclusively in the dorsal gut epithelium. It would 
also represent a conserved regulatory way for endocrine cell differentiation in vertebrates. 
However, it still remains obscure which regulatory mechanism promotes insulin expres-
sion in selected cells scattered in the Xhbox8 positive epithelium. Further experiments are 
required to finally determine the origin of early insulin positive cells in Xenopus.
In summary the results obtained describe two distinct functions for the transcription fac-
tor HNF1β in context of pancreas development: (1) an early role in pancreas specification 
within the gut epithelium by controling XlHbox8 gene expression and (2) a later role in 
endocrine cell differentiation by promoting insulin gene expression in the dorsal gut en-
doderm. The fact that HNF1β is only weakly expressed in the dorsal pancreas at stage 34 
and gets reduced by the time where insulin differentiation peaks (stage 36), favors the idea 
that it acts indirectly on insulin gene induction. One candidate that could mediate HNF1β 
activity in the dorsal pancreatic epithelium is XlHbox8. Following suggestions from ze-
brafish (Song et al., 2006), it can be speculated that HNF1β activates XlHbox8 expression 
in the dorsal pancreatic endoderm which- maybe via Ngn3-, directs endocrine cell differ-
entiation. In addition HNF1β appears to play a role in localising the ventral pancreas along 
the anterior-posterior axis of the gut tube.
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4.3 HNF1β is a mediator for RA-signalling in the endoderm
The posterior expansion of XlHbox8 in the dorsal endoderm and the increase of insulin 
positive cells that was induced upon pan-endodermal activation of HNF1β resembled the 
result observed upon activation of RA- signaling (Chen et al., 2004). It was demonstrated   
that RA caused a caudal extension of the XlHbox8 positive expression domain and pro-
moted insulin expression on the expense of exocrine tissue in the dorsal endoderm (Chen 
et al., 2004). In addition early RA promoted ventral exocrine tissue and also HNF1β pro-
moted ventro-posterior expansion of the XlHbox8 domain.
Nevertheless, some discrepancies between ectopic HNF1β activity and increased RA si-         
gnalling were observed. Head structures in RA treated embryos were nearly abolished,       
while they were only reduced in HNF1β depleted embryos. In contrast to posterior Xl-    
Hbox8 extension upon HNF1β overexpression, exogenous RA treatment also lead to an 
anterior reposition of insulin positive cells. This indicated that not only HNF1β is required 
but other signalling mechanism control correct A-P position of differentiating cells along 
the gut tube (table 4). 
HNF1β expression was initiated after MBT in the vegetal hemisphere of the blastula stage 
embryo that gives rise to the endodermal germlayer (Vignali et al., 2000). By the onset of 
gastrulation the RA synthesizing enzyme RALDH2 is expressed in the involuting meso-
derm, adjacent to the endogenous HNF1β expression domain (figure 1.5). Earlier studies 
in Xenopus laevis (Demartis et al., 1994) and zebrafish (Song et al., 2006) indicated that 
HNF1β was a RA responsive gene within the endoderm. Hence it was hypothesised that     
HNF1β could link early RA induced prepatterning steps in the dorsal endoderm in order 
to promote pancreas developement, in particular endocrine cell differentiation (Stafford 
et al., 2004; Chen et al., 2004). However it remained unclear when HNF1β expression was        
activated by RA and how it could mediate induction of pancreas development. So it was 
intriguing to investigate the role of RA to promote HNF1β gene activation. Therefore RA-  
signalling was activated in blastula stage embryos upon RA treatment and inhibited using 
the RAR antagonist BMS453 (Chen et al., 2004).
Expression analysis of HNF1β in RA treated embryos revealed slight induction within the 
endoderm at early stages while BMS453 treatment revealed no effect compared to cont-
rol. During subsequent development it was evident that endodermal expression level of 
HNF1β was elevated whereas BMS453 treatment rather repressed HNF1β transcription (fi-
gure 3.1.11). In particular, expression by the stage of pancreatic budding (stage 34), HNF1β 
expression was strongly increased in the dorsal pancreatic region. It was an established    
idea that RA is required for specification of the dorsal but not the ventral pancreas. This 
was conserved between vertebrates (Stafford and Prince 2002, Chen et al., 2004, Martin 
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et al., 2005). The increased HNF1β expression at stage 34 showed that the RA effect was             
persistent through time and not a transient event. This result favored the idea of a putative 
role of HNF1β as RA mediator for dorsal pancreas specification. 
In order to analyze direct activation of endodermal HNF1β expression, RA and BMS453 
treatments were done on whole endodermal explants and analysed by semquantitative RT-
PCR. HNF1β gene activation was altered upon exogenous application of RA and downre-
gulated upon BMS453 treatment. This data provided evidence that endodermal HNF1β 
expression was responsive to direct RA- signalling.   
A recent study reported that dorsal and ventral endoderm was differentially responsive 
to RA- signalling (Pan et al., 2007). As early HNF1β expression was in particular seen in 
the dorsal involuting endoderm, representing the prospective pancreatic tissue, it was of 
further interest to reveal whether HNF1β expression in the dorsal versus the ventral en-
doderm differed in responsivity to RA (figure 3.1.12). Therefore whole endoderm explants 
were dissected and treated with RA or BMS453. HNF1β was slightly elevated in dorsal 
and ventral endoderm explants and its expression was remarkably reduced in dorsal and 
ventral explants upon BMS453 treatment. These findings indicate that HNF1β expression  
is regulated by RA within the endoderm. But HNF1β was not obviously differentially re-
sponsive to RA signalling in the dorsal versus the ventral endoderm. However, this data 
remained to be confirm by quantitative RT-PCR.    
The morphogen RA is synthesised by RALDH2 in the adjacent dorsal involuting mesoderm 
and secreted into the neighbouring endoderm. Assuming the formation of a dorso-ven-
tral morphogen gradient, it can be speculated that under phyisological conditions, dorsal 
HNF1β expression is stronger influenced by RA than ventral HNF1β expression and that 
this expression difference determines the role of HNF1β during organ specification. Exog-
Table 4 Comparison of RA and HNF1β induced effects on pancreas development. First ��olumn in�i��ate� 
mananipulation of the embryos. The next ��olums in�i��ate expression levels of �lHbox� in the �orsal or 
ventral en�o�erm, level of en�o��rine ��ell �ifferentiation �en�o�, size of �orsal exo��rine ��ompartment �exo�, 
an� ��uut ��oilin�� effe��t. �+� elevate�, �-� re�u��e�, �++� e��topi��, �u��� un��han��e�. 
treatment dorsal 
XlHbox8
insulin exocrine �entral 
XlHbox8
gut coiling
defect
p48
RA + + - + + +
HNF1β + + - ++ + uc
BMS453 - - - uc + -
HNF1β-Mo1+2 - - - - + -
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enous RA or BMS453 treatment lacked this differential gradient formation and therefore 
might activate or inhibit ventral HNF1β expression to the same extend than in the dorsal 
explant tissue. As consequence, this resulted in a comparable HNF1β gene activation or 
inhibition in dorsal and ventral explants. 
Taken together, the results of this study support the idea that HNF1β is responsive to early 
RA signalling within the endoderm to direct dorsal pancreas development and endocrine 
cell differentiation, whereas it palys a distinct role in ventral pancreas specification. Hence, 
it would be of interest to investigate the effect on dorsal or ventral HNF1β expression upon 
region specific manipulation of RA- signalling. 
A previous study in zebrafish was investigating the role of RA in directly acting on the               
endoderm to induce β-cell fate (Stafford et al., 2006) and it was shown that RA was not able 
to rescue insulin expression in the absence of vHNF1, the zebrafish homologue, whereas 
vHNF1 overexpression restored insulin expression when RA- signalling was inhibited 
(Song et al., 2006). A recent study suggested a role of RALDH1 within the pancreas to pro-
mote endocrine cell differentiation (Öström et al., 2008). Data obtained in this study, as the 
RA-induced dorsal expression of HNF1β at stage 34, the HNF1β induced posterior expan-
sion of XlHbox8 and the increase in insulin positive cells, together with previous findings, 
provided strong evidence that HNF1β acts as RA downstream target mediating instructive 
signals for dorsal pancreas formation and endocrine cell differentiation. 
Apart from RA, many other signalling pathways were related to pancreas formation as 
the secreted factors SHH, BMPs and FGF (Hebrok et al., 1998; Kim et al., 2001; Hart et al., 
2000). In the study by Chen et al., it was reported that RA induced expansion of XlHbox8 
expression within the dorsal endoderm was associated with a decreased expression of SHH. 
As shown in chick repression of SHH was crucial to permit Pdx1/ XlHbox8 expression in 
the pancreatic epithelium (Hebrok et al., 1998). Otherwise inhibition of RA caused an ex-
pansion of the SHH expression domain in the endoderm. Antagonising action of SHH and 
RA was also demonstrated in chicken limb bud and zebrafish fin formation (Helm et al., 
1994; Niswanderer et al.,1994). In zebrafish, endoderm formation and patterning relied on 
BMP signalling (Tiso et al., 2002). In the same study it was demonstrated that vHNF1 was 
dependent on early active BMP signaling and it was responsible to mediate BMP depend-
ent endocrine cell differentiation in zebrafish. 
Conversely, in Xenopus laevis it was shown that BMP- and also Wnt- signalling must be           
repressed in the early dorsal endoderm in order to make the future anterior endoderm 
competent to acquire pancreatic cell fate (Pan et al., 2007; McLin et al., 2007; Spagnoli et al.,           
128
Discussion
2008). In addition, it was shown that RA- and BMP- signalling interacted with each other.               
Therefore it would be intriguing to analyses changes in early HNF1β expression within the 
dorsal endoderm in response to modulated BMP- and Wnt- signalling. 
4.4 Ectopic acti�ation of XHNF6 promotes pancreas de�elopment
In HNF1β loss and gain of function experiments it appeared that the expression of the 
second pancreatic key regulator Xp48 was less sever affected than XlHbox8 (figure 3.2.4, 
figure 3.2.8). Therefore it was postulated that Xp48 might be differentially regulated in the 
gut endoderm. From knockout studies in mouse it was postulated that the onecut trans-
cription factor HNF6 might function as upstream regulator for Pdx1/ XlHbox8 and Ptf1/ 
Xp48. In this context we isolated the Xenopus laevis homologue XHNF6 and characterised 
its expression pattern by WMISH and semiquantitative RT-PCR and compared it to its 
potential downstream targets Xp48 and XlHbox8. In order to be an upstream regulator 
spatial and temporal overlapping expression patterns were required. Regarding endoderm 
patterning and pancreas development, it was very interesting to detect XHNF6 transcripti-
on by the onset of gut tube patterning stage 22 in a small territory of the ventral foregut (fi-
gure 3.2.1). Expression increased and was spatially restricted to the liver and presumptive 
ventral and dorsal pancreastic anlage by stage 34. Hence, HNF6 was expressed in the ante-
rior endoderm before the initiation of Xp48 and XlHbox8. Spatial restriction of XHNF6 to 
the liver diverticulum was very similar to the anterior endodermal expression domain of 
HNF1β, living up for their names as liver enriched transcription factors. With the begin-
ning of pancreatic budding at stage 34, XHNF6 was clearly detectable in the ventral pan-
creatic region, whereas the dorsal pancreatic expression was onyl detectable by RT-PCR. 
HNF6 expression in mouse (Landry et al., 1997) as well as in zebrafish (Hong et al., 2002) 
demonstrated early onset of expression in the developing nervous system and in the endo-
derm derivatives as liver and pancreas. In the pancreas it was described in early progenitor 
cells, later becoming restricted to the pancreatic acinar and ductual cells (Pierreux et al., 
2006). In the adult Xenopus tissue, XHNF6 transcripts were identified in the liver, brain 
and pancreas while in mouse transcripts were in addition found in the testis and spleen 
(Lemaigre et al., 1996). In accordance with its early endodermal expression, gene knockout 
studies in mice have shown that HNF6 played an important role in liver and biliary duct 
formation (Clotman et al., 2005), as well as in pancreas organogenesis (Poll et al., 2006).              
During pancreas formation it was in particular described as direct regulator of Pdx1 and 
Ngn3 expression (Maestro et al., 2003). 
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In an attempt to characterise the function of XHNF6 during pancreas development the 
protein was panendodermal expressed by HNF6 capRNA injection. HNF6 overexpression 
caused an enlargement of the pancreatic territory as it was depicted upon Xp48 expression. 
In addition, at later stage 43 the pancreatic lobe was not only increase but additionally ex-
panded into an anterior region. Extended trypsin positive domain resembled the enlarge-
ment of the pancreatic domain that was observed upon ectopic activation of Xp48 (Afelik 
et al., 2006). As cleary evident in that study, p48 induced enlargement of the pancreas was 
restricted to the endogenous XlHbox8 positive region within stomach and duodenum, pro-
ving that a combined activation of XlHbox8 and p48 is required for pancreas specification 
in the gut tube. Assuming that HNF6 is an usptream regulator of Xp48, its ectopic activa-
tion would cause a comparible cell fate conversion of stomach into pancreas. As seen in the 
Xp48 expression of an HNF6 induced stage 39 embryo, it appeared that in particular the 
ventral Xp48 expression domain was extended. As the pancreatic lobes are fused at stage 
43, it is diffult to judge about the origine of the ectopic tissue, although from the position 
of the extending tissue it also appeared to derive from the ventral pancreatic lobe. 
So far HNF6 would be the first identified transcription factor that is required selectively 
for the specification of the ventral pancreas. In addition it would be the first upstream 
regulator of Xp48 described in Xenopus. However, these overexpression data are still very 
preliminary and further gain- and loss of function experiments have to be performed to 
confirm and specify HNF6 function during pancreas development in Xenopus laevis. 
4.5 Malectin, a no�el ER resident protein in Xenopus laevis 
The descriptive analysis of developmental defects during embryogenesis depends on a sui-
table set of genetic markers. One criteria for a suitable marker is a spatial and temporal 
defined expression in order to distinguish specific cell subgroups from the surrounding 
tissue. 
Many tissue specific markers were already identified in context of pancreas organogensis 
(Chen et al., 2003; Afelik et al., 2004; Zorn and Mason, 2001) but the increase in detai-
led knowledge about cell specification and differentiation processes demands for new and 
more specific genetic markers. 
In an attempt to identify new pancreas specific marker genes a cDNA library screen was 
performed of an adult pancreas cDNA library from Xenopus laevis using the WMISH tech-
nique (Afelik et al., 2004). Among others, the clone named “p150” showed pancreatic ex-
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pression and in addition a highly conserved amino acid sequence in vertebrates. Together 
these findings rised the interest to further exploit embryonic expression of p150 and to 
determine its potential function during pancreas organogenesis. By the time of first ex-
perimental investigation p150 was an unknown gene product- a white spot on the protein 
map. Hence p150 characterisation was approached in two ways: (1) by characterisation of 
its biochemical properties and (2) by analysing its expression and function during pan-
creas development. The first aspect was intensively investigated by the group of Claudia           
Muhle- Goll (EMBL, Heidelberg) that collaborated by solving p150 protein structure and 
renaming it “malectin”, according to its strong binding to the dissacharide maltose (Schal-
lus et al., 2008). The second aspect concerned the functional relevance of malectin during 
pancreas development. In this context, pancreatic expression of malectin was completed 
by generation of a detailed expression profile during Xenopus laevis organogenesis (figure 
3.3.2 ). Against expectations of an pancreas specific gene activation, the detailed expression 
analysis revealed a constant and ubiquitous presence of malectin in the embryo. Although 
it was expressed in different germ layer derivatives, it was still noteworthy that malectin 
was expressed especially in secreting tissues as the hatching gland, liver and pancreas. As 
described in Medaka (�amamoto T, 1975) the hatching gland is a endodermal derived 
organ that synthesises an enzyme called chorionase. Chorionase is required to digest the 
vitellin membrane during hatching phase, releasing the embryo into the medium. Also the 
pancreas is an endodermal derived organ that is highly active in secretion by synthesising 
digestive enzymes and educing them into the gastrointestinal tract.
Broad malectin expression was persistent in adult tissues (figure 3.3.2; tissue nothern blot: 
http://www.kazusa.or.jp/huge/gfimage/northern/html/KIAA0152.html). This broad ex-
pression pattern implied an early general role during embryogenesis rather than a later 
specific function during pancreas organogenesis. On the background, that the major sig-
nalling pathways during embryogenesis often play different roles depending on time and 
location of their activation, and concerning that most of these signalling pathways are re-
markably conserved troughout animal kingdom, it was still intriguing to exploit malectins 
role during Xenopus laevis embryogenesis. In this respect, malectin also showed a remark-
able high conservation among vertebrate, as also seen for the major signalling molecules. 
Two systems were used in order to specify the intracellular localisation of malectin: de-
tection of a flag- tagged malectin protein in animal cap explants and detection of overex-
pressed flag-tagged malectin protein in transient transfected eukaryotic cells (figure 3.3.4). 
Here, malectin protein was detected in small, partially elongated aggregates where it ac-
cumulated upon time. After 48 hr, malectin positive region was encompasing a large terri-
tory. This could be due to membrane clustering that might be induced by the high protein 
content in transfected cells that does not represent regular physiological conditions. The 
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time course experiment spanning 48 hr did not show malectin translocation to the cell 
surface but it rather stayed in a perinuclear region, resembling the position of the trans-
golgi network (Simpson et al., 2006). Although a detailed analysis by codetection of differ-
ent organ specific proteins was not performed, the shape of the tubular system and partial 
malectin colocalisation with the ER resident protein Hsp47 (Tasab et al., 2000) provided 
strong evidence for a ER localisation of malectin (Schallus et al., 2008). 
The expression profile of malectin indicated an early and broad distribution of malectin 
protein during embryogenesis. It was therefore suggested that malectin palyed a more ge-
neral rather than a specific regulatory role during embryogenesis that would concern in 
context of this study the formation of the pancreas. At late tadpole stages malectin tran-
sciption was spatially restricted to the pancreatic lobes (figure 3.4.2) and the adjacent liver 
whereas surrounding tissues as stomach and duodenum as well as intestine were devoid of 
malectin transcripts. In respect to the underlying idea of this study, it was still interesting 
to know whether malectin might affect organ formation. 
Functional characterisation of malectin protein was approached by loss and gain of func-
tion assays targeting the endoderm. For loss of function, malectin protein translation was 
downregulated in the whole embryo by morphlino injection. For the gain of function ap-
proach malectin protein was ectopically expressed in the whole endoderm. To target the   
later prospective endoderm morpholino was injected into the vegetal pole of the embryo 
thereby causing protein depletion by the onset of expression in the pancreas and liver. 
From the temporal expression profile that determined on RNA and protein level, it was 
known that malectin was already present in the embryo by the timepoint of injection. 
Together with its ubiquitous transcript distribution it was suggested that malectin excerts 
a general role during embryonic development. In both cases misexpression of malectin       
induced strong endodermal malformation associated with embryonic malformations and 
reduction in organ specific marker gene expression (figure 3.3.7). Although it appeared 
that malectin interferred with organ formation, these experiments did not further clarify 
how or when malectin was repsonsible to induce pleiotrophic phenotype. As malectin was   
ubiquitously expressed in space and time it was most likely that malectin played a second-
ary role and interferred with late organogenesis by inhibitory events in proliferation or by 
inducing apoptosis or necrosis of the malectin expressing tissue. 
This hypothesis additionally supported by the fact, that structural and biochemical analy-
sis of malectin proposed that the ER resident protein was involved in the N-glycosyla-
tionpathway (Schallus et al., 2008). NMR analysis revealed a novel lectin-like domain that 
specifically interacted with glucose-polymers. In the cell, the only glucose polymers exist 
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in the ER, namely nigerose and kojibiose. These two di-glucose residues are the substrate of 
the two ER resident enzymes glucosidase I and glucosidase II which are responsible for the 
synthesis of the glucose-precursor molecule (Essentials in Glycobiology, 1999). 
A role in regulation of N-glycosylation of secreted proteins links malectin to signalling 
molecules (BMP-1; Garrigue-Antar et al., 2002) and cell surface receptors. Signalling mo-
lecules are essential for germ layer formation, among them BMP4 that regulates endoderm 
and induces mesoderm and is as consequence essential for axis formation (anterior-poste-
rior axis (AP) and dorso-ventral axis (DV)). BMP4, a member of the transforming growth 
factor β (TGF β) -superfamily, is synthesised as large precursor protein that undergoes 
proteolytic maturation and N-gylcosylation along the secretory pathway. 
Assuming that malectin indeed maintains a regulative role in the N-glycosylation pathway 
and it is expressed from early stage onwards, its misexpression in the early embryo, either 
by overexpression or inhibition, should affect early embryogenesis already during germla-
yer formation. However, inhibition of protein translation by antisense morpholino injec-
tion might be silenced as the protein is already present in the unfertilized embryo. During 
later organogenesis, malectin morpholino might be effective as it targets regions of high 
transcription. 
Recently a similar function for glycosylation mechanism that regulate TGF-β signalling 
during embryogenesis was identified in the regulation for the O-glycosylation pathway 
(Herr et al., 2008). This study revealed an important role of a N-acetylgalactosaminyl-
transferase in the regulation of TGF-beta signalling. This novel regulatory mechanism is 
evolutionarily conserved and, thus, might provide a new paradigm for the regulation of 
TGF-beta signalling in vertebrates. In this regard, future investigations are intriguing to 
elucidate the role of malectin for signalling pathway regulation. 
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5 Abbreviations 
(v/v) percent per volume
(w/v) percent per weight
µL mikroliter
α anti
amp ampicillin
AP alkali phosphatase
APB alkaline phosphate buffer
APS ammoniumpersulfate 
dH2O bidestilled water
aa amino acid
bp basepair
BCIP 5-bromo-4-chloro-3-indolyl-
phosphate
BMB Boehringer Mannheim Block
BMS453 bristol meyers squib
BSA bovine serum albumine
°C degree celcius
cDNA complementary DNA
CHAPS 3-[(3-Cholamidopropyl) dime-
thylammonio-]1-propansulphate
DBD DNA binding domain
DEPC diethylpyrocarbonate
DIG-UTP digoxigenin 11-2´deoxyuridin-5´ -
triphosphate
DMSO Dimethylsulfoxid
DNA desoxiribonucleicacid
DTT 1,4-Dithiotreitol
dNTP desoxyribonucleotides
E. coli Escherichia Coli
EDTA Ethylen-diamin-tetra acetat
EGTA Ethylen-glycol-bis-tetra acetat
est expressed sequence tag
ER Endoplasmic reticulum
et al., et alter
EtBr ethidium bromid
EtOH ethanol
FCS fetal calv serum
g gramm
Gal galactosidase
GOF gain of function
bHLH basic helix-loop-helix
hr hour
HEPES 4-(2-Hydroxyethyl)-1-piperazin
kb kilobasepair
kD Kilodaltona
IPTG Isopropylthiogalactosid
incl. including
l litre
LB Luria broth base Medium
LOF loss of function
lacZ β-galactosidase gene
M Molar
mA Milliampere
MAB maleic acid buffer
max. maximal
MEM MOPS-EGTA-MgSO4 buffer
MEMFA  + 1% formaldehyde
MetOH methanol
mg milligramm
min minute
ml milliliter
mM millimolar
µg micro gram
µl microliter
MOD� maturity onset diabetes of the 
young
MOPS 4- Morpholinopropansulfonic acid
mRNA messenger ribonucleic acidsäure
MuLV murine leukemia Virus 
nm nanometer
OD optical density
oN over night
ORF open reading frame
PAGE polyacrylamid gelelectrophoreses
PBS phosphate buffered saline
PCR polymerase chain reaction
pH prepondirance of hydrogen ions
PMSF phenylmethylsulfonylfluorid
PP pancreatic polypeptide
PTU N-phenylthiourea
RA retinoic acid
rpm rounds per minute
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RT-PCR reverse transcription polymera-
se chain reaction
RT room temperature
s second
SDS sodiumdodecylsulfat
SSC sodiumchlorid/ sodiumcitrate 
Taq Thermus aquaticus
TAE Tris acetat EDTA
UV ultraviolet light
V Volt
W Watt
× g
X- gal 5-Bromo-4-chloro-3-indolyl-
D-galactopyranosid
∞ forever
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Appendix
7.1 Effect on XlHbox8 expression upon ectopic acti�ation of HNF1β
Figure 7.1 Effect on XlHbox8 expression upon ectopic activation of HNF1β. Embryos were inje��te� with 
100 p����E HNF1β- �R ��apRNA an� ��ulture� till sta��e 3��. HNF1β-�R was a��tivate� by �ex treatment at sta��e 
13 an� ��0 �+�ex13 an� +�ex��0�. White arrow hea� points to the ventral pan��reas. Re� arrow hea� points 
to the posterior e��topi�� �lHbox� positive territories. Bra��ket sizes the �orsal �lHbox� positive expression 
�omain that is expan�e� in inje��te� embryos upon early �ex treatment. 
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7.2 Phenotypes induced upon misexpression of HNF1β
Figure 7.2 Phenotypes induced upon misexpression of HNF1β. Embryos were inje��te� with 100 p����E 
HNF1β- �R, HNF1β-VP16�R an� HNF1β- En���R. HNF1β was a��tivate� by �ex treatement at sta��e 10.5. 
Embryos were ��rown till sta��e 3�� an� analyse� for ��han��es in expression of �lHbox�. Embryos are shown 
in lateral view with hea� to the left. n= in�i��ates the total number of embryos. Numbers in bra��ktes show 
the per��enta��e that is in��rease� or �e��rease�, ��ompare� to ��ontrol. White arrow points to the lo��ation of 
the ventral pan��reas, re� arrow points to the ventro- posterior e��topi�� expression of �lHbox�. White bra-
��ket in�i��ates the size of the �orsal pan��reati�� ru�iment �A- I�. Bla��k arrow point to the presumptive �orsal 
pan��reati�� re��ion �J- ��. �reen arrow hea� in�i��tate� re�u��tion of anterior hea� stru��tures.↑= in��rease; 
↓= decrease. asterisk indicates edema formation. 
The expression of �lHbox� is stron��ly influen��e� upon HNF1β misexpression. Early e��topi�� HNF1β a��tiva-
tion either upon HNF1β- �R inje��tion or HNF1β- VP16�R inje��tion ��ause� a broa� ��au�al expansion of the 
�orsal an� ventral �lHbox� expression �omain. In a��ition, �lHbox� expression appeare� e��topi��ally in 
ventroposterior territories of the embryos. Stron�� a��tivation of HNF1β is evi�ent in the untreate� ��ontrol 
embryos �-�ex� that alrea�y show �lHbox� expansion. Upon HNF1β-VP16 a��tivation, embryos not only 
show in��rease in �lHbox� expression but also show e�ema formation in the fore��ut, similar to RA treate� 
embryos at that sta��e �Chen et al., ��004�. 100% of HNF1β-En���R inje��te� embryos show �e��rease� �lH-
box� expression. 66% untreate� HNF1β-En���R inje��te� embryos alrea�y show re�u��e� pan��reati�� but 
re��ular �uo�enal stainin��. 
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7.3 Statistical �alues of affected insulin expression upon HNF1β    
 misexpression
Table 5: Statistical values of affected insulin expression upon HNF1β misexpression(A)         Effe��t on insu-
lin expression in HNF1β loss of fun��tion (B) Effe��t on insulin expression on HNF1β ��ain of fun��tion. First 
��olumn in�i��ates amount of embryos evaluate�. CE= uninje��te� ��ontrol embryos. -�ex = untreate� ��on-
trol embryos. +�ex 13-��6: �examethason treate� embryos. Co�o= ��ontrolmorpholino inje��te� embryos. 
HNF1β-�o1+��= embryos inje��te� with HNF1β spe��ifi�� morpholinos. AV= avera��e value. S�= stan�ar� �e-
viation.
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7.4 Sequence alignment of XHNF6 and eukaryotic onecut proteins
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Figure 7.3 Sequence alignment of XHNF6 and eukaryotic onecut proteins. Compare� sequen��es ��or-
respon� to or��anisms state� to the left. Sequen��e a����enssion numbers are liste� in table 3.1. I�enti��al 
resi�ues are un�erlaye� in re�. Numbers on top of ea��h lane in�i��ates number of resi�ues. Numbers to the 
ri��ht state position of amino a��i�. Lines in�i��ate resi�ue ��aps between sequen��es. Resi�ues un�erlaye� in 
rose are i�enti��al between vertebrates but �iffer from �rosophila. The CUT �omain is frame� in ��reen an� 
the H��E�B�� �omain is frame� in re�. 
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